
<html lang="en"     class="pb-page"  data-request-id="bc5d6b17-9736-448c-ab98-078242410e9d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2020.63.issue-14;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c00688"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Novel Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis: A Clinical Candidate Discovered Using DNA-Encoded Chemistry" /></meta><meta name="dc.Creator" content="John W.  Cuozzo" /></meta><meta name="dc.Creator" content="Matthew A.  Clark" /></meta><meta name="dc.Creator" content="Anthony D.  Keefe" /></meta><meta name="dc.Creator" content="Anna  Kohlmann" /></meta><meta name="dc.Creator" content="Mark  Mulvihill" /></meta><meta name="dc.Creator" content="Haihong  Ni" /></meta><meta name="dc.Creator" content="Louis M.  Renzetti" /></meta><meta name="dc.Creator" content="Daniel I.  Resnicow" /></meta><meta name="dc.Creator" content="Frank  Ruebsam" /></meta><meta name="dc.Creator" content="Eric A.  Sigel" /></meta><meta name="dc.Creator" content="Heather A.  Thomson" /></meta><meta name="dc.Creator" content="Ce  Wang" /></meta><meta name="dc.Creator" content="Zhifeng  Xie" /></meta><meta name="dc.Creator" content="Ying  Zhang" /></meta><meta name="dc.Description" content="The activity of the secreted phosphodiesterase autotaxin produces the inflammatory signaling molecule LPA and has been associated with a number of human diseases including idiopathic pulmonary fibr..." /></meta><meta name="Description" content="The activity of the secreted phosphodiesterase autotaxin produces the inflammatory signaling molecule LPA and has been associated with a number of human diseases including idiopathic pulmonary fibr..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 25, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00688" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00688" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00688" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00688" /></link>
        
    
    

<title>Novel Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis: A Clinical Candidate Discovered Using DNA-Encoded Chemistry | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00688" /></meta><meta property="og:title" content="Novel Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis: A Clinical Candidate Discovered Using DNA-Encoded Chemistry" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0016.jpeg" /></meta><meta property="og:description" content="The activity of the secreted phosphodiesterase autotaxin produces the inflammatory signaling molecule LPA and has been associated with a number of human diseases including idiopathic pulmonary fibrosis (IPF). We screened a single DNA-encoded chemical library (DECL) of 225 million compounds and identified a series of potent inhibitors. Optimization of this series led to the discovery of compound 1 (X-165), a highly potent, selective, and bioavailable small molecule. Cocrystallization of compound 1 with human autotaxin demonstrated that it has a novel binding mode occupying both the hydrophobic pocket and a channel near the autotaxin active site. Compound 1 inhibited the production of LPA in human and mouse plasma at nanomolar levels and showed efficacy in a mouse model of human lung fibrosis. After successfully completing IND-enabling studies, compound 1 was approved by the FDA for a Phase I clinical trial. These results demonstrate that DECL hits can be readily optimized into clinical candidates." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00688"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00688">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00688&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00688&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00688&amp;href=/doi/10.1021/acs.jmedchem.0c00688" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 7840-7856</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00558" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00698" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis: A Clinical Candidate Discovered Using DNA-Encoded Chemistry</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">John W. Cuozzo</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John W. Cuozzo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">X-Chem, Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</div></div><span class="conrtib-corresp"><strong>*</strong>email: <a href="/cdn-cgi/l/email-protection#e9838a9c86939386a9938c8b808880c78a8684"><span class="__cf_email__" data-cfemail="3f555c4a504545507f455a5d565e56115c5052">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+W.++Cuozzo">John W. Cuozzo</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6229-0395" title="Orcid link">http://orcid.org/0000-0002-6229-0395</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthew A. Clark</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew A. Clark</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">X-Chem, Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+A.++Clark">Matthew A. Clark</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anthony D. Keefe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anthony D. Keefe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">X-Chem, Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+D.++Keefe">Anthony D. Keefe</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anna Kohlmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anna Kohlmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">X-Chem, Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Kohlmann">Anna Kohlmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mark Mulvihill</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark Mulvihill</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">X-Rx, Inc., 430 East 29th Street, Suite 1060, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Mulvihill">Mark Mulvihill</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Haihong Ni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haihong Ni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">BioDuro, LLC, Building E, No. 29 Life Science Park Road, Changping District, Beijing 102206, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haihong++Ni">Haihong Ni</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Louis M. Renzetti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Louis M. Renzetti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">X-Rx, Inc., 430 East 29th Street, Suite 1060, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Louis+M.++Renzetti">Louis M. Renzetti</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel I. Resnicow</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel I. Resnicow</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">X-Chem, Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+I.++Resnicow">Daniel I. Resnicow</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Frank Ruebsam</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frank Ruebsam</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">BioDuro, LLC, Building E, No. 29 Life Science Park Road, Changping District, Beijing 102206, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Ruebsam">Frank Ruebsam</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eric A. Sigel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eric A. Sigel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">X-Chem, Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eric+A.++Sigel">Eric A. Sigel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Heather A. Thomson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Heather A. Thomson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">X-Chem, Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Heather+A.++Thomson">Heather A. Thomson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ce Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ce Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">BioDuro, LLC, Building E, No. 29 Life Science Park Road, Changping District, Beijing 102206, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ce++Wang">Ce Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhifeng Xie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhifeng Xie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">BioDuro, LLC, Building E, No. 29 Life Science Park Road, Changping District, Beijing 102206, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhifeng++Xie">Zhifeng Xie</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ying Zhang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ying Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">X-Chem, Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</div></div><span class="conrtib-corresp"><strong>*</strong>email: <a href="/cdn-cgi/l/email-protection#99e0e3f1f8f7fed9e1b4faf1fcf4ebe1b7faf6f4"><span class="__cf_email__" data-cfemail="4b3231232a252c0b336628232e26393365282426">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ying++Zhang">Ying Zhang</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00688&amp;href=/doi/10.1021%2Facs.jmedchem.0c00688" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 7840–7856</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 25, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 April 2020</li><li><span class="item_label"><b>Published</b> online</span>25 June 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 July 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00688" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00688</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7840%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJohn%2BW.%2BCuozzo%252C%2BMatthew%2BA.%2BClark%252C%2BAnthony%2BD.%2BKeefe%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D14%26contentID%3Dacs.jmedchem.0c00688%26title%3DNovel%2BAutotaxin%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BIdiopathic%2BPulmonary%2BFibrosis%253A%2BA%2BClinical%2BCandidate%2BDiscovered%2BUsing%2BDNA-Encoded%2BChemistry%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7856%26publicationDate%3DJuly%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00688"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2848</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00688" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis: A Clinical Candidate Discovered Using DNA-Encoded Chemistry&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;W. Cuozzo&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;A. Clark&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;D. Keefe&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Kohlmann&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Mulvihill&quot;},{&quot;first_name&quot;:&quot;Haihong&quot;,&quot;last_name&quot;:&quot;Ni&quot;},{&quot;first_name&quot;:&quot;Louis&quot;,&quot;last_name&quot;:&quot;M. Renzetti&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;I. Resnicow&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Ruebsam&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;A. Sigel&quot;},{&quot;first_name&quot;:&quot;Heather&quot;,&quot;last_name&quot;:&quot;A. Thomson&quot;},{&quot;first_name&quot;:&quot;Ce&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Zhifeng&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Ying&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;7840-7856&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00688&quot;},&quot;abstract&quot;:&quot;The activity of the secreted phosphodiesterase autotaxin produces the inflammatory signaling molecule LPA and has been associated with a number of human diseases including idiopathic pulmonary fibrosis (IPF). We screened a single DNA-encoded chemical library (DECL) of 225 million compounds and identified a series of potent inhibitors. Optimization of this series led to the discovery of compound 1 (X-165), a highly potent, selective, and bioavailable small molecule. Cocrystallization of compound 1 with human autotaxin demonstrated that it has a novel binding mode occupying both the hydrophobic pocket and a channel near the autotaxin active site. Compound 1 inhibited the production of LPA in human and mouse plasma at nanomolar levels and showed efficacy in a mouse model of human lung fibrosis. After successfully completing IND-enabling studies, compound 1 was approved by the FDA for a Phase I clinical trial. These results demonstrate that DECL hits can be readily optimized into clinical candidates.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00688&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00688" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00688&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00688" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00688&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00688" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00688&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00688&amp;href=/doi/10.1021/acs.jmedchem.0c00688" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00688" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00688" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00688%26sid%3Dliteratum%253Aachs%26pmid%3D32584034%26genre%3Darticle%26aulast%3DCuozzo%26date%3D2020%26atitle%3DNovel%2BAutotaxin%2BInhibitor%2Bfor%2Bthe%2BTreatment%2Bof%2BIdiopathic%2BPulmonary%2BFibrosis%253A%2BA%2BClinical%2BCandidate%2BDiscovered%2BUsing%2BDNA-Encoded%2BChemistry%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D14%26spage%3D7840%26epage%3D7856%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291120" title="Hydrophobicity">Hydrophobicity</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/jmcmar.2020.63.issue-14/20200723/jmcmar.2020.63.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The activity of the secreted phosphodiesterase autotaxin produces the inflammatory signaling molecule LPA and has been associated with a number of human diseases including idiopathic pulmonary fibrosis (IPF). We screened a single DNA-encoded chemical library (DECL) of 225 million compounds and identified a series of potent inhibitors. Optimization of this series led to the discovery of compound <b>1</b> (X-165), a highly potent, selective, and bioavailable small molecule. Cocrystallization of compound <b>1</b> with human autotaxin demonstrated that it has a novel binding mode occupying both the hydrophobic pocket and a channel near the autotaxin active site. Compound <b>1</b> inhibited the production of LPA in human and mouse plasma at nanomolar levels and showed efficacy in a mouse model of human lung fibrosis. After successfully completing IND-enabling studies, compound <b>1</b> was approved by the FDA for a Phase I clinical trial. These results demonstrate that DECL hits can be readily optimized into clinical candidates.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41145" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41145" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Autotaxin (ENPP2, ectonucleotide pyrophosphatase/phosphodiesterase family member 2) is a secreted glycoprotein that hydrolyzes lysophosphatidylcholine (LPC) with various fatty acyl chains such as linoleic acid (18:2) to lysophosphatidic acid (LPA) and choline.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> LPA acts as a chemoattractant for a wide variety of cell types including fibroblasts via activation of the LPA<sub>1</sub> receptor.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Autotaxin is likely the major source of blood-borne LPA since a heterozygous autotaxin gene deletion in mice reduces LPA blood levels by half.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In humans, autotaxin protein levels in serum are highly correlated with LPA levels.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Genetic studies initially indicated that autotaxin may play a role in mouse models of lung fibrosis,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and a study of idiopathic pulmonary fibrosis (IPF) patients found increased levels of LPA in bronchoalveolar lavage (BAL) fluid and exhaled breath condensate.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> High levels of autotaxin have also been observed in the lungs of IPF patients.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The strongest validation for the link between autotaxin activity and IPF is from a recently completed Phase II clinical trial of the autotaxin inhibitor GLPG1690 at 600 mg per day over a 12 week period in a small cohort of IPF patients.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Lung function, as measured by forced vital capacity (FVC), declined in the placebo group over the course of the study, while FVC values remained stable or improved slightly in GLPG1690-treated patients. Imaging studies performed on GLPG1690-treated patients also demonstrated significant improvement in airway volume. An association between reduced disease severity and autotaxin inhibition was demonstrated by a decrease in plasma LPA 18:2 levels of nearly 90% at week 12 in GLPG1690-treated patients. Since approved treatments for IPF only slow down the course of the disease,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> the observation that an autotaxin inhibitor can stabilize and, in some cases, improve lung function was an encouraging result for IPF patients and GLPG1690 is currently in two Phase III clinical trials.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The Phase II results with GLPG1690 have continued to drive interest in the prospect of finding new, more potent, autotaxin inhibitors that could be dosed at lower levels than GLPG1690 and thus could potentially be combined with approved therapeutics to provide even more benefit to IPF patients. New autotaxin inhibitors could also potentially be used to treat other diseases such as liver fibrosis<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and some cancers.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p last">DNA-encoded chemical library (DECL) technology utilizes large combinatorial libraries of small molecules each of which is covalently attached to a DNA sequence. This DNA sequence encodes the chemical history of each individual library member and may be used to elucidate its chemical structure. In combination with affinity-mediated selection, PCR amplification, cloning, and deep sequencing, DNA-encoded chemical library technology may be used to identify rare members within numerically large libraries that bind to targets of interest. Resynthesis of off-DNA compounds and testing in biochemical or biophysical assays can then be used to determine which enriched library members bind to their cognate targets in a manner that modulates target activity in the desired fashion. This technology is increasingly being applied to the identification of novel chemical equity to initiate drug discovery projects and is the subject of recent reviews<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> and references cited therein. Examples of DECL-initiated drug discovery projects that have reached the clinic include those directed at receptor interacting protein 1 kinase (RIP1K)<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> and soluble epoxide hydrolase (sEH).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> We used this approach to identify a new autotaxin inhibitor that showed nearly 20-fold superior potency when compared to GLPG1690 in human plasma along with reduced protein-binding and hERG activity. This series of compounds led to the development of compound <b>1</b> (X-165) that was recently approved by the FDA for Phase I human clinical studies.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76724" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76724" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The DNA-encoded library from which the autotaxin inhibitor was identified was constructed with three cycles of chemistry applying a split-and-pool synthesis strategy with encoding using DNA oligonucleotides during each cycle (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). In the first cycle of library synthesis (cycle A), the DNA headpiece (HP) was split into 300 wells and ligation to a unique DNA tag occurred within each well. Each of the 300 Fmoc amino acids was subsequently installed via acylation of the primary amine on the HP, also within each well. After pooling, mixing, deprotection of the N-Fmoc, and purification, the cycle A material was split into 300 wells, with each being ligated to one of 300 unique DNA tags prior to installing 300 Fmoc amino acids via acylation. The resulting cycle B material was pooled and purified prior to being split into 2,500 wells. The final diversification step (cycle C) was achieved by the installation of 2500 carboxylic acids via acylation after each was ligated to one of 2500 DNA tags. Upon completion of the final step, the wells were pooled, and the resultant completed library was purified using RP-HPLC, resulting in a library of 225 million encoded members.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Scheme for synthesis of the DNA-encoded chemical library of 225 million compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Affinity-mediated selection for autotaxin binders was carried out by combining the DNA-encoded chemical library and FLAG-tagged autotaxin in solution, capturing the protein on an anti-FLAG matrix, along with associated DNA-encoded library members, washing, and then heat-eluting prior to input into a second round of affinity-mediated selection with fresh protein. Encoding oligonucleotides present in the round-two eluate were then amplified, clustered, and sequenced. Sequencing was also performed for PCR-amplified samples of the unselected library and the output of a no-target selection performed in parallel in the absence of autotaxin. Sequence data were converted back into encoded chemical information, and demographic and statistical information were calculated for individual building block combinations. We observed a large number of strongly enriched features in the selection output. The most evident of these contained a phosphonate-containing amino acid building block that was enriched in a wide range of contexts including in the first or second cycles of chemical synthesis. These features were designated as Families A and B (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). The next-most strongly enriched set of highly structurally related compounds included the chemotype that is the subject of this paper. This chemotype was designated as Family C (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a,b).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Three-dimensional (3D) scatter plots showing individual enriched features against autotaxin. (a) Selection output showing phosphonate-containing families in red and green and family C in blue. (b) is the same as for (a), but with phosphonate-containing families removed and the vertical scale adjusted with the four most enriched disynthons indicated. The <i>x</i>- and <i>y</i>-axes represent individual building blocks at the indicated cycles of synthesis. The <i>z</i>-axis represents a statistical metric of enrichment significance (ENRv1) for each disynthon (negative log<sub>10</sub> of the asymptotic significance value).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Families A and B were both defined by the same amino acid building block, 4-phosphonomethly-<span class="smallcaps smallerCapital">l</span>-phenylalanine. Family A was designated as comprising all compounds for which this phosphonate building block was enriched in the central cycle of chemistry with coenrichment observed for a range of α, β, and γ amino acids at the initial cycle of chemistry, most of which were aromatic. Building blocks enriched in the terminal cycle of chemistry in Family A included a wide range of mono- and bicyclic aromatic carboxylates. Family B was designated as comprising all compounds for which the phosphonate building block was enriched in the initial cycle of chemistry with coenrichment observed for a range of mostly aromatic α, β, and γ amino acids at the central cycle of chemistry and a wide range of mono- and bicyclic aromatic carboxylates at the terminal cycle. Resynthesized compounds representative of these families were active in the high nanomolar range, and the similarity of these two families suggests significant opportunities for truncation, but the presence of the phosphonate and the negative charge it carries led us to decide not to attempt to progress this series further. Instead of exploring the potential of replacing the phosphonate group within this series, we sought to further examine the selection output data to identify coenriched building block combinations that did not contain a phosphonate or other negatively charged groups.</div><div class="NLM_p">Family C is distinct from Families A and B in that it does not contain a negatively charged functional group and is instead defined by an unusual spirocyclic amino acid for which other closely related building blocks were not present in the library. The coenriched building blocks derived from the second chemistry cycle are α-amino acids with small hydrophobic side chains (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>a) and the third by a wide range of small halogenated aromatic carboxylates (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>b). These data were then used to inform the design of compounds for off-DNA synthesis.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Feature Prevalence Table of the Top Five Building Block Structures (Fmoc removed)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0012.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Feature prevalence table showing structures of the top five building blocks at cycle B that coenrich with the indicated cycles A and C building block pair and define tolerated variability within the active chemotype as indicated in the selection output data at cycle B. The relative prevalence of each building block B, in terms of the percent representation in the total number of coenriched compounds, is indicated below each building block.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Same as for (a) but showing all building blocks at cycle C that coenrich with the indicated cycles A and B building block pair. No tolerated variation was observed at cycle A presumably because of the relative uniqueness of this building block.</p></div></div><div></div></div><div class="NLM_p">To determine if the building block combinations enriched by affinity-mediated selection were able to inhibit the activity of autotaxin, we designed and synthesized representative compounds from Family C without the DNA tag (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The DNA linkage point was arbitrarily truncated to N-methylamide. A relatively wide range of building blocks was observed at cycle C, but many highly enriched examples contain meta-substituted benzoate moieties and so we synthesized compounds <b>2</b> and <b>3</b>. These two initial compounds were tested as inhibitors in an autotaxin enzymatic assay using an artificial fluorescent substrate (FS-3), and they both were able to potently inhibit autotaxin with IC<sub>50</sub> values in the single-digit nM range (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Compound <b>4</b>, the corresponding benzoate derivative, showed a loss in potency of greater than 100-fold in the FS-3 assay, indicating the importance of the aromatic substituents at cycle C. The SAR at the DNA linkage was also explored in the synthesis of compound <b>5</b>, which differs from <b>2</b> by additional linkage truncation to remove the amide group and showed similar activity in the FS-3 assay and improved ligand efficiency (LE).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Representative Compounds from Family C Off-DNA<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NH<sub>2</sub>Me, EDCI, HOBT, DIEA, DMF, RT; (b) HCl (gas), MeOH, RT; (c) (<i>R</i>)-2-((<i>tert</i>-butoxycarbonyl) amino)-2-cyclohexylacetic acid, EDCI, HOBT, DIEA, DMF, RT; (d) substituted benzoic acid, EDCI, HOBT, DIEA, DMF, RT.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Table for Compounds Derived from Family C</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0013.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0014.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0015.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_p">The composition of enriched cycle B building blocks indicates a preference for hydrophobic side chains at this position (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The design of compounds with an isopropyl group was intended to improve the overall log <i>P</i> and LE while maintaining the hydrophobic nature at the position. Replacing the cyclohexyl group with isopropyl, e.g., compounds <b>6</b> and <b>7</b>, maintained activity in the FS-3 assay (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). This promising result allowed us to further optimize other regions of the hit compounds and resulted in potent (nM) binders with improved physicochemical properties.</div><div class="NLM_p">As we continued to explore the structure–activity relationships of this series, we developed an assay using the natural autotaxin substrate LPC rather than the artificial substrate FS-3. There was a notable shift in the observed IC<sub>50</sub> values of compounds between the FS-3 and LPC assays as demonstrated by initial library-derived compounds <b>2</b> and <b>5</b>.</div><div class="NLM_p">It was also observed from the prevalence of enriched cycle B building blocks that the R-configuration of chiral amino acids was preferred when both R and S-isomers were present in the library. Stereospecific binding was confirmed when LPC IC<sub>50</sub> values were compared for <b>8</b> and <b>9</b>, and <b>1</b> and <b>10</b> as matched pairs. In both cases, compounds with an R-configuration were substantially more active than their S-isomers.</div><div class="NLM_p">Family C was defined by a single building block at cycle A for which closely related variants were not included in the library. The spiro ring structure provides rigidity that locks the hydrophobic <i>N</i>-phenyl in a conformation that projects it toward the hydrophobic pocket of autotaxin. We observed over 10-fold loss of potency in the LPC assay relative to <b>5</b> when <i>N</i>-phenyl was replaced by N-cyclopropyl in <b>11</b> or N-pyridyl in <b>12</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Optimization at this position focused on the design of additional spiro moieties (<b>13</b>), which led to the discovery of the hydantoin series (examples in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <b>14</b>–<b>18</b>, <b>20</b>–<b>23</b>), and resulted in compound <b>1</b> (X-165) with potency and ADME properties suitable for testing in animal models.</div><div class="NLM_p">The synthesis of the compounds described above employed two general strategies. The first resembles the DECL library synthetic route wherein the corresponding amino acids and carboxylic acids are coupled in a linear fashion (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, compounds <b>2</b>–<b>4</b>). The alternative approach (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) couples the spiropiperidine intermediate to a preassembled fragment. The intermediate <b>1d</b> was prepared using a hydantoin formation reaction where the cyano intermediate <b>1c</b> reacted with chlorosulfonyl isocyanate (CSI). Upon methylation of the hydantoin NH, followed by N-Boc deprotection of the piperidine, the resulting compound <b>1f</b> was subjected to a standard amide coupling reaction with the advanced starting material <b>1a</b> using HATU as coupling reagent to give <b>1g</b>. Removal of the N-Cbz protecting group afforded the title compound <b>1</b> in a cumulative yield of 18% (over 4 steps). Compounds <b>5</b>–<b>23</b> were prepared analogously, and their respective intermediates were synthesized via various pathways (<a class="ref internalNav" href="#sch3" aria-label="Schemes 3">Schemes 3</a> and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>1</b> and Its Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) methyl <i>D</i>-valinate.HCl, HATU, DIEA, CH<sub>2</sub>Cl<sub>2</sub>; (b) LiOH, THF, H<sub>2</sub>O; (c) 1<i>H</i>-indazol-5-amine, TMSCN, AcOH; (d) K<sub>2</sub>CO<sub>3</sub>, CbzCl, THF/H<sub>2</sub>O; (e) NCOSO<sub>2</sub>Cl, CH<sub>2</sub>Cl<sub>2</sub>, HCl/H<sub>2</sub>O; (f) (Boc)<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub>, THF; (g) Mel, K<sub>2</sub>CO<sub>3</sub>, DMF; (h) HCl/dioxane; (i) <b>1a</b>, HATU, DIEA, CH<sub>2</sub>Cl<sub>2</sub>; (j) Pd/C, H<sub>2</sub>, MeOH</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of N-Substituted 1,3,8-Triazaspiro[4,5]decan-4-one<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Mel, NaH, THF; (b) HCl (g), MeOH; (c) trimethoxymethane, AcOH; (d) NaBH4, MeOH; THF; (e) HCl/dioxane; (f) 2-bromopyridine, Pd<sub>2</sub>(dba)<sub>3</sub>, X-Phos, <i>t</i>-BuOK, toluene.</p></p></figure><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <i>N</i>-1,3,8-Triazaspiro[4.5]decane-2,4-dione<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) substituted aniline, TMSCN, AcOH; (b) NCOSO<sub>2</sub>Cl, CH<sub>2</sub>Cl<sub>2</sub>, HCl/H<sub>2</sub>O; (c) (Boc)<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub>, THF; (d) Mel, K<sub>2</sub>CO<sub>3</sub>, DMF; (e) NaOH, MeOH; (f) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF; (g) HCl/dioxane.</p></p></figure><div class="NLM_p">Compound <b>1</b> was cocrystallized with human autotaxin (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The structure of the complex was obtained at 1.98 Å resolution. The crystals contained one monomer of autotaxin in the asymmetric unit. The structure revealed the unique binding mode of <b>1</b>. In contrast to previously reported structures<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> that engage one of the catalytic zinc ions, compound <b>1</b> extends across the binding site to occupy both the hydrophobic pocket and the hydrophobic channel of autotaxin. The hydrophobic pocket normally binds LPC, and the hydrophobic channel is proposed to be involved in transport of LPA to target receptors.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> A similar mode of inhibition was previously reported for the clinical candidate GLPG1690,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> but a comparison of the binding modes revealed different trajectories linking the binding elements in the hydrophobic pocket and the hydrophobic channel.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cocrystal structure of compound <b>1</b> in the active site of autotaxin (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W35">6W35</a>). The ligand is shown in green, the binding site residues are depicted in gold, and water molecules are represented as red spheres. Yellow dashes indicate hydrogen-bonding networks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The 2-fluoro-5-trifluoromethylphenyl group occupies the hydrophobic pocket and forms a T-shaped π–π interaction with the aromatic side chain of Phe274 and hydrophobic contacts with surrounding side chains of Leu217, Ile168, Ala305, Leu214, and Phe274. The 2-fluoro is in a favorable close-to-coplanar conformation with the amide hydrogen. Removal of the fluoro (<b>14</b>) resulted in a 10-fold loss of potency, while substitution with a bulkier nonpolar methyl (<b>15</b>) or chloro (<b>16</b>) pushed the amide out of plane and reduced potency into the micromolar range. Moreover, replacement of the amide hydrogen with methyl to form the <i>N</i>-Me derivative resulted in a significant reduction of potency to >10 μM (compound not shown).</div><div class="NLM_p">The isopropyl group fills the hydrophobic pocket formed by Phe211, Phe275, Leu214, and Trp255. This pocket is large enough to accommodate a substantial hydrophobic substituent, such as a cyclopentyl (<b>17</b>). Removing the substituent entirely (<b>18</b>) resulted in loss of potency.</div><div class="NLM_p">The piperidinyl carbonyl forms a water-mediated hydrogen bond to the backbone amine of Phe274. The hydantoin group is positioned in the hydrophobic channel. The carbonyl at the 4 position is involved in water-mediated hydrogen bonds to Trp261 and Tyr215, and the carbonyl at the 2-position hydrogen bonds to Tyr83 and is involved in a water-mediated hydrogen-bonding network with the backbone carbonyl of Phe250. The bifurcated hydrogen bond to Tyr83 potentially weakens the hydrogen-bonding potential of the hydroxyl, and removal of the oxygen at the 2-position (compound <b>19</b>) yielded a more potent compound.</div><div class="NLM_p">Finally, the indazole group in the hydrophobic channel points toward the solvent, forming an edge-to-face π–π interaction with Phe250 and a hydrogen bond to Ser82. Removal of this indazole (<b>20</b>) accounts for loss in potency due to loss of the hydrogen bond to Ser82 and the π–π interaction with Phe250. Since the hydroxyl group of Ser82 can function as a hydrogen-bond donor, a carboxylic acid is tolerated at the para position of the phenyl ring without loss of potency (<b>21</b>). Hydrophobic substitutions at the para and meta positions are also tolerated (<b>22</b> and <b>23</b>).</div><div class="NLM_p">Compound <b>1</b> demonstrated low nanomolar potency in both mouse and human plasma autotaxin assays, with 60- and nearly 20-fold lower IC<sub>50</sub> values than reported for GLPG1690 in mouse and human plasma, respectively<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Side-by-side plasma LPA inhibition assays with compound <b>1</b> and GLPG1690 in our hands confirmed this potency difference (data not shown). Compound <b>1</b> also demonstrated excellent selectivity against related targets showing no inhibition of the homologous enzyme ENPP1, which is 45% identical to autotaxin (ENPP2), and no activity against LPA receptors, which may have been expected if the compound was purely a substrate mimetic (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Compound <b>1</b> was highly soluble in water and had a low rate of clearance in rat and human microsomes. Furthermore, compound <b>1</b> showed no inhibition of hERG or cytochromes at concentrations 1000-fold over its inhibitory concentration of LPA production in plasma (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) as compared to a 60-fold window for GLPG1690.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Compound <b>1</b> also demonstrated lower protein-binding (r/hPPB 72.7/88.7%) than GLPG1690 (>99%),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> which may explain the better potency of compound <b>1</b> in plasma. Pharmacokinetic experiments in mice showed that compound <b>1</b> demonstrated 80% oral bioavailability and a plasma half-life of 2.5 h. An oral dose of 30 mg/kg maintained plasma concentrations above the IC<sub>90</sub> value for LPA (60 ng/ml, ∼100 nM) for 12 h in mice (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Compound <b>1</b> was also orally bioavailable in rats and dogs (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), the designated species for toxicology studies, when dosed in a 0.5% methylcellulose suspension formulation.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>1</b> plasma levels exceed IC<sub>90</sub> for up to 12 h when dosed orally in mice. A total of nine mice were dosed orally with compound <b>1</b> at 30 mg/kg, and plasma concentrations were determined up to 12 h using three mice per time point (green). The IC<sub>90</sub> of compound <b>1</b> in mouse plasma is indicated (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Compound <b>1</b> Potency in the Autotaxin LPC Enzymatic Assay, Mouse and Human Plasma LCMS-/MS-Based Autotaxin Assays</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay</th><th class="colsep0 rowsep0" align="center" char=".">compound 1 potency (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LPC assay (<i>K</i><sub>i</sub>)</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse plasma (IC<sub>50,</sub> LPA 18:2)</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human plasma (IC<sub>50,</sub> LPA 18:2)</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Compound <b>1</b> Selectivity, hERG, CYP Activity, Solubility, and Microsomal Stability. MPC, Manual Patch Clamp Assay; GLP, Good Laboratory Practices</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">compound 1</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG (IC<sub>50</sub>, μM)</td><td class="colsep0 rowsep0" align="left">>50 (MPC, GLP)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP3A4, CYP2D6, CYP1A2 (IC<sub>50</sub>, μM)</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP2C9 (IC<sub>50</sub>, μM)</td><td class="colsep0 rowsep0" align="left">10.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP2C19 (IC<sub>50</sub>, μM)</td><td class="colsep0 rowsep0" align="left">46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ENPP1 (IC<sub>50</sub>, μM)</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LPAR1-3 antagonist and agonist (IC<sub>50</sub>, μM)</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Rat/human liver microsomes T<sub>1/2</sub> (min)</td><td class="colsep0 rowsep0" align="left">277/533</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Thermodynamic solubility at pH 7.4 (μM)</td><td class="colsep0 rowsep0" align="left">452</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Compound <b>1</b> Mouse, Rat, and Dog PK</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="4" align="center">compound <b>1</b> PK</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="7" align="left">mouse</td><td class="colsep0 rowsep0" rowspan="3" align="left">(iv) 1 mg/kg</td><td class="colsep0 rowsep0" align="left">CL (mL/(min kg))</td><td class="colsep0 rowsep0" align="char" char=".">54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">0.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="char" char=".">1.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">(po) 10 mg/kg</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="char" char=".">744</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>last</sub> (h ng/mL)</td><td class="colsep0 rowsep0" align="char" char=".">2587</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i>%</td><td class="colsep0 rowsep0" align="char" char=".">81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="7" align="left">rat</td><td class="colsep0 rowsep0" rowspan="3" align="left">(iv) 1 mg/kg</td><td class="colsep0 rowsep0" align="left">CL (mL/(min kg))</td><td class="colsep0 rowsep0" align="char" char=".">36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="char" char=".">1.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">(po) 5 mg/kg</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="char" char=".">160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>last</sub> (h ng/mL)</td><td class="colsep0 rowsep0" align="char" char=".">518</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i>%</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="7" align="left">dog</td><td class="colsep0 rowsep0" rowspan="3" align="left">(iv) 1 mg/kg</td><td class="colsep0 rowsep0" align="left">CL (mL/(min kg))</td><td class="colsep0 rowsep0" align="char" char=".">7.96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="char" char=".">0.655</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">(po) 1 mg/kg</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="char" char=".">374</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>last</sub> (h ng/mL)</td><td class="colsep0 rowsep0" align="char" char=".">3081</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i>%</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr></tbody></table></div></div><div class="NLM_p">A study of compound <b>1</b> inhibition of plasma LPA production relative to the plasma levels of the compound was performed in rats (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Rats were dosed orally with compound <b>1</b> and both LPA 20:4 levels, since LPA 20:4 is more abundant in rats<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> than in humans or mice, and compound <b>1</b> levels were measured in plasma at 4 h postdose. A dose-dependent relationship between the plasma compound levels and the percent inhibition of LPA production was observed with an IC<sub>50</sub> value of 6.5 nM, which is very close to the IC<sub>50</sub> values calculated from <i>ex vivo</i> experiments using mouse and human plasma (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The demonstration of a dose-dependent effect on LPA levels <i>in vivo</i> and the near identity of the <i>in vivo</i> and <i>in vitro</i> plasma and enzyme assay IC<sub>50</sub> results indicated that the reduction of LPA levels by compound <b>1</b> was consistent with this effect being due to on-target activity.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>1</b> inhibits LPA production <i>in vivo</i>. A range of compound <b>1</b> doses was orally administered to rats, and both LPA 20:4 and compound <b>1</b> levels were measured by liquid chromatography mass spectrometry (LCMS/MS) in rat blood 4 h post dosing. Average percent inhibition of LPA levels was then plotted against plasma levels of compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The development of lung fibrosis in the mouse following bleomycin-induced injury has been used to demonstrate the antifibrotic activity of multiple compounds including those that are currently approved for treating human idiopathic pulmonary fibrosis.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The combination of potency, selectivity, and pharmacokinetic properties of compound <b>1</b> made it an excellent candidate for testing its potential antifibrotic activity in this model. Compound <b>1</b> was tested in both prophylactic and therapeutic modes at 30, 100, and 300 mg/kg BID (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). In the prophylactic mode, compound <b>1</b> dosing began one day prior to bleomycin treatment, and in the therapeutic mode, compound <b>1</b> dosing began seven days after bleomycin treatment. After 21 days postbleomycin treatment, the mice were sacrificed and the amount of fibrosis in the lung was quantitated in one group of mice by measuring hydroxyproline levels and in another group of mice by trichrome staining of lung tissue. GLPG1690, at doses of 30 and 100 mg/kg BID, was used as a control in both models.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Oral dosing of compound <b>1</b> demonstrates efficacy in prophylactic (a) and therapeutic (b) models of bleomycin-induced lung fibrosis. Lung hydroxyproline levels are plotted for each mouse. Median levels and p-values relative to bleomycin + vehicle are indicated for each group (* ≤ 0.05, ** ≤ 0.01). GLPG1690 (GLPG) was used as a control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The results of the prophylactic study show a clear decrease in hydroxyproline levels at the lowest dose of compound <b>1</b>, 30 mg/kg. A statistically significant decrease in hydroxyproline was observed at both 100 and 300 mg/kg. The GLPG1690 controls reduced fibrosis as expected, and compound <b>1</b> was active in the same range of doses as GLPG1690 in this model. Similar results were also observed in the therapeutic model of fibrosis. Treatment with compound <b>1</b> after 7 days of the initial bleomycin-induced injury showed a statistically significant reduction in lung hydroxyproline levels at both dosing levels of 100 and 300 mg/kg. A reduction in lung hydroxyproline concentration was also observed at 30 mg/kg compound <b>1</b> although it was not statistically significant (<i>p</i> = 0.24) compared to the vehicle plus bleomycin control group. GLGP1690 appeared to be slightly more active in the therapeutic model of disease than compound <b>1</b> but also showed a reverse dose response, which may be more related to the inherent variability in this model rather than actual pharmacology.</div><div class="NLM_p">Lungs from mice that were dosed therapeutically with compound <b>1</b> were sectioned and examined for fibrosis using trichrome staining (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Bleomycin treatment resulted in the development of fibrosis as indicated by darkly stained areas in the lung. Treatment with compound <b>1</b> markedly reduced lung fibrosis at both the 100 and 300 mg/kg doses. At the lowest dose, 30 mg/kg, compound <b>1</b> also showed a moderate reduction in lung fibrosis. Overall, these results indicate that compound <b>1</b> reduced fibrosis in the mouse bleomycin model in a dose-dependent manner. It is interesting that even though compound <b>1</b> is more potent than GLPG1690 in plasma, the dose response in the bleomycin model appears to be similar. Plasma levels of LPA measured 2–4 h after the last dose of compound in both the prophylactic and therapeutic models were reduced to background levels in compound <b>1</b> and GLPG1690-treated animals at all doses (data not shown). It is likely that other non-LPA-related factors are involved in the development of fibrosis in the mouse bleomycin model, which may be quite different from the etiology of human IPF.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>1</b> reduces lung fibrosis in the therapeutic bleomycin model. Representative trichrome-stained thin sections of mouse lungs are shown for each compound <b>1</b> dose group. Darkly stained regions are indicative of advanced fibrosis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40507" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40507" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">DNA-encoded chemical libraries have been a productive source of hit and lead molecules for a large variety of target classes, but questions have remained about the ability of DECL technology to generate safe and effective clinical candidates. Our work with autotaxin has demonstrated that DECL screening can produce a novel, safe, and efficacious IND-approved clinical candidate for fibrotic disease. The initial hits from the DECL selection were structurally similar to the clinical candidate, compound <b>1</b>, and only required a relatively modest medicinal chemistry campaign for optimization. The DECL hits showed excellent potency against autotaxin, and this potency was maintained as the chemistry progressed. Furthermore, the SAR of this series is consistent with the relatively unique binding mode of the compound as determined by cocrystallography, strongly supporting the concept that future DECL hits for other targets can be rapidly optimized using structural data. The medicinal chemistry program was geared both toward improving the ADME properties of the initial hit series and the potency against the natural substrate, LPC. These efforts resulted in a compound with low nanomolar potency for LPA production in plasma both <i>in vitro</i> and <i>in vivo</i> and excellent metabolic stability. The improved metabolic stability resulted in increased bioavailability of the series and allowed for testing in animal models of fibrotic disease. Compound <b>1</b> (X-165) demonstrated efficacy in both prophylactic and therapeutic models of fibrosis and was active in the same dose range as GLPG1690 for the prophylactic model. Compound <b>1</b> was also shown to be safe in IND-enabling studies, including 28 day toxicity studies in rats and dogs, standard safety pharmacology studies, and genetic toxicity studies (data not shown), which led to its approval by the FDA for Phase I studies in humans. Modeling studies, based on PK results from multiple species and human plasma potency, suggested that the effective human dose of compound <b>1</b> could be fivefold to tenfold lower than the dose of GLPG1690 currently being used in the clinic (data not shown). These estimates would need to be validated by a Phase I human PK/PD study using plasma LPA as a readout. Overall, these results demonstrate that DNA-encoded chemical libraries can be a productive source of potent and selective lead compounds that can be readily optimized into approved clinical candidates for the treatment of human disease.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58536" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58536" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Unless otherwise noted, starting materials and reagents were purchased from commercial sources and used without further purification. Air- or moisture-sensitive reactions were carried out under a nitrogen atmosphere. Anhydrous solvents were obtained from commercial sources. Silica gel chromatography was performed using standard techniques or using silica gel cartridges (Santai normal phase disposable flash columns) on an ISCO CombiFlash. Microwave reactions were carried out on a CEM Discover system with appropriate heating programs. Final compounds were synthesized analogously to <b>1</b> following general procedure A or to <b>2</b> following general procedure B. <sup>1</sup>H NMR spectra were recorded on a Bruker Avance III 400 (400 MHz) or a Varian Mercury 300 (300 MHz) and were determined in CDCl<sub>3</sub>, dimethyl sulfoxide (DMSO)-<i>d</i><sub>6</sub>, or MeOH-<i>d</i><sub>4</sub>. Chemical shifts are expressed in parts per million (ppm, δ units) relative to TMS (0.00 ppm). Coupling constants are in units of hertz (Hz). Splitting patterns describe apparent multiplicities and are designated as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), and br (broad peak). The analytical low-resolution mass spectra (MS) were recorded on an Agilent 6125 UPLC with G1315D DAD detectors using a Waters CORTECS C18, 4.6 × 30 mm<sup>2</sup>, 2.7 μm using a gradient elution method. Solvent A: 0.05% formic acid (FA) in water. Solvent B: 0.05% FA in acetonitrile; 5% B to 95% B in 1.0 min, hold 1.0 min, total 2.5 min; flow rate: 1.8 mL/min; column temp: 45°. All tested compounds were determined to be ≥95% purity by LCMS.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General Procedure A</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> (2-Fluoro-5-(trifluoromethyl)benzoyl)-<span class="smallcaps smallerCapital">d</span>-valine (<b>1a</b>)</h4><div class="NLM_p">To a solution of 2-fluoro-5-(trifluoromethyl)benzoic acid (0.75 g, 3.6 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) were added methyl-<span class="smallcaps smallerCapital">d</span>-valinate hydrochloride (0.61 g, 3.6 mmol), HATU (2.1 g, 0.55 mmol), and DIEA (1.2 g, 9 mmol). The reaction was stirred at RT for 1 h and quenched with water (5 mL). The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (5 mL, 3 times). The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. The residue was purified using a Combiflash column (petroleum ether/EtOAc = 1:5) to give methyl (2-fluoro-5-(trifluoromethyl)benzoyl)-<span class="smallcaps smallerCapital">d</span>-valinate as a yellow oil (0.9 g, 80%). LCMS (electrospray ionization, ESI): <i>m</i>/<i>z</i> 321 (M + 1)<sup>+</sup>.</div><div class="NLM_p last">A solution of methyl-(2-fluoro-5-(trifluoromethyl)benzoyl)-<span class="smallcaps smallerCapital">d</span>-valinate (18.6, 50 mmol) and LiOH/H<sub>2</sub>O (44 mL, 2 N) in MeOH (50 mL) was stirred at RT for 2 h. To the reaction mixture was added dropwise aq. conc. HCl (5 mL) to adjust the pH to ∼3.0. The precipitate was filtered and collected. The solid was washed with water (5 mL, 3 times) and dried under vacuum to give <b>1a</b> as a white solid (16.7 g, 94%). LCMS (ESI): <i>m</i>/<i>z</i> 307 (M + 1)<sup>+</sup>.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> <i>Tert</i>-butyl 4-((1<i>H</i>-indazol-5-yl)amino)-4-cyanopiperidine-1-carboxylate (<b>1b</b>)</h4><div class="NLM_p last">To a solution of 1<i>H</i>-indazol-5-amine (2.0 g, 15 mmol) in acetic acid (20 mL) was added <i>tert</i>-butyl 4-oxopiperidine-1-carboxylate (3.3 g, 16 mmol). The resulting mixture was cooled to 0 °C, and TMSCN (1.8 g, 18 mmol) was added. The resulting solution was stirred overnight at room temperature. Saturated aqueous ammonium chloride solution (50 mL) was added. The resulting mixture was filtered, and the filter cake was washed with water (5 mL, 3 times) to afford the desired product <b>1b</b> (6.0 g, 97%). LCMS (ESI): <i>m</i>/<i>z</i> 342 (M + 1)<sup>+</sup>.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Benzyl-5-((1-(<i>tert</i>-butoxycarbonyl)-4-cyanopiperidin-4-yl)amino)-1<i>H</i>-indazole-1-carboxylate (<b>1c</b>)</h4><div class="NLM_p last">To a solution of <b>1b</b> (6.0 g, 5.8 mmol) in THF/water (15 mL/15 mL) were added K<sub>2</sub>CO<sub>3</sub> (1.6 g, 11.7 mmol) and CbzCl (1.5 g, 8.8 mmol) at 0 °C. After stirring overnight, the organic layer was isolated and the aqueous layer was extracted with ethyl acetate (20 mL, 2 times). The combined layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The residue was purified using silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 100:1) to afford the desired product <b>1c</b> as a yellow oil (0.9 g, 32%). LCMS (ESI): <i>m</i>/<i>z</i> 476 (M + 1)<sup>+</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>Tert</i>-butyl 1-(1-((benzyloxy)carbonyl)-1<i>H</i>-indazol-5-yl)-2,4-dioxo-1,3,8-triazaspiro[4.5]decane-8-carboxylate (<b>1d</b>)</h4><div class="NLM_p last">To a solution of <b>1c</b> (0.8 g, 1.6 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) was added NCOSO<sub>2</sub>Cl (1.6 g, 3.2 mmol) at 0 °C. After stirring for 30 min at 0 °C, the reaction was quenched by addition of 5% aqueous HCl solution (8 mL). The solvent was removed under reduced pressure, and ethanol (16 mL) was added. The mixture was stirred for 30 min at 80 °C. The solvent was removed under reduced pressure, the residue was added to THF (20 mL), and the pH was adjusted to 8 by the addition of 15% aqueous potassium carbonate solution, before (Boc)<sub>2</sub>O (1.0 g, 4.6 mmol) in THF (10 mL) was added. After stirring at RT overnight, the solvent was removed under reduced pressure and the residue was purified using silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 50:1) to afford <b>1d</b> (0.25 g, 27%). LCMS (ESI): <i>m</i>/<i>z</i> 520 (M + 1)<sup>+</sup>.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>Tert</i>-butyl 1-(1-((benzyloxy)carbonyl)-1<i>H</i>-indazol-5-yl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decane-8-carboxylate (<b>1e</b>)</h4><div class="NLM_p last">To a solution of <b>1d</b> (0.5 g, 1.5 mmol) in DMF (5 mL) was added potassium carbonate (0.42 g, 3.0 mmol) before iodomethane (0.32 g, 3.0 mmol) was added. The reaction was stirred at RT for 2 h and quenched by the addition of water (5 mL). The mixture was extracted with ethyl acetate (10 mL, 3 times), and the combined organic layers were dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified using Combiflash (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 20:1) to afford the desired product <b>1e</b> as a white solid (0.54 g). LCMS (ESI): <i>m</i>/<i>z</i> = 534 (M + 1)<sup>+</sup>.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Benzyl-5-(3-methyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-1-yl)-1<i>H</i>-indazole-1-carboxylate (<b>1f</b>)</h4><div class="NLM_p last">A solution of <b>1e</b> (270 mg, 0.5 mmol) in HCl in dioxane (10 mL) was stirred at RT overnight. The mixture was concentrated in vacuo to afford the desired product <b>1f</b> (crude) as a white solid, which was used for the next step without further purification. LCMS (ESI): <i>m</i>/<i>z</i> = 434 (M + 1)<sup>+</sup>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Benzyl-5-(8-((2-fluoro-5-(trifluoromethyl)benzoyl)-<span class="smallcaps smallerCapital">d</span>-valyl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-1-yl)-1<i>H</i>-indazole-1-carboxylate (<b>1g</b>)</h4><div class="NLM_p last">To a solution of <b>1f</b> in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) were added sequentially <b>1a</b> (155 mg, 0.5 mmol), HATU (287 mg, 0.76 mmol), and DIPEA (170 mg, 1.26 mmol). The reaction was stirred at RT for 2 h before being quenched by the addition of water (10 mL). The mixture was extracted with ethyl acetate (10 mL, 3 times), and the combined organic layers were dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified using silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 100:1) to afford the desired product <b>1g</b> (350 mg, 96%) as a colorless oil. LCMS (ESI): <i>m</i>/<i>z</i> 723 (M + 1)<sup>+</sup>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>R</i>)-N-(1-(1-(1<i>H</i>-Indazol-5-yl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl)-3-methyl-1-oxobutan-2-yl)-2-fluoro-5-(trifluoromethyl)benzamide (<b>1</b>)</h4><div class="NLM_p last">A solution of <b>1g</b> (350 mg, 0.48 mmol) and Pd/C (35 mg, 10%) in methanol (15 mL) was stirred at RT overnight under a hydrogen atmosphere. The resulting mixture was filtered and washed with methanol (5 mL, 2 times). The filtrate was concentrated under reduced pressure. The residue was purified using Prep-HPLC to afford the desired product 1 as a white solid (78 mg, 27%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 0.76–1.04 (m, 6H), 1.75–2.15 (m, 5H), 3.18 (s, 3H), 3.48–3.55 (m, 1H), 3.98–4.08 (m, 2H), 4.51–4.64 (m, 1H), 5.00–5.03 (m, 1H), 6.95–7.72 (m, 6H), 7.92–8.03 (m, 1H), 8.16–8.34 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 589.2 (M + 1)<sup>+</sup>. <sup>13</sup>C NMR (75 MHz CDCl<sub>3</sub>) δ = 175.1, 169.7, 161.8, 155.8, 139.5, 134.8, 130.4, 129.5, 128.4, 124.9, 123.5, 123.4, 121.9, 121.7, 117.3, 117.0, 111.1, 62.5, 54.1, 41.6, 37.8, 32.7, 31.7, 25.0, 19.7, 17.3.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure B</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>Tert</i>-butyl-3-(2-(methylamino)-2-oxoethyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane-8-carboxylate (<b>2a</b>)</h4><div class="NLM_p last">A solution of 2-(8-(<i>tert</i>-butoxycarbonyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)acetic acid (1.7 g, 4.37 mmol), EDCI (1.1 g, 5.68 mmol), HOBT (767 mg, 5.68 mmol), and DIEA (1.46 g, 11.36 mmol) in DMF (20 mL) was stirred at RT for 1 h. Methylamine (500 mg, 16 mmol) was added, and the mixture was stirred at rt overnight. The resulting solution was diluted with ethyl acetate (50 mL), washed with 1N HCl (50 mL), aqueous sat. NaHCO<sub>3</sub> (50 mL, 2 times), and brine (50 mL, 2 times), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuum to give the crude product 2a (1.5 g, 92%) as a light-yellow solid. LCMS (ESI): <i>m</i>/<i>z</i> 403 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-Methyl-2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)acetamide (<b>2b</b>)</h4><div class="NLM_p last">HCl (gas) was bubbled into MeOH (50 mL) at 0 °C for 1 h. <b>2a</b> (2.2 g, 5.47 mmol) was added, and the mixture was stirred at RT for 3 h. The resulting solution was concentrated under vacuum to give crude product <b>2b</b> (1.5 g, 90%) as a yellow solid. LCMS (ESI): <i>m</i>/<i>z</i> 303 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>R</i>)-2-(8-(2-Amino-2-cyclohexylacetyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)-<i>N</i>-methylacetamide (<b>2c</b>)</h4><div class="NLM_p last">A solution of (<i>R</i>)-2-((<i>tert</i>-butoxycarbonyl)amino)-2-cyclohexylacetic acid (516 mg, 2 mmol), EDCI (490 mg, 2.6 mmol), HOBT (351 mg, 2.6 mmol), and DIEA (660 mg, 5.1 mmol) in DMF (10 mL) was stirred at RT for 1 h. <b>2b</b> (500 mg, 1.7 mmol) was added, and the mixture was stirred at RT overnight. The resulting solution was diluted with ethyl acetate (50 mL), washed with 1 N HCl (50 mL), aqueous sat. NaHCO<sub>3</sub> (50 mL, 2 times), and brine (50 mL, 2 times), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuum to give the crude product <i>tert</i>-butyl (<i>R</i>)-(1-cyclohexyl-2-(3-(2-(methylamino)-2-oxoethyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-2-oxoethyl)carbamate (800 mg, 94%) as a light-yellow solid. LCMS (ESI): <i>m</i>/<i>z</i> 542 (M + 1)<sup>+</sup>. The crude product was dissolved in 50 mL of MeOH bubbled with HCl (gas) and stirred at RT for 3 h. The resulting solution was concentrated under vacuum to give the crude product 2c (680 mg, 90%) as a yellow solid. LCMS (ESI): <i>m</i>/<i>z</i> 442 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>R</i>)-<i>N</i>-(1-Cyclohexyl-2-(3-(2-(methylamino)-2-oxoethyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-2-oxoethyl)-2-fluoro-3-methylbenzamide (<b>2</b>)</h4><div class="NLM_p last">(<i>R</i>)-<i>N</i>-(1-Cyclohexyl-2-(3-(2-(methylamino)-2-oxoethyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-2-oxoethyl)-2-fluoro-3-methylbenzamide (<b>2</b>): A solution of 2-fluoro-3-methylbenzoic acid (92 mg, 0.6 mmol), EDCI (143 mg, 0.75 mmol), HOBT (101 mg, 0.75 mmol), and DIEA (194 mg, 1.5 mmol) in DMF (8 mL) was stirred at RT for 1 h. <b>2c</b> (220 mg, 0.5 mmol) was added, and the mixture was stirred at RT overnight. The resulting solution was diluted with ethyl acetate (50 mL), washed with 1 N HCl (50 mL), aqueous sat. NaHCO<sub>3</sub> (50 mL, 2 times), and brine (50 mL, 2 times), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuum. The residue was purified using silica gel column chromatography (EA/PE = 2:1) to give <b>2</b> (110 mg, 50%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.84–7.75 (m, 1H), 7.55–7.48 (m, 1H), 7.33–7.28 (m, 1H), 7.16–7.10 (m, 2H), 6.90–6.75 (m, 3H), 5.94 (bs, 1H), 5.13–5.11 (m, 1H), 4.82 (dd, 2H), 4.70–4.50 (m, 1H), 4.06 (s, 3H), 4.00–3.90 (m, 1H), 3.53–3.46 (m, 1H), 2.86 (d, <i>J</i> = 6.0 Hz, 3H), 2.70–2.40 (m, 2H), 2.33 (s, 3H), 1.95–1.55 (m, 8H), 1.45–1.11 (m, 6H). LCMS (ESI): <i>m</i>/<i>z</i> 578 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>R</i>)-3-Chloro-<i>N</i>-(1-cyclohexyl-2-(3-(2-(methylamino)-2-oxoethyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-2-oxoethyl)benzamide (<b>3</b>)</h4><div class="NLM_p last">General procedure B was followed. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.82–7.75 (m, 1H), 7.69 (t, <i>J</i> = 6.0 Hz, 1H), 7.50–7.26 (m, 2H), 7.16–7.05 (m, 2H), 6.90–6.78 (m, 1H), 6.75–6.68 (m, 2H), 6.05–5.90 (m, 1H), 5.15–5.02 (m, 1H), 4.83 (d, <i>J</i> = 15.0 Hz, 2H), 4.65–4.50 (m, 1H), 4.07–3.90 (m, 4H), 3.56–3.48 (m, 1H), 2.85 (s, 3H), 2.70–2.30 (m, 2H), 1.86–1.62 (m, 8H), 1.25–1.11 (m, 6H). LCMS (ESI): <i>m</i>/<i>z</i> 580 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>R</i>)-<i>N</i>-(1-Cyclohexyl-2-(3-(2-(methylamino)-2-oxoethyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-2-oxoethyl)benzamide (<b>4</b>)</h4><div class="NLM_p last">General procedure B was followed. <sup>1</sup>H NMR (300 MHz, DMSO) δ 8.73–8.51 (m, 1H), 8.10–7.85 (m, 3H), 7.60–7.40 (m, 3H), 7.25–7.00 (m, 2H), 6.79–6.62 (m, 3H), 4.80 (m, 1H), 4.71–4.65 (m, 2H), 4.50–4.20 (m, 2H), 3.98 (s, 2H), 3.80–3.60 (m, 1H), 2.61 (s, 3H), 2.45–2.25 (m, 1H), 1.96–1.62 (m, 9H), 1.25–0.85 (m, 6H). LCMS (ESI): <i>m</i>/<i>z</i> 546 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>R</i>)-<i>N</i>-(1-Cyclohexyl-2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-2-oxoethyl)-2-fluoro-3-methylbenzamide (<b>5</b>)</h4><div class="NLM_p last">General procedure A was followed in the synthesis of <b>5</b> using <b>5b</b> as the starting material. <sup>1</sup>H NMR (300 MHz, DMSO) δ 8.51–8.48 (m, 1H), 7.50–7.30 (m, 2H), 7.22–7.11 (m, 2H), 7.05–7.00 (m, 1H), 6.79–6.62 (m, 3H), 4.68–4.66 (m, 2H), 4.50–4.30 (m, 1H), 4.24–4.21 (m, 1H), 3.87–3.78 (m, 1H), 3.40–3.35 (m, 1H), 2.90 (s, 3H), 2.75–2.50 (m, 1H), 2.39–2.24 (m, 4H), 1.80–1.63 (m, 8H), 1.23–1.06 (m, 6H). LCMS (ESI): <i>m</i>/<i>z</i> 521 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>R</i>)-3-Fluoro-N-(3-methyl-1-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-oxobutan-2-yl)benzamide (<b>6</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.92–8.90 (m, 1H), 7.84–7.76 (m, 2H), 7.52–7.50 (m, 1H), 7.41–7.37 (m, 1H), 7.25–7.15 (m, 1H), 7.02 (t, <i>J</i> = 8.0 Hz, 1H), 6.79–6.63 (m, 3H), 4.78–4.64 (m, 3H), 4.45–4.20 (m, 2H), 3.86–3.80 (m, 1H), 3.40–3.30 (m, 1H), 2.90 (s, 3H), 2.61–2.50 (m, 1H), 2.34–2.23 (m, 2H), 1.61–1.50 (m, 2H), 1.03–0.92 (m, 6H). LCMS (ESI): <i>m</i>/<i>z</i> 467 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>R</i>)-3-Methyl-<i>N</i>-(3-methyl-1-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-oxobutan-2-yl)benzamide (<b>7</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, d<sub>6</sub>-DMSO): 8.75–8.45 (m, 1H), 7.85–7.70 (m, 2H), 7.40–7.25 (m, 2H), 7.25–6.95 (m, 2H), 6.84–6.70 (m, 1H), 6.70–6.60 (m, 2H), 4.76 (t, <i>J</i> = 8 Hz, 1H), 4.73–4.60 (m, 2H), 4.50–4.20 (m, 2H), 3.85–3.70 (m, 1H), 3.40–3.25 (m, 1H), 2.95–2.85 (m, 3H), 2.70–2.60 (m, 1H), 2.40–2.15 (m, 5H), 1.80–1.50 (m, 2H), 1.05–0.90 (m, 6H). LCMS (ESI): <i>m</i>/<i>z</i> 463 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>R</i>)-3-Methyl-<i>N</i>-(2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-2-oxo-1-(tetrahydro-4<i>H</i>-4l3-pyran-4-yl)ethyl)benzamide (<b>8</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 1.54–1.90 (m, 7H), 2.42–2.66 (m, 5H), 3.05 (s, 3H), 3.36–3.45 (m, 2H), 3.54–3.64 (m, 2H), 3.97–4.14 (m, 4H), 4.54–4.66 (m, 1H), 4.71–4.76 (m, 2H), 5.17–5.23 (m, 1H), 6.98–7.24 (m, 5H), 7.62–7.66 (m, 4H). LCMS (ESI): m/z 505 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>S</i>)-3-Methyl-<i>N</i>-(2-(3-methyl-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-2-oxo-1-(tetrahydro-4<i>H</i>-4l3-pyran-4-yl)ethyl)benzamide (<b>9</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 1.54–1.90 (m, 7H), 2.42–2.66 (m, 5H), 3.05 (s, 3H), 3.36–3.45 (m, 2H), 3.54–3.64 (m, 2H), 3.97–4.14 (m, 4H), 4.54–4.66 (m, 1H), 4.71–4.76 (m, 2H), 5.17–5.23 (m, 1H), 6.98–7.24 (m, 5H), 7.62–7.66 (m, 4H). LCMS (ESI): m/z 505 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>S</i>)-<i>N</i>-(1-(1-(1<i>H</i>-Indazol-5-yl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl)-3-methyl-1-oxobutan-2-yl)-2-fluoro-5-(trifluoromethyl)benzamide (<b>10</b>)</h4><div class="NLM_p last">General procedure A was followed in preparing <b>10</b> to yield the desired product as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): 8.15–7.87 (m, 1H), 7.87–7.75 (m, 2H), 7.68–7.16 (m, 3H), 4.84–4.80 (m, 1H), 4.52–4.18 (m, 2H), 4.00–3.94 (m, 1H), 3.54–3.48 (m, 1H), 3.11(s,3H), 2.26–1.74 (m, 5H), 0.99–0.67 (m, 6H). LCMS (ESI): <i>m</i>/<i>z</i> 589 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>R</i>)-<i>N</i>-(1-Cyclohexyl-2-(1-cyclopropyl-3-methyl-4-oxo-1,3,8-triazaspiro[4.5]decan-8-yl)-2-oxoethyl)-2-fluoro-3-methylbenzamide (<b>11</b>)</h4><div class="NLM_p last">General procedure A was followed in the synthesis of <b>11</b> using starting material <b>11c</b> to yield the desired product as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO) δ 8.35–8.32 (m, 1H), 7.39 (t, <i>J</i> = 6.0 Hz, 1H), 7.37 (s, 1H), 7.14 (t, <i>J</i> = 6.0 Hz, 1H), 4.81 (t, <i>J</i> = 9.0 Hz, 1H), 4.25–4.12 (m, 3H), 4.02–3.98 (m, 1H), 3.77–3.70 (m, 1H), 3.35–3.32 (m, 1H), 2.76 (s, 3H), 2.26 (s, 3H), 2.07–1.62 (m, 11H), 1.16–0.90 (m, 5H), 0.44–0.31 (m, 4H). LCMS (ESI): <i>m</i>/<i>z</i> 485 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>R</i>)-<i>N</i>-(1-Cyclohexyl-2-(3-methyl-4-oxo-1-(pyridin-2-yl)-1,3,8-triazaspiro[4.5]decan-8-yl)-2-oxoethyl)-3-methylbenzamide (<b>12</b>)</h4><div class="NLM_p last">General procedure A was followed in the synthesis of <b>12</b> using <b>12d</b> as the starting material to give the desired product as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO) δ 8.15–7.90 (m, 2H), 7.75–7.65 (m, 2H), 7.50–7.25 (m, 3H), 6.75–6.55 (m, 1H), 6.48 (d, <i>J</i> = 9.0 Hz, 1H), 4.90 (t, <i>J</i> = 9.0 Hz, 1H), 4.76 (s, 2H), 4.50–4.10 (m, 3H), 3.90–3.75 (m, 1H), 3.50–3.25 (m, 1H), 2.93 (s, 3H), 2.37 (s, 2H), 1.82–1.63 (m, 9H), 1.27–1.11 (m, 6H). LCMS (ESI): <i>m</i>/<i>z</i> 504 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>R</i>)-2-Fluoro-3-methyl-<i>N</i>-(3-methyl-1-(3-methyl-2,4-dioxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-oxobutan-2-yl)benzamide (<b>13</b>)</h4><div class="NLM_p last">General procedure A was followed to afford the desired product <b>13</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CD3OD): δ 7.60–7.20 (m, 7H), 7.16(t, <i>J</i> = 7.6Hz, 1H), 4.84 (t, <i>J</i> = 7.6Hz, 1H), 4.55–4.35 (m, 1H), 4.35–4.20 (m, 1H), 4.00–3.90 (m, 1H), 3.55–3.45 (m, 1H), 3.15(s, 3H), 2.33(s, 3H), 2.26–1.60 (m, 5H), 1.02–0.77 (m, 6H). LCMS (ESI): <i>m</i>/<i>z</i> 495 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>R</i>)-<i>N</i>-(1-(1-(1<i>H</i>-Indazol-5-yl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl)-3-methyl-1-oxobutan-2-yl)-3-(trifluoromethyl)benzamide (<b>14</b>)</h4><div class="NLM_p last">General procedure A was followed to obtain <b>14</b> as a white solid. <sup>1</sup>H NMR (400 MHz, MeOD) δ = 8.18–8.01 (m, 2H), 7.96–7.77 (m, 2H), 7.67–7.58 (m, 2H), 7.51–7.47 (m, 1H), 7.29–7.15 (m, 1H), 4.78–4.74 (m, 1H), 4.52–4.42 (m, 2H), 3.99–3.92 (m, 1H), 3.53–3.46 (m, 1H), 3.10 (s, 3H), 2.25–1.75 (m, 5H), 1.09–0.94 (m, 4H), 0.88–0.86 (m, 1H), 0.62–0.61 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 571 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>R</i>)-<i>N</i>-(1-(1-(1<i>H</i>-Indazol-5-yl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl)-3-methyl-1-oxobutan-2-yl)-2-methyl-5-(trifluoromethyl)benzamide (<b>15</b>)</h4><div class="NLM_p last">General procedure A was followed to obtain <b>15</b> as a white solid. <sup>1</sup>H NMR (400 MHz, MeOD) δ = 8.08 (m, 1H), 7.84–7.50 (m, 3H), 7.44 (m, 1H), 7.25 (m, 2H), 4.75 (m, 1H), 4.62–4.17 (m, 2H), 4.00 (m, 1H), 3.51 (m, 1H), 3.12 (s, 3H), 2.43 (m, 1H), 2.12 (m, 4H), 1.89–1.70 (m, 3H), 1.10–0.58 (m, 6H). LCMS (ESI): <i>m</i>/<i>z</i> 585 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>R</i>)-<i>N</i>-(1-(1-(1<i>H</i>-Indazol-5-yl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl)-3-methyl-1-oxobutan-2-yl)-2-chloro-5-(trifluoromethyl)benzamide (<b>16</b>)</h4><div class="NLM_p last">General procedure A was followed to obtain <b>16</b> as a white solid. <sup>1</sup>H NMR (400 MHz, MeOD) δ = 8.16–8.00 (m, 1H), 7.78–7.68 (m, 3H), 7.57–7.51 (m, 1H), 7.45–7.40 (m, 1H), 7.18–7.34 (m, 1H), 4.82–4.74 (m, 1H), 4.54–4.34 (m, 2H), 4.05–3.94 (m, 1H), 3.58–3.48 (m, 1H), 3.12 (s, 3H), 2.28–2.00 (m, 4H), 1.80–1.71 (m, 1H), 0.99–066 (m, 6H). LCMS (ESI): <i>m</i>/<i>z</i> 605 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (<i>R</i>)-<i>N</i>-(2-(1-(1<i>H</i>-Indazol-5-yl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl)-1-cyclopentyl-2-oxoethyl)-2-fluoro-5-(trifluoromethyl)benzamide (<b>17</b>)</h4><div class="NLM_p last">General procedure A was followed to obtain <b>17</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 8.15–7.96 (m, 1H), 7.86–7.74 (m, 2H), 7.68–7.66 (m, 1H), 7.52–7.39 (m, 1H), 7.30–7.14 (m, 2H), 4.84–4.83 (m, 1H, contained in solvent), 4.51–4.47 (m, 1H), 4.33–4.30 (m, 1H), 4.00–3.92 (m, 1H), 3.54–3.48 (m, 1H), 3.10 (s, 3H), 2.40–2.34 (m, 1H), 2.23–2.09 (m, 2H), 1.96–1.23 (m, 10H). LCMS (ESI): <i>m</i>/<i>z</i> 615 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(2-(1-(1<i>H</i>-Indazol-5-yl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl)-2-oxoethyl)-2-fluoro-5-(trifluoromethyl)benzamide (<b>18</b>)</h4><div class="NLM_p last">General procedure A was followed to obtain <b>18</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/MeOD) δ = 1.80–2.13 (m, 5H), 3.10 (s, 3H), 3.42–3.61 (m, 1H), 3.83–3.91 (m, 2H), 4.21–4.23 (m, 2H), 4.39–4.49 (m, 1H), 7.20–7.23 (m, 1H), 7.34–7.40 (m, 1H), 7.60–7.63 (m, 1H), 7.71–7.72 (m, 1H), 7.82–7.83 (m, 1H), 8.09–8.11 (m, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 547 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (<i>R</i>)-<i>N</i>-(1-(1-(1<i>H</i>-Indazol-5-yl)-3-methyl-4-oxo-1,3,8-triazaspiro[4.5]decan-8-yl)-3-methyl-1-oxobutan-2-yl)-2-fluoro-5-(trifluoromethyl)benzamide (<b>19</b>)</h4><div class="NLM_p last">General procedure A was followed to obtain <b>19</b> as a white solid. <sup>1</sup>H NMR (400 MHz, MeOD) δ = 8.21–8.01 (m, 1H), 7.93–7.80 (m, 2H), 7.53–7.17 (m, 4H), 5.01–4.98 (m, 1H), 4.78–4.75 (m, 2H), 4.34–3.94 (m, 3H), 3.66–3.56 (m, 1H), 3.02 (s, 3H), 2.19–1.82 (m, 5H), 1.06–0.85 (m, 6H). LCMS (ESI): <i>m</i>/<i>z</i> 575 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>R</i>)-2-Fluoro-<i>N</i>-(3-methyl-1-(3-methyl-2,4-dioxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-1-oxobutan-2-yl)-5-(trifluoromethyl)benzamide (<b>20</b>)</h4><div class="NLM_p last">General procedure A was followed to obtain <b>20</b> as a white solid. <sup>1</sup>H NMR (400 MHz, MeOD) δ = 0.78–1.02 (m, 6H), 1.67–1.88 (m, 1H), 1.98–2.18 (m, 4H), 3.09 (s, 3H), 3.45–3.52 (m, 1H), 3.92–4.00 (m, 1H), 4.18–4.30 (m, 1H), 4.39–4.51 (m, 1H), 4.85 (d, 1H), 7.23–7.32 (m, 2H), 7.38–7.52 (m, 4H), 7.86–8.02 (m, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 549 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4-(8-((2-Fluoro-5-(trifluoromethyl)benzoyl)-<span class="smallcaps smallerCapital">d</span>-valyl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-1-yl)benzoic acid (<b>21</b>)</h4><div class="NLM_p last">General procedure A was followed to obtain <b>21</b> as a white solid. <sup>1</sup>H NMR (400 MHz, MeOD) δ = 8.16–8.00 (m, 2H), 7.88–7.85 (m, 2H), 7.46–7.34 (m, 3H), 4.87–4.83 (m, 1H), 4.59–4.43 (m, 1H), 4.31–4.20 (m, 1H), 3.99–3.93 (m, 1H), 3.54–3.47 (m, 1H), 3.10 (s, 3H), 2.24–1.88 (m, 4H), 1.86–1.70 (m, 1H), 1.01–0.80 (m, 6H). LCMS (ESI): <i>m</i>/<i>z</i> 593 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>R</i>)-2-Fluoro-<i>N</i>-(3-methyl-1-(3-methyl-2,4-dioxo-1-(p-tolyl)-1,3,8-triazaspiro[4.5]decan-8-yl)-1-oxobutan-2-yl)-5-(trifluoromethyl)benzamide (<b>22</b>)</h4><div class="NLM_p last">General procedure A was followed to obtain <b>22</b> as a white solid. <sup>1</sup>H NMR (400 MHz, MeOD) δ = 0.78–0.99 (m, 6H), 1.65–2.18 (m, 5H), 2.30–2.41 (m, 3H), 3.08 (s, 3H), 3.44–3.52 (m, 1H), 3.90–3.99 (m, 1H), 4.16–4.50 (m, 2H), 4.84–4.88 (m, 1H), 7.08–7.46 (m, 5H), 7.88–8.02 (m, 2H), 8.43–8.52 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 563 (M + 1)<sup>+</sup>.</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (<i>R</i>)-<i>N</i>-(1-(1-(3-Chlorophenyl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl)-3-methyl-1-oxobutan-2-yl)-2-fluoro-5-(trifluoromethyl)benzamide (<b>23</b>)</h4><div class="NLM_p last">General procedure A was followed to obtain <b>23</b> as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ = 0.87–1.05 (m, 6H), 1.77–1.80 (m, 1H), 1.91–2.12 (m, 4H), 3.15 (s, 3H), 3.46–3.53 (m, 1H), 3.98–4.04 (m, 2H), 4.63–4.66 (m, 1H), 4.98–5.01 (m, 1H), 7.05–7.11 (m, 1H), 7.17–7.29 (m, 2H), 7.35–7.46 (m, 3H), 7.75–7.78 (m, 1H), 8.25–8.36 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 583 (M + 1)<sup>+</sup>.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Protein Production</h3><div class="NLM_p last">FLAG-tagged human autotaxin was purified from the media of the human cell line Freestyle 293 and shown to be active using the synthetic substrate FS-3. Prior to selection, autotaxin was confirmed to be a monomer by size-exclusion chromatography, and it was also shown to be enzymatically active after immobilization on an anti-FLAG resin.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Affinity-Mediated Selection</h3><div class="NLM_p last">A set of 11 different DNA-encoded chemical libraries and autotaxin were combined together in a model extracellular buffer and incubated for 1 h. The concentration of each library was 1.7 μM, the concentration of autotaxin was 100 nM, and the buffer contained HEPES (20 mM), potassium acetate (4 mM), sodium acetate (26 mM), sodium chloride (112 mM), magnesium acetate (1.5 mM), calcium acetate (1.8 mM), and sheared salmon sperm DNA (1 mg/ml, Invitrogen), Tween 20 (0.02%) at pH 7.4. The mixture was then flowed over a 5 μl bed of M2 Anti-FLAG matrix (Sigma, St Louis, MO) contained within a Phynexus PhyTip<sup>TM</sup> (Phynexus, San Jose, CA) mounted on a computer-controlled multichannel pipettor with 20 passages followed by successive washes with eight 200 μL incubation buffer aliquots. Retained library members were then eluted by incubation with 60 μL of the buffer heated at 72 °C for 5 min followed by a further incubation with a second 5 μL resin bed of M2 Anti-FLAG Matrix to remove any eluted protein. This protocol was repeated with a fresh addition of autotaxin to half of the round-one eluate. Encoding oligonucleotides present in the round-two eluate were then amplified using Platinum PCR Supermix (Invitrogen) with denaturation at 94 °C, annealing at 55 °C, and extension at 72 °C using 5′- and 3′-primers (each at 0.5 μM) that each include sequences complementary to the library tailpiece or headpiece along with the Illumina READ1 or READ2 sequences required to support clustering and subsequent single-read 100 base-pair sequencing on an Illumina HiSeq. 2500 in the high-output mode. Sequencing was also performed for PCR-amplified samples of the naïve (unselected) library and the output of a no-target selection performed in parallel in the absence of autotaxin. In total, 3 731 886 sequence reads were determined from the selection output using 100 nM autotaxin and 1 349 039 were from the no-target selection. Sequence data were converted back into encoded chemical information computationally, and demographic and statistical information were calculated for individual building block combinations.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Autotaxin Enzyme Assays</h3><div class="NLM_p">Initially, autotaxin activity was measured using the fluorescent substrate FS-3 (Echelon Biosciences). Purified autotaxin was diluted to a final concentration of 10 nM in an FS-3 assay buffer (50 mM Tris-HCl pH 8, 140 mM NaCl, 5 mM KCl, 1 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>). A total of 16 μL of diluted enzyme was added to wells of a 384-well assay plate, followed by 2 μL of 10× compound in assay buffer plus 10% DMSO. The reaction was started by the addition of 2 μL of a 10 μM FS-3 reagent so that the final concentration of FS-3 was 1 μM. The cleavage of FS-3 resulted in an increase of fluorescence that was monitored kinetically on a Tecan M200 plate reader set to an excitation wavelength of 485 nM and an emission wavelength of 520 nM.</div><div class="NLM_p last">Autotaxin activity was also measured by determining the amount of choline released from LPC 16:0 using a choline oxidase/HRP coupled assay (BioDuro, Shanghai). Human autotaxin was produced by overexpression of a full-length C-terminal FLAG-tagged construct in Freestyle 293 cells (Thermo Fisher Scientific). Secreted autotaxin was purified from the media using affinity purification with an anti-FLAG resin (Millipore Sigma A2220) according to the instructions provided by the vendor. For the activity assay, 5 μL of 20 nM purified human autotaxin was premixed with an equal volume of the test compound in a 384-well plate in a choline assay buffer (100 mM Tris-HCl pH 9, 500 mM NaCl, 5 mM MgCl<sub>2</sub>, 5 mM CaCl<sub>2</sub>, 0.05% Triton X-100) and incubated for 10 min at room temperature. To initiate the reaction, 5 μL of 400 μM LPC 16:0 in methanol (Millipore Sigma L5254) was added to the wells and the plate was incubated for 1 h at room temperature while shaking. The amount of choline released during this reaction was measured by the addition of 2.5 μL of a mixture of 0.8 U/mL choline oxidase (Millipore Sigma C5896) and 8 U/mL horseradish peroxidase (Millipore Sigma P8375) followed by the addition of 2.5 μL of 400 μM Ampliflu Red (Millipore Sigma 90101) to bring the total reaction volume to 20 μL. The reaction was incubated for 10 min at room temperature, and then, the fluorescence intensity using excitation wavelength of 530 nM and emission wavelength of 590 nM was read on the Enspire plate reader (PerkinElmer).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Human Plasma Autotaxin Assay</h3><div class="NLM_p last">Autotaxin inhibitory activity of compounds in human plasma was determined using an LCMS-/MS-based detection method for the LPA products (BioDuro, Shanghai). Compounds were serially diluted 1:3 in pure DMSO. Human whole blood was transferred to a deep 96-well plate, 500 μL per well. Then, 0.5 μL of compounds was added to each well of the plate. The top concentration of compounds was 10 μM, while the DMSO concentration was 0.1%. The plate was incubated at 37 °C for 2 h. The reaction was stopped by centrifugation at 800 g for 10 min to generate the plasma samples. Another plate at time 0 (before the incubation) was used as the low control. The LPA 20:4, LPA 18:2, LPA 18:1, and LPA 16:0 production in this period was determined using LCMS/MS. Briefly, 10 μL of plasma sample was extracted with 200 μL of acetonitrile/methanol/acetic acid (50:50:1) containing LPA 17:0 at 5 ng/mL as the internal standard, and the supernatant was used for LCMS analysis. All separations were performed on a Phenomenex Luna 5u C5 column (2.0 × 30 mm<sup>2</sup>) at room temperature with a flow rate of 1.00 mL/min. Mobile phase A consisted of 10 mM ammonium acetate and 0.1% formic acid in water, and mobile phase B consisted of 0.1% formic acid in acetonitrile. Chromatography used a step gradient by maintaining 22% mobile phase B for 0.5 min, 22–85% mobile phase B over 0.5 min, and maintaining at 85% mobile phase B for 1.5 min, and then re-equilibration back to 22% B. The total run time was 3.00 min. For all samples, 10 μL aliquot of the sample was injected. The mass spectrometer (API 4500 QTrap, Applied Biosystems/MDS SCIEX Instruments, Foster City, CA) was operated in the positive ion multiple reaction monitoring mode (MRM). The data were normalized (reaction without inhibitor = 0% inhibition; reaction at time 0 = 100% inhibition), and IC<sub>50</sub> values were calculated by a 4-parameter fit with Prism.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Mouse Plasma Autotaxin Assay</h3><div class="NLM_p last">Autotaxin activity in mouse plasma was measured using an LCMS-/MS-based detection system (Seventh Wave, MO). Animal studies conducted at Seventh Wave used AAALAC-accredited animal facilities at St. Louis University’s Department of Comparative Medicine and were approved by an independent IACUC at St. Louis University. Two groups of 10 naive mice/group were used to create two different lots of freshly collected plasma in EDTA. Following collection, plasma was placed on wet ice and sent for use in the LPA assay. Plasma was aliquoted in equal volumes and then spiked with compound <b>1</b> or GLPG1690 with a 9-point concentration curve ranging from 0.153 to 10 000 nM. Samples were kept on wet ice until the start of the assay. After spiking with the test article, samples were placed in a 37 °C incubator for 2 h. At the end of the 2 h incubation, samples were extracted with a protein precipitate quench in acetonitrile containing the internal standard LPA 17:0. Samples were analyzed for three LPAs—16:0, 18:2, and 20:4—using standard LCMS/MS methods.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Inhibition of LPA Production after Oral Dosing of Compound <b>1</b> in Rats</h3><div class="NLM_p last">For the rat compound <b>1</b><i>ex vivo</i> study, a total of 45 male rats (BioDuro, Shanghai, China) were divided into 9 groups, with 5 rats/group. All animal work at BioDuro was conducted in compliance with institutional guidelines in their Assessment and Accreditation of Laboratory Animal Care (AAALAC) accredited facility and approved by an independent Institutional Animal Care and Use Committee (IACUC). Groups 1, 4, and 7 were dosed with vehicle only (0.5% methylcellulose), group 2 received 10 mg/kg compound <b>1</b>, group 3 received 30 mg/kg compound <b>1</b>, group 5 received 1 mg/kg compound <b>1</b>, group 6 received 3 mg/kg compound <b>1</b>, group 8 received 0.1 mg/kg compound <b>1</b>, and group 9 received 0.3 mg/kg compound <b>1</b>, all dosed via oral gavage. Blood samples were collected into 10 mL heparinized tubes predose and at 4 h after dosing and immediately centrifuged at 800<i>g</i> for 10 min at 4 °C and then frozen at 80 °C. For analysis of autotaxin activity, samples of both pouch and plasma were incubated at room temperature for 4 h. LPA 20:4 was produced from existing LPC and autotaxin levels in those fluids. The difference in LPA levels from time 0–4 h was used to calculate the autotaxin activity. LPA 20:4 was analyzed using LCMS/MS. In brief, 10 μL of the sample was extracted with 200 μL of acetonitrile/methanol/acetic acid (50:50:1) containing LPA 17:0 at 5 ng/mL as the internal standard, and the supernatant was used for LCMS analysis. The concentration of compound <b>1</b> in both rat air pouch fluid (APF) and plasma samples was also determined by LCMS/MS. In brief, 50 HL of samples was extracted by acetonitrile (150 UL) containing terfenadine at 50 ng/mL as the internal standard, and the supernatant was injected for LCMS/MS analysis.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Mouse Lung Fibrosis Models</h3><div class="NLM_p">The effects of compound <b>1</b> on bleomycin-induced fibrosis were tested in both prophylactic and therapeutic modes (Aragen Bioscience, CA). Aragen Bioscience is fully accredited by AAALAC, and all studies were conducted under the oversight of an independent IACUC, responsible for monitoring all associated animal care and use. In the prophylactic model, dosing was initiated prior to bleomycin treatment. A total of 140 male C57BL/6 mice, 6–7 weeks of age, were randomized into seven groups, each with subgroup A and subgroup B. There were 10 animals per subgroup such that mean body weights were similar for the different groups. Treatment in groups 2–7 was initiated one day prior to bleomycin administration through to the study end on day 21. On day 1, animals were dosed twice daily (BID) via oral gavage with a vehicle control (0.5% methylcellulose; group 2), compound <b>1</b> at 30 mg/kg/dose, 100 mg/kg/dose, or 300 mg/kg/dose (group 3, group 4, and group 5, respectively), or GLPG1690 at 30 mg/kg/dose or 100 mg/kg/dose (group 6 and group 7, respectively) for the duration of the 21 days. On day 0, all mice in groups 2–7 received a single instillation of bleomycin (1.5 U/kg) oropharyngeally to induce pulmonary fibrosis. Animals in group 1 were not instilled with bleomycin but instead received a single dose of saline and were considered sham-negative control mice.</div><div class="NLM_p">For A subgroups, lungs were fixed in 10% NBF and used for histopathology analysis. For B subgroups, absolute lung weights and lung weights normalized to body weights were measured from all surviving animals on day 21 and the lung tissue was snap-frozen for hydroxyproline analysis.</div><div class="NLM_p last">The therapeutic study was designed to test the effects of compound <b>1</b> on bleomycin-induced fibrosis when dosing was initiated after bleomycin treatment. On day 0, 150 male mice received a single instillation of bleomycin to induce pulmonary fibrosis. Animals designated for groups 1A and 1B were not instilled with bleomycin but instead received a single dose of saline and were considered sham-negative control mice. On day 7, animals were weighed, and 120 bleomycin-instilled animals were randomized into six groups, each with subgroup A and subgroup B. There were 10 animals per subgroup such that mean body weights were similar for the different groups. The selected animals were transferred to new cages, while the remaining 30 animals with lower or higher body weights were excluded from the study. Starting on day 7, animals were dosed twice daily (BID) via oral gavage with a vehicle control (0.5% methylcellulose; group 2), compound <b>1</b> at 30 mg/kg/dose, 100 mg/kg/dose, or 300 mg/kg/dose (group 3, group 4, and group 5, respectively), or GLPG1690 at 30 mg/kg/dose or 100 mg/kg/dose (group 6 and group 7, respectively) until study termination at 21 days. Lung tissues were treated in the same way as described for the prophylactic study.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00688" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22444" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22444" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00688?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00688</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthesis of intermediates, NMR spectra and LCMS profile, animal model supplemental data, and cocrystallization protocol (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00688/suppl_file/jm0c00688_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and associated biological assay data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00688/suppl_file/jm0c00688_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00688/suppl_file/jm0c00688_si_001.pdf">jm0c00688_si_001.pdf (857.23 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00688/suppl_file/jm0c00688_si_002.csv">jm0c00688_si_002.csv (2.01 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB ID for the cocrystal structure of compound <b>1</b> with human autotaxin is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W35">6W35</a>. The authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c00688" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18670" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18670" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John W. Cuozzo</span> - <span class="hlFld-Affiliation affiliation">X-Chem,
Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</span>; 
    <span>Present Address:
                        ZebiAI Therapeutics, 100 Beaver Street, Suite 201, Waltham, Massachusetts 02543, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6229-0395" title="Orcid link">http://orcid.org/0000-0002-6229-0395</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bed4ddcbd1c4c4d1fec4dbdcd7dfd790ddd1d3"><span class="__cf_email__" data-cfemail="8ee4edfbe1f4f4e1cef4ebece7efe7a0ede1e3">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying Zhang</span> - <span class="hlFld-Affiliation affiliation">X-Chem,
Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9ce5e6f4fdf2fbdce4b1fff4f9f1eee4b2fff3f1"><span class="__cf_email__" data-cfemail="5821223039363f1820753b303d352a20763b3735">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew A. Clark</span> - <span class="hlFld-Affiliation affiliation">X-Chem,
Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony D. Keefe</span> - <span class="hlFld-Affiliation affiliation">X-Chem,
Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Kohlmann</span> - <span class="hlFld-Affiliation affiliation">X-Chem,
Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</span>; 
    <span>Present Address:
                        Black Diamond Therapeutics, 139 Main Street, Suite 301, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Mulvihill</span> - <span class="hlFld-Affiliation affiliation">X-Rx,
Inc., 430 East 29th Street,
Suite 1060, New York, New
York 10016, United
States</span>; 
    <span>Present Address:
                        Hibercell, 619 West 54th Street, 8th Floor, New York, New York 10019, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haihong Ni</span> - <span class="hlFld-Affiliation affiliation">BioDuro,
LLC, Building E, No. 29 Life Science Park Road, Changping
District, Beijing 102206, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louis M. Renzetti</span> - <span class="hlFld-Affiliation affiliation">X-Rx,
Inc., 430 East 29th Street,
Suite 1060, New York, New
York 10016, United
States</span>; 
    <span>Present Address:
                        Bridge Medicines, LLC, 420 East 70th Street, New York, New York 10021, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel I. Resnicow</span> - <span class="hlFld-Affiliation affiliation">X-Chem,
Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Ruebsam</span> - <span class="hlFld-Affiliation affiliation">BioDuro,
LLC, Building E, No. 29 Life Science Park Road, Changping
District, Beijing 102206, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric A. Sigel</span> - <span class="hlFld-Affiliation affiliation">X-Chem,
Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</span>; 
    <span>Present Address:
                        ZebiAI Therapeutics, 100 Beaver Street, Suite 201, Waltham, Massachusetts 02543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heather A. Thomson</span> - <span class="hlFld-Affiliation affiliation">X-Chem,
Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ce Wang</span> - <span class="hlFld-Affiliation affiliation">BioDuro,
LLC, Building E, No. 29 Life Science Park Road, Changping
District, Beijing 102206, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhifeng Xie</span> - <span class="hlFld-Affiliation affiliation">BioDuro,
LLC, Building E, No. 29 Life Science Park Road, Changping
District, Beijing 102206, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.W.C. performed the initial protein expression and purification, developed enzymatic activity assays, designed and oversaw the mouse PK, ex vivo work, animal efficacy studies, and IND-enabling studies, and performed data interpretation. A.D.K., D.I.R., and H.A.T. designed the affinity-mediated selection. D.I.R. and H.A.T. performed affinity-mediated selections. A.D.K. and Y.Z. interpreted the selection output data. Y.Z. and M.A.C. designed compounds. L.M.R. and M.M. led X-Rx late-stage lead optimization as well as the drug discovery and development campaign through development candidate nomination. F.R. led the hit to lead and lead optimization chemistry at BioDuro. CW led the early hit expansion at BioDuro. H.N. provided computational chemistry support, and Z.X. led the synthetic chemistry efforts at BioDuro. A.K. interpreted the crystallography data. A.D.K., A.K., J.W.C., and Y.Z. wrote the manuscript. All authors have given approval to the final version of the manuscript with the exception of H.A.T., who is deceased.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): All authors are current or former employees of X-Chem Pharmaceuticals, X-Rx, Inc. or BioDuro as noted in their author affiliations.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e2978-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83374" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83374" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors would like to acknowledge the involvement of X-Rx and BioDuro in the lead optimization efforts for the autotaxin program and Seventh Wave for the mouse plasma assay, bioanalytical support, and preclinical development activities. The authors would also like to acknowledge Aragen Bioscience for running the bleomycin mouse models. The X-ray structure of autotaxin in complex with compound <b>1</b> was generated at Proteros Biostructures GmbH, Martinsried, Germany. The authors would also like to acknowledge Patrick Mullins (X-Chem) for generating the <sup>1</sup>H and <sup>13</sup>C NMR spectra and the LCMS profile of compound <b>1</b> provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00688/suppl_file/jm0c00688_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ATX</td><td class="NLM_def"><p class="first last">autotaxin</p></td></tr><tr><td class="NLM_term">Bleo</td><td class="NLM_def"><p class="first last">bleomycin</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum serum concentration</p></td></tr><tr><td class="NLM_term">CYP3A4</td><td class="NLM_def"><p class="first last">cytochrome P450 3A4</p></td></tr><tr><td class="NLM_term">CYP2D6</td><td class="NLM_def"><p class="first last">cytochrome P450 2D6</p></td></tr><tr><td class="NLM_term">CYP1A2</td><td class="NLM_def"><p class="first last">cytochrome P450 1A2</p></td></tr><tr><td class="NLM_term">CYP2C9</td><td class="NLM_def"><p class="first last">cytochrome P450 2C9</p></td></tr><tr><td class="NLM_term">CYP2C19</td><td class="NLM_def"><p class="first last">cytochrome P450 2C19</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">DECL</td><td class="NLM_def"><p class="first last">DNA-encoded chemical library</p></td></tr><tr><td class="NLM_term">ENPP1</td><td class="NLM_def"><p class="first last">ectonucleotide pyrophosphatase/phosphodiesterase family member 1</p></td></tr><tr><td class="NLM_term">FVC</td><td class="NLM_def"><p class="first last">forced vital capacity</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">IPF</td><td class="NLM_def"><p class="first last">idiopathic pulmonary fibrosis</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography mass spectrometry</p></td></tr><tr><td class="NLM_term">LPA</td><td class="NLM_def"><p class="first last">lysophosphatidic acid</p></td></tr><tr><td class="NLM_term">LPC</td><td class="NLM_def"><p class="first last">lysophosphatidylcholine</p></td></tr><tr><td class="NLM_term">NBF</td><td class="NLM_def"><p class="first last">neutral buffered formalin</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per os</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">steady-state volume of distribution</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakanaga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span> <span> </span><span class="NLM_article-title">Autotaxin--an LPA producing enzyme with diverse functions</span>. <i>J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1093/jb/mvq052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1093%2Fjb%2Fmvq052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=20495010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlChsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2010&pages=13-24&author=K.+Nakanagaauthor=K.+Hamaauthor=J.+Aoki&title=Autotaxin%2D%2Dan+LPA+producing+enzyme+with+diverse+functions&doi=10.1093%2Fjb%2Fmvq052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin-an LPA producing enzyme with diverse functions</span></div><div class="casAuthors">Nakanaga, Keita; Hama, Kotaro; Aoki, Junken</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-24</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX) is an ecto-enzyme responsible for lysophosphatidic acid (LPA) prodn. in blood.  ATX is present in various biol. fluids such as cerebrospinal and seminal fluids and accounts for bulk LPA prodn. in these fluids.  ATX is a member of the nucleotide pyrophosphatase/phosphodiesterase (NPP) family and was originally isolated from conditioned medium of melanoma cells as an autocrine motility stimulating factor.  LPA, a second-generation lipid mediator, binds to its cognate G protein-coupled receptors through which it exerts a no. of biol. functions including influencing cell motility and proliferation stimulating activity.  Some of the biol. roles of LPA can be mediated by ATX.  However, there are other LPA-producing pathways independent of ATX.  The accumulating evidences for physiol. and pathol. functions of ATX strongly support that ATX is an important therapeutic target.  This review summarizes the historical aspects, structural basis, pathophysiol. functions identified in mice studies and clin. relevance discovered by measuring the blood ATX level in human.  The general features and functions of each NPP family member will be also briefly reviewed.  The presence of the ATX gene in other model organisms and recently developed ATX inhibitors, both of which will be definitely useful for further functional anal. of ATX, will also be mentioned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd2JaqHS4pL7Vg90H21EOLACvtfcHk0lj-_IpABU7oZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlChsLg%253D&md5=584a80ff7d28d8bdec20ff6615897a25</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvq052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvq052%26sid%3Dliteratum%253Aachs%26aulast%3DNakanaga%26aufirst%3DK.%26aulast%3DHama%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26atitle%3DAutotaxin--an%2520LPA%2520producing%2520enzyme%2520with%2520diverse%2520functions%26jtitle%3DJ.%2520Biochem.%26date%3D2010%26volume%3D148%26spage%3D13%26epage%3D24%26doi%3D10.1093%2Fjb%2Fmvq052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukaya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">17634</span>– <span class="NLM_lpage">17639</span>, <span class="refDoi"> DOI: 10.1074/jbc.M313927200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1074%2Fjbc.M313927200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=14744855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1Gntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=17634-17639&author=K.+Hamaauthor=J.+Aokiauthor=M.+Fukayaauthor=Y.+Kishiauthor=T.+Sakaiauthor=R.+Suzukiauthor=H.+Ohtaauthor=T.+Yamoriauthor=M.+Watanabeauthor=J.+Chunauthor=H.+Arai&title=Lysophosphatidic+acid+and+autotaxin+stimulate+cell+motility+of+neoplastic+and+non-neoplastic+cells+through+LPA1&doi=10.1074%2Fjbc.M313927200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic Acid and Autotaxin Stimulate Cell Motility of Neoplastic and Non-neoplastic Cells through LPA1</span></div><div class="casAuthors">Hama, Kotaro; Aoki, Junken; Fukaya, Masahiro; Kishi, Yasuhiro; Sakai, Teruyuki; Suzuki, Rika; Ohta, Hideo; Yamori, Takao; Watanabe, Masahiko; Chun, Jerold; Arai, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">17634-17639</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is a tumor cell motility-stimulating factor originally isolated from melanoma cell supernatant that has been implicated in regulation of invasive and metastatic properties of cancer cells.  Recently, the authors showed that ATX is identical to lysophospholipase D, which converts lysophosphatidylcholine to a potent bioactive phospholipid mediator, lysophosphatidic acid (LPA), raising the possibility that autocrine or paracrine prodn. of LPA by ATX contributes to tumor cell motility.  Here the authors demonstrate that LPA and ATX mediate cell motility-stimulating activity through the LPA receptor, LPA1.  In fibroblasts isolated from lpa1-/- mice, but not from wild-type or lpa2-/-, cell motility stimulated with LPA and ATX was completely absent.  In the lpa1-/- cells, LPA-stimulated lamellipodia formation was markedly diminished with a concomitant decrease in Rac1 activation.  LPA stimulated the motility of multiple human cancer cell lines expressing LPA1, and the motility was attenuated by an LPA1-selective antagonist, Ki16425.  The present study suggests that ATX and LPA1 represent potential targets for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXizglGW6GZ7Vg90H21EOLACvtfcHk0lgDluDVooMSSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1Gntb8%253D&md5=1e8f83147cd198f84a531c6b4b629719</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M313927200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M313927200%26sid%3Dliteratum%253Aachs%26aulast%3DHama%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DFukaya%26aufirst%3DM.%26aulast%3DKishi%26aufirst%3DY.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DOhta%26aufirst%3DH.%26aulast%3DYamori%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DArai%26aufirst%3DH.%26atitle%3DLysophosphatidic%2520acid%2520and%2520autotaxin%2520stimulate%2520cell%2520motility%2520of%2520neoplastic%2520and%2520non-neoplastic%2520cells%2520through%2520LPA1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D17634%26epage%3D17639%26doi%3D10.1074%2Fjbc.M313927200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Meeteren, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruurs, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stortelers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouwman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rooijen, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradere, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakelam, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saulnier-Blache, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mummery, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moolenaar, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonkers, J.</span></span> <span> </span><span class="NLM_article-title">Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5015</span>– <span class="NLM_lpage">5022</span>, <span class="refDoi"> DOI: 10.1128/MCB.02419-05</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1128%2FMCB.02419-05" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=16782887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVSlurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=5015-5022&author=L.+A.+van%0AMeeterenauthor=P.+Ruursauthor=C.+Stortelersauthor=P.+Bouwmanauthor=M.+A.+van+Rooijenauthor=J.+P.+Pradereauthor=T.+R.+Pettitauthor=M.+J.+Wakelamauthor=J.+S.+Saulnier-Blacheauthor=C.+L.+Mummeryauthor=W.+H.+Moolenaarauthor=J.+Jonkers&title=Autotaxin%2C+a+secreted+lysophospholipase+D%2C+is+essential+for+blood+vessel+formation+during+development&doi=10.1128%2FMCB.02419-05"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development</span></div><div class="casAuthors">van Meeteren, Laurens A.; Ruurs, Paula; Stortelers, Catelijne; Bouwman, Peter; van Rooijen, Marga A.; Pradere, Jean Philippe; Pettit, Trevor R.; Wakelam, Michael J. O.; Saulnier-Blache, Jean Sebastien; Mummery, Christine L.; Moolenaar, Wouter H.; Jonkers, Jos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5015-5022</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Autotaxin (ATX), or nucleotide pyrophosphatase-phosphodiesterase 2, is a secreted lysophospholipase D that promotes cell migration, metastasis, and angiogenesis.  ATX generates lysophosphatidic acid (LPA), a lipid mitogen and motility factor that acts on several G protein-coupled receptors.  Here we report that ATX-deficient mice die at embryonic day 9.5 (E9.5) with profound vascular defects in yolk sac and embryo resembling the Gα13 knockout phenotype.  Furthermore, at E8.5, ATX-deficient embryos showed allantois malformation, neural tube defects, and asym. headfolds.  The onset of these abnormalities coincided with increased expression of ATX and LPA receptors in normal embryos.  ATX heterozygous mice appear healthy but show half-normal ATX activity and plasma LPA levels.  Our results reveal a crit. role for ATX in vascular development, indicate that ATX is the major LPA-producing enzyme in vivo, and suggest that the vascular defects in ATX-deficient embryos may be explained by loss of LPA signaling through Gα13.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoymaMrK5zKdLVg90H21EOLACvtfcHk0lgDluDVooMSSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVSlurs%253D&md5=d2f5f00f531895912bc2932ff868db73</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FMCB.02419-05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.02419-05%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DRuurs%26aufirst%3DP.%26aulast%3DStortelers%26aufirst%3DC.%26aulast%3DBouwman%26aufirst%3DP.%26aulast%3Dvan%2BRooijen%26aufirst%3DM.%2BA.%26aulast%3DPradere%26aufirst%3DJ.%2BP.%26aulast%3DPettit%26aufirst%3DT.%2BR.%26aulast%3DWakelam%26aufirst%3DM.%2BJ.%26aulast%3DSaulnier-Blache%26aufirst%3DJ.%2BS.%26aulast%3DMummery%26aufirst%3DC.%2BL.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DJonkers%26aufirst%3DJ.%26atitle%3DAutotaxin%252C%2520a%2520secreted%2520lysophospholipase%2520D%252C%2520is%2520essential%2520for%2520blood%2520vessel%2520formation%2520during%2520development%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D5015%26epage%3D5022%26doi%3D10.1128%2FMCB.02419-05" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nangaku, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yatomi, Y.</span></span> <span> </span><span class="NLM_article-title">Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation</span>. <i>Clin. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.cca.2007.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1016%2Fj.cca.2007.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=17963703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOltLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2008&pages=51-58&author=K.+Nakamuraauthor=K.+Igarashiauthor=K.+Ideauthor=R.+Ohkawaauthor=S.+Okuboauthor=H.+Yokotaauthor=A.+Masudaauthor=N.+Oshimaauthor=T.+Takeuchiauthor=M.+Nangakuauthor=S.+Okudairaauthor=H.+Araiauthor=H.+Ikedaauthor=J.+Aokiauthor=Y.+Yatomi&title=Validation+of+an+autotaxin+enzyme+immunoassay+in+human+serum+samples+and+its+application+to+hypoalbuminemia+differentiation&doi=10.1016%2Fj.cca.2007.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation</span></div><div class="casAuthors">Nakamura, Kazuhiro; Igarashi, Koji; Ide, Kazufumi; Ohkawa, Ryunosuke; Okubo, Shigeo; Yokota, Hiromitsu; Masuda, Akiko; Oshima, Noriko; Takeuchi, Takumi; Nangaku, Masaomi; Okudaira, Shinichi; Arai, Hiroyuki; Ikeda, Hitoshi; Aoki, Junken; Yatomi, Yutaka</div><div class="citationInfo"><span class="NLM_cas:title">Clinica Chimica Acta</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">51-58</span>CODEN:
                <span class="NLM_cas:coden">CCATAR</span>;
        ISSN:<span class="NLM_cas:issn">0009-8981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background: Autotaxin (ATX), a tumor cell motility-stimulating factor, regulates the blood concns. of lysophosphatidic acid (LPA), an important and multi-functional bioactive lipid, through its lysophospholipase D activity (lysoPLD).  The introduction of ATX measurements into clin. lab. testing is urgently needed.  Methods: Anti-human ATX monoclonal antibodies were produced by immunization of recombinant human ATX expressed in a baculovirus system.  An immunoassay for the quant. detn. of ATX was established, and human serum samples were assayed.  Results: The within-run and between-run precision, interference, detection limit, and linearity studies were satisfactory.  The central 95 percentile ref. interval for the serum ATX antigen concn. in healthy subjects was 0.468-1.134 mg/l (n = 120) and was strongly correlated with the serum lysoPLD activity.  The ATX concn. was significantly (p < 0.001) higher in women (0.625-1.323 mg/l) than in men (0.438-0.914 mg/l).  The serum ATX concns. were increased in patients with chronic liver diseases and decreased in postoperative prostate cancer patients but were not altered in nephrosis patients.  Thus, serum ATX antigen concns. could be used to discriminate these hypoalbuminemia conditions.  Conclusions: The present ATX antigen assay may be useful for clin. lab. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAP_2yrAa16LVg90H21EOLACvtfcHk0lgDluDVooMSSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOltLbE&md5=1870c68e6ddd690bca9bf1f26721806a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cca.2007.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cca.2007.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DK.%26aulast%3DIde%26aufirst%3DK.%26aulast%3DOhkawa%26aufirst%3DR.%26aulast%3DOkubo%26aufirst%3DS.%26aulast%3DYokota%26aufirst%3DH.%26aulast%3DMasuda%26aufirst%3DA.%26aulast%3DOshima%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DNangaku%26aufirst%3DM.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DYatomi%26aufirst%3DY.%26atitle%3DValidation%2520of%2520an%2520autotaxin%2520enzyme%2520immunoassay%2520in%2520human%2520serum%2520samples%2520and%2520its%2520application%2520to%2520hypoalbuminemia%2520differentiation%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D2008%26volume%3D388%26spage%3D51%26epage%3D58%26doi%3D10.1016%2Fj.cca.2007.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oikonomou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouratis, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzouvelekis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaffe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valavanis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilaras, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karameris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prestwich, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aidinis, V.</span></span> <span> </span><span class="NLM_article-title">Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2012-0004OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1165%2Frcmb.2012-0004OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=22744859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A280%3ADC%252BC38jlvVGisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=566-574&author=N.+Oikonomouauthor=M.+A.+Mouratisauthor=A.+Tzouvelekisauthor=E.+Kaffeauthor=C.+Valavanisauthor=G.+Vilarasauthor=A.+Karamerisauthor=G.+D.+Prestwichauthor=D.+Bourosauthor=V.+Aidinis&title=Pulmonary+autotaxin+expression+contributes+to+the+pathogenesis+of+pulmonary+fibrosis&doi=10.1165%2Frcmb.2012-0004OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis</span></div><div class="casAuthors">Oikonomou Nikos; Mouratis Marios-Angelos; Tzouvelekis Argyris; Kaffe Eleanna; Valavanis Christos; Vilaras George; Karameris Andreas; Prestwich Glenn D; Bouros Demosthenes; Aidinis Vassilis</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory cell and molecular biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">566-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic form of diffuse lung disease occurring mainly in older adults.  Increased lysophosphatidic acid (LPA) concentrations have been reported in the alveolar space of both idiopathic pulmonary fibrosis patients and a corresponding animal model, whereas the genetic deletion or pharmacological inhibition of LPA receptor 1 attenuated the development of the modeled disease, suggesting a direct involvement of LPA in disease pathogenesis.  In this report, increased concentrations of autotaxin (ATX; ENPP2), the enzyme largely responsible for extracellular LPA production, were detected in both murine and human fibrotic lungs.  The genetic deletion of ATX from bronchial epithelial cells or macrophages attenuated disease severity, establishing ATX as a novel player in IPF pathogenesis.  Furthermore, the pharmacological inhibition of ATX attenuated the development of the modeled disease, suggesting that ATX is a possible therapeutic target in IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLNdXayAacMr5XHngOXiV_fW6udTcc2eaBwlJWsFRGWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jlvVGisw%253D%253D&md5=f89e6297df4584c0b50c4ef5a33b0565</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2012-0004OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2012-0004OC%26sid%3Dliteratum%253Aachs%26aulast%3DOikonomou%26aufirst%3DN.%26aulast%3DMouratis%26aufirst%3DM.%2BA.%26aulast%3DTzouvelekis%26aufirst%3DA.%26aulast%3DKaffe%26aufirst%3DE.%26aulast%3DValavanis%26aufirst%3DC.%26aulast%3DVilaras%26aufirst%3DG.%26aulast%3DKarameris%26aufirst%3DA.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26aulast%3DBouros%26aufirst%3DD.%26aulast%3DAidinis%26aufirst%3DV.%26atitle%3DPulmonary%2520autotaxin%2520expression%2520contributes%2520to%2520the%2520pathogenesis%2520of%2520pulmonary%2520fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D47%26spage%3D566%26epage%3D574%26doi%3D10.1165%2Frcmb.2012-0004OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montesi, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathai, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorshkova, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berdyshev, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tager, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shea, B. S.</span></span> <span> </span><span class="NLM_article-title">Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis</span>. <i>BMC Pulm. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>, <span class="NLM_elocation-id">5</span> <span class="refDoi"> DOI: 10.1186/1471-2466-14-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1186%2F1471-2466-14-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=24468008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A280%3ADC%252BC2czptlOqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&author=S.+B.+Montesiauthor=S.+K.+Mathaiauthor=L.+N.+Brennerauthor=I.+A.+Gorshkovaauthor=E.+V.+Berdyshevauthor=A.+M.+Tagerauthor=B.+S.+Shea&title=Docosatetraenoyl+LPA+is+elevated+in+exhaled+breath+condensate+in+idiopathic+pulmonary+fibrosis&doi=10.1186%2F1471-2466-14-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Montesi Sydney B; Mathai Susan K; Brenner Laura N; Gorshkova Irina A; Berdyshev Evgeny V; Tager Andrew M; Shea Barry S</div><div class="citationInfo"><span class="NLM_cas:title">BMC pulmonary medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with no effective medical therapies.  Recent research has focused on identifying the biological processes essential to the development and progression of fibrosis, and on the mediators driving these processes.  Lysophosphatidic acid (LPA), a biologically active lysophospholipid, is one such mediator.  LPA has been found to be elevated in bronchoalveolar lavage (BAL) fluid of IPF patients, and through interaction with its cell surface receptors, it has been shown to drive multiple biological processes implicated in the development of IPF.  Accordingly, the first clinical trial of an LPA receptor antagonist in IPF has recently been initiated.  In addition to being a therapeutic target, LPA also has potential to be a biomarker for IPF.  There is increasing interest in exhaled breath condensate (EBC) analysis as a non-invasive method for biomarker detection in lung diseases, but to what extent LPA is present in EBC is not known.  METHODS:  In this study, we used liquid chromatography-tandem mass spectrometry (LC-MS/MS) to assess for the presence of LPA in the EBC and plasma from 11 IPF subjects and 11 controls.  RESULTS:  A total of 9 different LPA species were detectable in EBC.  Of these, docosatetraenoyl (22:4) LPA was significantly elevated in the EBC of IPF subjects when compared to controls (9.18 pM vs. 0.34 pM; p = 0.001).  A total of 13 different LPA species were detectable in the plasma, but in contrast to the EBC, there were no statistically significant differences in plasma LPA species between IPF subjects and controls.  CONCLUSIONS:  These results demonstrate that multiple LPA species are detectable in EBC, and that 22:4 LPA levels are elevated in the EBC of IPF patients.  Further research is needed to determine the significance of this elevation of 22:4 LPA in IPF EBC, as well as its potential to serve as a biomarker for disease severity and/or progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOxFjWK8pBEny-c-E1v-fmfW6udTcc2eaBwlJWsFRGWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czptlOqtA%253D%253D&md5=596c17030d7c144d3730e54b71f89829</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2F1471-2466-14-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2466-14-5%26sid%3Dliteratum%253Aachs%26aulast%3DMontesi%26aufirst%3DS.%2BB.%26aulast%3DMathai%26aufirst%3DS.%2BK.%26aulast%3DBrenner%26aufirst%3DL.%2BN.%26aulast%3DGorshkova%26aufirst%3DI.%2BA.%26aulast%3DBerdyshev%26aufirst%3DE.%2BV.%26aulast%3DTager%26aufirst%3DA.%2BM.%26aulast%3DShea%26aufirst%3DB.%2BS.%26atitle%3DDocosatetraenoyl%2520LPA%2520is%2520elevated%2520in%2520exhaled%2520breath%2520condensate%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DBMC%2520Pulm.%2520Med.%26date%3D2014%26volume%3D14%26doi%3D10.1186%2F1471-2466-14-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maher, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Aar, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Steen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allamassey, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desrivot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fieuw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuyts, W.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial</span>. <i>Lancet Respir. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">635</span>, <span class="refDoi"> DOI: 10.1016/S2213-2600(18)30181-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1016%2FS2213-2600%2818%2930181-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=29792287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpslygs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=627-635&author=T.+M.+Maherauthor=E.+M.+van+der+Aarauthor=O.+Van+de+Steenauthor=L.+Allamasseyauthor=J.+Desrivotauthor=S.+Dupontauthor=L.+Fagardauthor=P.+Fordauthor=A.+Fieuwauthor=W.+Wuyts&title=Safety%2C+tolerability%2C+pharmacokinetics%2C+and+pharmacodynamics+of+GLPG1690%2C+a+novel+autotaxin+inhibitor%2C+to+treat+idiopathic+pulmonary+fibrosis+%28FLORA%29%3A+a+phase+2a+randomised+placebo-controlled+trial&doi=10.1016%2FS2213-2600%2818%2930181-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial</span></div><div class="casAuthors">Maher, Toby M.; van der Aar, Ellen M.; Van de Steen, Olivier; Allamassey, Lisa; Desrivot, Julie; Dupont, Sonia; Fagard, Liesbeth; Ford, Paul; Fieuw, Ann; Wuyts, Wim</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Respiratory Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-635</span>CODEN:
                <span class="NLM_cas:coden">LRMAAU</span>;
        ISSN:<span class="NLM_cas:issn">2213-2600</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) causes irreversible loss of lung function.  People with IPF have increased concns. of autotaxin in lung tissue and lysophosphatidic acid (LPA) in bronchoalveolar lavage fluid and exhaled condensate.  GLPG1690 (Galapagos, Mechelen, Belgium) is a novel, potent, selective autotaxin inhibitor with good oral exposure.  We explored the effects of GLPG1690 in patients with IPF.  This was a randomised, double-blind, placebo-controlled phase 2a study done in 17 centers in Italy, Ukraine and the UK.  Eligible patients were aged 40 years or older, non-smokers, not taking pirfenidone or nintedanib, and had a centrally confirmed diagnosis of IPF.  We used a computer-generated randomisation schedule to assign patients 1:3 to receive placebo or 600 mg oral GLPG1690 once daily for 12 wk.  The primary outcomes were safety (adverse events), tolerability, pharmacokinetics, and pharmacodynamics.  Spirometry was assessed as a secondary outcome.  This trial is registered with ClinicalTrials.gov, no. NCT02738801.  Between March 24, 2016, and May 2, 2017, 72 patients were screened., of whom 49 were ineligible and 23 were enrolled in eight centers (six in Ukraine and two in the UK).  Six patients were assigned to receive placebo and 17 to receive GLPG1690. 20 patients completed the study after one in each group discontinued because of adverse events and one in the GLPG1690 group withdrew consent.  Four (67%) patients in the placebo group and 11 (65%) in the GLPG1690 group had treatment-emergent adverse events, most of which were mild to moderate.  The most frequent events in the GLPG1690 group were infections and infestations (ten events) and respiratory, thoracic, and mediastinal disorders (eight events) with no apparent differences from the placebo group.  Two (12%) patients in the GLPG1690 group had events that were judged to be related to treatment.  Serious adverse events were seen in two patients in the placebo group (one had a urinary tract infection, acute kidney injury, and lower respiratory tract infection and the other had atrioventricular block, second degree) and one in the GLPG1690 group (cholangiocarcinoma that resulted in discontinuation of treatment).  No patients died.  The pharmacokinetic and pharmacodynamic profiles of GLPG1690 were similar to those previously shown in healthy controls.  LPA C18:2 concns. in plasma were consistently decreased.  Mean change from baseline in forced vital capacity at week 12 was 25 mL (95% CI -75 to 124) for GLPG1690 and -70 mL (-208 to 68 mL) for placebo.  Our findings support further development of GLPG1690 as a novel treatment for IPF.Galapagos.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1oZ4wAtGZurVg90H21EOLACvtfcHk0lj1PNRs-6nbaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpslygs7k%253D&md5=e46089ac67abde0d487855d4a265d153</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS2213-2600%2818%2930181-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS2213-2600%252818%252930181-4%26sid%3Dliteratum%253Aachs%26aulast%3DMaher%26aufirst%3DT.%2BM.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%2BM.%26aulast%3DVan%2Bde%2BSteen%26aufirst%3DO.%26aulast%3DAllamassey%26aufirst%3DL.%26aulast%3DDesrivot%26aufirst%3DJ.%26aulast%3DDupont%26aufirst%3DS.%26aulast%3DFagard%26aufirst%3DL.%26aulast%3DFord%26aufirst%3DP.%26aulast%3DFieuw%26aufirst%3DA.%26aulast%3DWuyts%26aufirst%3DW.%26atitle%3DSafety%252C%2520tolerability%252C%2520pharmacokinetics%252C%2520and%2520pharmacodynamics%2520of%2520GLPG1690%252C%2520a%2520novel%2520autotaxin%2520inhibitor%252C%2520to%2520treat%2520idiopathic%2520pulmonary%2520fibrosis%2520%2528FLORA%2529%253A%2520a%2520phase%25202a%2520randomised%2520placebo-controlled%2520trial%26jtitle%3DLancet%2520Respir.%2520Med.%26date%3D2018%26volume%3D6%26spage%3D627%26epage%3D635%26doi%3D10.1016%2FS2213-2600%2818%2930181-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daccord, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, T. M.</span></span> <span> </span><span class="NLM_article-title">Recent advances in understanding idiopathic pulmonary fibrosis</span>. <i>F1000Res</i> <span class="NLM_year" style="font-weight: bold;">2016</span>, <span class="NLM_elocation-id">F1000</span> <span class="refDoi"> DOI: 10.12688/f1000research.8209.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.12688%2Ff1000research.8209.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=27303645" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=C.+Daccordauthor=T.+M.+Maher&title=Recent+advances+in+understanding+idiopathic+pulmonary+fibrosis&doi=10.12688%2Ff1000research.8209.1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.12688%2Ff1000research.8209.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12688%252Ff1000research.8209.1%26sid%3Dliteratum%253Aachs%26aulast%3DDaccord%26aufirst%3DC.%26aulast%3DMaher%26aufirst%3DT.%2BM.%26atitle%3DRecent%2520advances%2520in%2520understanding%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DF1000Res%26date%3D2016%26doi%3D10.12688%2Ff1000research.8209.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maher, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreuter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuyts, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbruggen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutvoet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fieuw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abi-Saab, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijsenbeek, M.</span></span> <span> </span><span class="NLM_article-title">Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)</span>. <i>BMJ Open Respir. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e000422</span> <span class="refDoi"> DOI: 10.1136/bmjresp-2019-000422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1136%2Fbmjresp-2019-000422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=31179008" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&author=T.+M.+Maherauthor=M.+Kreuterauthor=D.+J.+Ledererauthor=K.+K.+Brownauthor=W.+Wuytsauthor=N.+Verbruggenauthor=S.+Stutvoetauthor=A.+Fieuwauthor=P.+Fordauthor=W.+Abi-Saabauthor=M.+Wijsenbeek&title=Rationale%2C+design+and+objectives+of+two+phase+III%2C+randomised%2C+placebo-controlled+studies+of+GLPG1690%2C+a+novel+autotaxin+inhibitor%2C+in+idiopathic+pulmonary+fibrosis+%28ISABELA+1+and+2%29&doi=10.1136%2Fbmjresp-2019-000422"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1136%2Fbmjresp-2019-000422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmjresp-2019-000422%26sid%3Dliteratum%253Aachs%26aulast%3DMaher%26aufirst%3DT.%2BM.%26aulast%3DKreuter%26aufirst%3DM.%26aulast%3DLederer%26aufirst%3DD.%2BJ.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DWuyts%26aufirst%3DW.%26aulast%3DVerbruggen%26aufirst%3DN.%26aulast%3DStutvoet%26aufirst%3DS.%26aulast%3DFieuw%26aufirst%3DA.%26aulast%3DFord%26aufirst%3DP.%26aulast%3DAbi-Saab%26aufirst%3DW.%26aulast%3DWijsenbeek%26aufirst%3DM.%26atitle%3DRationale%252C%2520design%2520and%2520objectives%2520of%2520two%2520phase%2520III%252C%2520randomised%252C%2520placebo-controlled%2520studies%2520of%2520GLPG1690%252C%2520a%2520novel%2520autotaxin%2520inhibitor%252C%2520in%2520idiopathic%2520pulmonary%2520fibrosis%2520%2528ISABELA%25201%2520and%25202%2529%26jtitle%3DBMJ%2520Open%2520Respir.%2520Res.%26date%3D2019%26volume%3D6%26doi%3D10.1136%2Fbmjresp-2019-000422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yatomi, Y.</span></span> <span> </span><span class="NLM_article-title">Autotaxin in liver fibrosis</span>. <i>Clin. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>413</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1821</span>, <span class="refDoi"> DOI: 10.1016/j.cca.2012.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1016%2Fj.cca.2012.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=22820036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KrsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2012&pages=1817-1821&author=H.+Ikedaauthor=Y.+Yatomi&title=Autotaxin+in+liver+fibrosis&doi=10.1016%2Fj.cca.2012.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin in liver fibrosis</span></div><div class="casAuthors">Ikeda, Hitoshi; Yatomi, Yutaka</div><div class="citationInfo"><span class="NLM_cas:title">Clinica Chimica Acta</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">413</span>
        (<span class="NLM_cas:issue">23-24</span>),
    <span class="NLM_cas:pages">1817-1821</span>CODEN:
                <span class="NLM_cas:coden">CCATAR</span>;
        ISSN:<span class="NLM_cas:issn">0009-8981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX) hydrolyzes lysophosphatidylcholine to produce lysophosphatidic acid (LPA), a multi-functional bioactive lipid mediator.  ATX is a major determinant of LPA levels in the blood, and the pathophysiol. functions of ATX are thought to be largely attributed to its ability to produce LPA.  Liver fibrosis is one of the rare disorders exhibiting the increased ATX and LPA levels in the blood.  This review summarizes the recent findings on the relation between ATX or LPA and liver fibrosis, the usefulness of serum ATX levels to predict the stages of liver fibrosis, and speculated roles of increased serum ATX and plasma LPA levels in liver fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4F1Go0hSrrLVg90H21EOLACvtfcHk0liK_tAAnMAkCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KrsrvJ&md5=daa6c56f61eeb2132f81ca4d1e5a2ebd</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cca.2012.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cca.2012.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DYatomi%26aufirst%3DY.%26atitle%3DAutotaxin%2520in%2520liver%2520fibrosis%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D2012%26volume%3D413%26spage%3D1817%26epage%3D1821%26doi%3D10.1016%2Fj.cca.2012.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benesch, M. G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, I. T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMullen, T. P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindley, D. N.</span></span> <span> </span><span class="NLM_article-title">Coming of age for autotaxin and lysophosphatidate signaling: clinical applications for preventing, detecting and targeting tumor-promoting inflammation</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">73</span> <span class="refDoi"> DOI: 10.3390/cancers10030073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.3390%2Fcancers10030073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtV2htLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&author=M.+G.+K.+Beneschauthor=I.+T.+K.+MacIntyreauthor=T.+P.+W.+McMullenauthor=D.+N.+Brindley&title=Coming+of+age+for+autotaxin+and+lysophosphatidate+signaling%3A+clinical+applications+for+preventing%2C+detecting+and+targeting+tumor-promoting+inflammation&doi=10.3390%2Fcancers10030073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Coming of age for autotaxin and lysophosphatidate signaling: clinical applications for preventing, detecting and targeting tumor-promoting inflammation</span></div><div class="casAuthors">Benesch, Matthew G. K.; MacIntyre, Iain T. K.; McMullen, Todd P. W.; Brindley, David N.</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">73/1-73/25</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Aquarter-century after the discovery of autotaxin in cell culture, the autotaxin-lysophosphatidate (LPA)-lipid phosphate phosphatase axis is nowa promising clin. target for treating chronic inflammatory conditions, mitigating fibrosis progression, and improving the efficacy of existing cancer chemotherapies and radiotherapy.  Nearly half of the literature on this axis has been published during the last five years.  In cancer biol., LPA signaling is increasingly being recognized as a centralmediator of the progression of chronic inflammation in the establishment of a tumormicroenvironment which promotes cancer growth, immune evasion, metastasis, and treatment resistance.  In this review, we will summarize recent advances made in understanding LPA signaling with respect to chronic inflammation and cancer.  We will also provide perspectives on the applications of inhibitors of LPA signaling in preventing cancer initiation, as adjuncts extending the efficacy of current cancer treatments by blocking inflammation caused by either the cancer or the cancer therapy itself, and by disruption of the tumormicroenvironment.  Overall, LPA, a simplemol. thatmediates a plethora of biol. effects, can be targeted at its levels of prodn. by autotaxin, LPA receptors or through LPA degrdn. by lipid phosphate phosphatases.  Drugs for these applications will soon be entering clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF5wFMu-ZgPbVg90H21EOLACvtfcHk0liK_tAAnMAkCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtV2htLnL&md5=11bb9a865e10b031baf1253c470db9fd</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3390%2Fcancers10030073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers10030073%26sid%3Dliteratum%253Aachs%26aulast%3DBenesch%26aufirst%3DM.%2BG.%2BK.%26aulast%3DMacIntyre%26aufirst%3DI.%2BT.%2BK.%26aulast%3DMcMullen%26aufirst%3DT.%2BP.%2BW.%26aulast%3DBrindley%26aufirst%3DD.%2BN.%26atitle%3DComing%2520of%2520age%2520for%2520autotaxin%2520and%2520lysophosphatidate%2520signaling%253A%2520clinical%2520applications%2520for%2520preventing%252C%2520detecting%2520and%2520targeting%2520tumor-promoting%2520inflammation%26jtitle%3DCancers%26date%3D2018%26volume%3D10%26doi%3D10.3390%2Fcancers10030073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodnow, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumelin, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefe, A. D.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1038%2Fnrd.2016.213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=27932801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=131-147&author=R.+A.+Goodnowauthor=C.+E.+Dumelinauthor=A.+D.+Keefe&title=DNA-encoded+chemistry%3A+enabling+the+deeper+sampling+of+chemical+space&doi=10.1038%2Fnrd.2016.213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span></div><div class="casAuthors">Goodnow, Robert A. Jr; Dumelin, Christoph E.; Keefe, Anthony D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-147</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  DNA-encoded chem. library technologies are increasingly being adopted in drug discovery for hit and lead generation.  DNA-encoded chem. enables the exploration of chem. spaces four to five orders of magnitude more deeply than is achievable by traditional high-throughput screening methods.  Operation of this technol. requires developing a range of capabilities including aq. synthetic chem., building block acquisition, oligonucleotide conjugation, large-scale mol. biol. transformations, selection methodologies, PCR, sequencing, sequence data anal. and the anal. of large chem. spaces.  This Review provides an overview of the development and applications of DNA-encoded chem., highlighting the challenges and future directions for the use of this technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdEd70MeexerVg90H21EOLACvtfcHk0lg5QVIQeR0UAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM&md5=7ca97b01d75e600378799baf77665c07</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.213%26sid%3Dliteratum%253Aachs%26aulast%3DGoodnow%26aufirst%3DR.%2BA.%26aulast%3DDumelin%26aufirst%3DC.%2BE.%26aulast%3DKeefe%26aufirst%3DA.%2BD.%26atitle%3DDNA-encoded%2520chemistry%253A%2520enabling%2520the%2520deeper%2520sampling%2520of%2520chemical%2520space%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2017%26volume%3D16%26spage%3D131%26epage%3D147%26doi%3D10.1038%2Fnrd.2016.213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neri, D.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded chemical libraries: foundations and applications in lead discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1828</span>– <span class="NLM_lpage">1834</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2016.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1016%2Fj.drudis.2016.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=27477486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ymsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1828-1834&author=G.+Zimmermannauthor=D.+Neri&title=DNA-encoded+chemical+libraries%3A+foundations+and+applications+in+lead+discovery&doi=10.1016%2Fj.drudis.2016.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-encoded chemical libraries: foundations and applications in lead discovery</span></div><div class="casAuthors">Zimmermann, Gunther; Neri, Dario</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1828-1834</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  DNA-encoded chem. libraries have emerged as a powerful tool for hit identification in the pharmaceutical industry and in academia.  Similar to biol. display techniques (such as phage display technol.), DNA-encoded chem. libraries contain a link between the displayed chem. building block and an amplifiable genetic barcode on DNA.  Using routine procedures, libraries contg. millions to billions of compds. can be easily produced within a few weeks.  The resulting compd. libraries are screened in a single test tube against proteins of pharmaceutical interest and hits can be identified by PCR amplification of DNA barcodes and subsequent high-throughput sequencing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBDbHHc6g_krVg90H21EOLACvtfcHk0lg5QVIQeR0UAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ymsbvK&md5=112af87dee3a38ebf41d1a094943cbc7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2016.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2016.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DG.%26aulast%3DNeri%26aufirst%3DD.%26atitle%3DDNA-encoded%2520chemical%2520libraries%253A%2520foundations%2520and%2520applications%2520in%2520lead%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D1828%26epage%3D1834%26doi%3D10.1016%2Fj.drudis.2016.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhaus, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vossenkamper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1247-1261&author=P.+A.+Harrisauthor=S.+B.+Bergerauthor=J.+U.+Jeongauthor=R.+Nagillaauthor=D.+Bandyopadhyayauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=P.+M.+Eidamauthor=J.+N.+Fingerauthor=S.+J.+Hoffmanauthor=J.+Kangauthor=V.+Kasparcovaauthor=B.+W.+Kingauthor=R.+Lehrauthor=Y.+Lanauthor=L.+K.+Leisterauthor=J.+D.+Lichauthor=T.+T.+MacDonaldauthor=N.+A.+Millerauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+Rahmanauthor=M.+A.+Reillyauthor=A.+R.+Rendinaauthor=E.+J.+Riveraauthor=M.+C.+Schaefferauthor=C.+A.+Sehonauthor=R.+R.+Singhausauthor=H.+H.+Sunauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=A.+Vossenkamperauthor=P.+Wardauthor=D.+D.+Wisnoskiauthor=D.+Zhangauthor=R.+W.+Marquisauthor=P.+J.+Goughauthor=J.+Bertin&title=Discovery+of+a+first-in-class+receptor+interacting+protein+1+%28RIP1%29+kinase+specific+clinical+candidate+%28GSK2982772%29+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Facs.jmedchem.6b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases</span></div><div class="casAuthors">Harris, Philip A.; Berger, Scott B.; Jeong, Jae U.; Nagilla, Rakesh; Bandyopadhyay, Deepak; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Eidam, Patrick M.; Finger, Joshua N.; Hoffman, Sandra J.; Kang, James; Kasparcova, Viera; King, Bryan W.; Lehr, Ruth; Lan, Yunfeng; Leister, Lara K.; Lich, John D.; MacDonald, Thomas T.; Miller, Nathan A.; Ouellette, Michael T.; Pao, Christina S.; Rahman, Attiq; Reilly, Michael A.; Rendina, Alan R.; Rivera, Elizabeth J.; Schaeffer, Michelle C.; Sehon, Clark A.; Singhaus, Robert R.; Sun, Helen H.; Swift, Barbara A.; Totoritis, Rachel D.; Vossenkamper, Anna; Ward, Paris; Wisnoski, David D.; Zhang, Daohua; Marquis, Robert W.; Gough, Peter J.; Bertin, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1247-1261</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RIP1 regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases.  Small-mol. inhibitors of RIP1 kinase that are suitable for advancement into the clinic have yet to be described.  Herein, the authors report the lead optimization of a benzoxazepinone hit from a DNA-encoded library and the discovery and profile of clin. candidate GSK2982772 (compd. I), currently in phase 2a clin. studies for psoriasis, rheumatoid arthritis, and ulcerative colitis.  Compd. I potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking many TNF-dependent cellular responses.  Highlighting its potential as a novel anti-inflammatory agent, the inhibitor was also able to reduce spontaneous prodn. of cytokines from human ulcerative colitis explants.  The highly favorable physicochem. and ADMET properties of I, combined with high potency, led to a predicted low oral dose in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZGRDTQv-vs7Vg90H21EOLACvtfcHk0lg5QVIQeR0UAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D&md5=ee0c3c60bb1351dff696490ac9edb1cc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01751%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DMacDonald%26aufirst%3DT.%2BT.%26aulast%3DMiller%26aufirst%3DN.%2BA.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRivera%26aufirst%3DE.%2BJ.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DSinghaus%26aufirst%3DR.%2BR.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DVossenkamper%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520first-in-class%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%2520specific%2520clinical%2520candidate%2520%2528GSK2982772%2529%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1247%26epage%3D1261%26doi%3D10.1021%2Facs.jmedchem.6b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakdawala, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded library screening identifies benzo[b][1,4]oxazepin-4-ones as highly potent and monoselective receptor interacting protein 1 kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2178</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01898</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01898" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2163-2178&author=P.+A.+Harrisauthor=B.+W.+Kingauthor=D.+Bandyopadhyayauthor=S.+B.+Bergerauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=J.+N.+Fingerauthor=L.+C.+Gradyauthor=S.+J.+Hoffmanauthor=J.+U.+Jeongauthor=J.+Kangauthor=V.+Kasparcovaauthor=A.+S.+Lakdawalaauthor=R.+Lehrauthor=D.+E.+McNultyauthor=R.+Nagillaauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+R.+Rendinaauthor=M.+C.+Schaefferauthor=J.+D.+Summerfieldauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=P.+Wardauthor=A.+Zhangauthor=D.+Zhangauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Gough&title=DNA-encoded+library+screening+identifies+benzo%5Bb%5D%5B1%2C4%5Doxazepin-4-ones+as+highly+potent+and+monoselective+receptor+interacting+protein+1+kinase+inhibitors&doi=10.1021%2Facs.jmedchem.5b01898"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors</span></div><div class="casAuthors">Harris, Philip A.; King, Bryan W.; Bandyopadhyay, Deepak; Berger, Scott B.; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Finger, Joshua N.; Grady, LaShadric C.; Hoffman, Sandra J.; Jeong, Jae U.; Kang, James; Kasparcova, Viera; Lakdawala, Ami S.; Lehr, Ruth; McNulty, Dean E.; Nagilla, Rakesh; Ouellette, Michael T.; Pao, Christina S.; Rendina, Alan R.; Schaeffer, Michelle C.; Summerfield, Jennifer D.; Swift, Barbara A.; Totoritis, Rachel D.; Ward, Paris; Zhang, Aming; Zhang, Daohua; Marquis, Robert W.; Bertin, John; Gough, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2163-2178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent discovery of the role of receptor interacting protein 1 (RIP1) kinase in tumor necrosis factor (TNF)-mediated inflammation has led to its emergence as a highly promising target for the treatment of multiple inflammatory diseases.  The authors screened RIP1 against GSK's DNA-encoded small-mol. libraries and identified a novel highly potent benzoxazepinone inhibitor series.  The authors demonstrate that this template possesses complete monokinase selectivity for RIP1 plus unique species selectivity for primate vs. nonprimate RIP1.  The authors elucidate the conformation of RIP1 bound to this benzoxazepinone inhibitor driving its high kinase selectivity and design specific mutations in murine RIP1 to restore potency to levels similar to primate RIP1.  This series differentiates itself from known RIP1 inhibitors in combining high potency and kinase selectivity with good pharmacokinetic profiles in rodents.  The favorable developability profile of this benzoxazepinone template, as exemplified by compd. 14 (GSK'481), makes it an excellent starting point for further optimization into a RIP1 clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XvpziWGWg7Vg90H21EOLACvtfcHk0lj-ZgEiqDzPag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D&md5=d6325dcaed97b7c339d1830ca041298c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01898%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DGrady%26aufirst%3DL.%2BC.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DLakdawala%26aufirst%3DA.%2BS.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSummerfield%26aufirst%3DJ.%2BD.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26atitle%3DDNA-encoded%2520library%2520screening%2520identifies%2520benzo%255Bb%255D%255B1%252C4%255Doxazepin-4-ones%2520as%2520highly%2520potent%2520and%2520monoselective%2520receptor%2520interacting%2520protein%25201%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2163%26epage%3D2178%26doi%3D10.1021%2Facs.jmedchem.5b01898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazaar, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, D. I.</span></span> <span> </span><span class="NLM_article-title">Discovering Drugs with DNA-Encoded Library Technology: From concept to clinic with an inhibitor of soluble epoxide hydrolase</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">837</span>– <span class="NLM_lpage">842</span>, <span class="refDoi"> DOI: 10.1002/cbic.201700014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1002%2Fcbic.201700014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=28281333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvVWjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=837-842&author=S.+L.+Belyanskayaauthor=Y.+Dingauthor=J.+F.+Callahanauthor=A.+L.+Lazaarauthor=D.+I.+Israel&title=Discovering+Drugs+with+DNA-Encoded+Library+Technology%3A+From+concept+to+clinic+with+an+inhibitor+of+soluble+epoxide+hydrolase&doi=10.1002%2Fcbic.201700014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering Drugs with DNA-Encoded Library Technology: From Concept to Clinic with an Inhibitor of Soluble Epoxide Hydrolase</span></div><div class="casAuthors">Belyanskaya, Svetlana L.; Ding, Yun; Callahan, James F.; Lazaar, Aili L.; Israel, David I.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">837-842</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">DNA-encoded chem. library technol. was developed with the vision of its becoming a transformational platform for drug discovery.  The hope was that a new paradigm for the discovery of low-mol.-wt. drugs would be enabled by combining the vast mol. diversity achievable with combinatorial chem., the information-encoding attributes of DNA, the power of mol. biol., and a streamlined selection-based discovery process.  Here, we describe the discovery and early clin. development of GSK2256294, an inhibitor of sol. epoxide hydrolase (sEH, EPHX2), by using encoded-library technol. (ELT).  GSK2256294 is an orally bioavailable, potent and selective inhibitor of sEH that has a long half life and produced no serious adverse events in a first-time-in-human clin. study.  To our knowledge, GSK2256294 is the first mol. discovered from this technol. to enter human clin. testing and represents a realization of the vision that DNA-encoded chem. library technol. can efficiently yield mols. with favorable properties that can be readily progressed into high-quality drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7WTPZp2SE0rVg90H21EOLACvtfcHk0lj-ZgEiqDzPag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvVWjurk%253D&md5=a34e28c8817864356f6ff689e9236940</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201700014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201700014%26sid%3Dliteratum%253Aachs%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DLazaar%26aufirst%3DA.%2BL.%26aulast%3DIsrael%26aufirst%3DD.%2BI.%26atitle%3DDiscovering%2520Drugs%2520with%2520DNA-Encoded%2520Library%2520Technology%253A%2520From%2520concept%2520to%2520clinic%2520with%2520an%2520inhibitor%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DChemBioChem%26date%3D2017%26volume%3D18%26spage%3D837%26epage%3D842%26doi%3D10.1002%2Fcbic.201700014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koval, E. E.</span></span> <span> </span><span class="NLM_article-title">Koval, E. E. X-Rx announces FDA acceptance of IND application for X-165</span>. <a href="https://www.businesswire.com/news/home/20190124005063/en/X-Rx-Announces-FDA-Acceptance-IND-Application-X-165" class="extLink">https://www.businesswire.com/news/home/20190124005063/en/X-Rx-Announces-FDA-Acceptance-IND-Application-X-165</a>. Accessed June 14, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=E.+E.+Koval&title=Koval%2C+E.+E.+X-Rx+announces+FDA+acceptance+of+IND+application+for+X-165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DKoval%26aufirst%3DE.%2BE.%26atitle%3DKoval%252C%2520E.%2520E.%2520X-Rx%2520announces%2520FDA%2520acceptance%2520of%2520IND%2520application%2520for%2520X-165%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bleisch, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durbin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimkowski, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rito, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mudra, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oskins, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swearingen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thirunavukkarasu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, B. H.</span></span> <span> </span><span class="NLM_article-title">Novel autotaxin inhibitors for the treatment of osteoarthritis pain: lead optimization via structure-based drug design</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">861</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00207</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00207" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Ggtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=857-861&author=S.+B.+Jonesauthor=L.+A.+Pfeiferauthor=T.+J.+Bleischauthor=T.+J.+Beauchampauthor=J.+D.+Durbinauthor=V.+J.+Klimkowskiauthor=N.+E.+Hughesauthor=C.+J.+Ritoauthor=Y.+Daoauthor=J.+M.+Gruberauthor=H.+Buiauthor=M.+G.+Chambersauthor=S.+Chandrasekharauthor=C.+Linauthor=D.+J.+McCannauthor=D.+R.+Mudraauthor=J.+L.+Oskinsauthor=C.+A.+Swearingenauthor=K.+Thirunavukkarasuauthor=B.+H.+Norman&title=Novel+autotaxin+inhibitors+for+the+treatment+of+osteoarthritis+pain%3A+lead+optimization+via+structure-based+drug+design&doi=10.1021%2Facsmedchemlett.6b00207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design</span></div><div class="casAuthors">Jones, Spencer B.; Pfeifer, Lance A.; Bleisch, Thomas J.; Beauchamp, Thomas J.; Durbin, Jim D.; Klimkowski, V. Joseph; Hughes, Norman E.; Rito, Christopher J.; Dao, Yen; Gruber, Joseph M.; Bui, Hai; Chambers, Mark G.; Chandrasekhar, Srinivasan; Lin, Chaohua; McCann, Denis J.; Mudra, Daniel R.; Oskins, Jennifer L.; Swearingen, Craig A.; Thirunavukkarasu, Kannan; Norman, Bryan H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">857-861</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to develop a novel therapeutic agent aimed at addressing the unmet need of patients with osteoarthritis pain, the authors set out to develop an inhibitor for autotaxin with excellent potency and phys. properties to allow for the clin. investigation of autotaxin-induced nociceptive and neuropathic pain.  An initial hit identification campaign led to an aminopyrimidine series with an autotaxin IC50 of 500 nM.  X-ray crystallog. enabled the optimization to a lead compd. I that demonstrated favorable potency (IC50 = 2 nM), PK properties, and a robust PK/PD relationship.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8LOQIFg8_0bVg90H21EOLACvtfcHk0lgJgUo6DZpdtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Ggtr3K&md5=c167f3fb691f8916fbce425701f8c7e8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00207%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%2BB.%26aulast%3DPfeifer%26aufirst%3DL.%2BA.%26aulast%3DBleisch%26aufirst%3DT.%2BJ.%26aulast%3DBeauchamp%26aufirst%3DT.%2BJ.%26aulast%3DDurbin%26aufirst%3DJ.%2BD.%26aulast%3DKlimkowski%26aufirst%3DV.%2BJ.%26aulast%3DHughes%26aufirst%3DN.%2BE.%26aulast%3DRito%26aufirst%3DC.%2BJ.%26aulast%3DDao%26aufirst%3DY.%26aulast%3DGruber%26aufirst%3DJ.%2BM.%26aulast%3DBui%26aufirst%3DH.%26aulast%3DChambers%26aufirst%3DM.%2BG.%26aulast%3DChandrasekhar%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DMcCann%26aufirst%3DD.%2BJ.%26aulast%3DMudra%26aufirst%3DD.%2BR.%26aulast%3DOskins%26aufirst%3DJ.%2BL.%26aulast%3DSwearingen%26aufirst%3DC.%2BA.%26aulast%3DThirunavukkarasu%26aufirst%3DK.%26aulast%3DNorman%26aufirst%3DB.%2BH.%26atitle%3DNovel%2520autotaxin%2520inhibitors%2520for%2520the%2520treatment%2520of%2520osteoarthritis%2520pain%253A%2520lead%2520optimization%2520via%2520structure-based%2520drug%2520design%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D857%26epage%3D861%26doi%3D10.1021%2Facsmedchemlett.6b00207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuttruff, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bretschneider, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handschuh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosse, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicklin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, G. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of BI-2545: A novel autotaxin inhibitor that significantly reduces LPA levels in vivo</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1252</span>– <span class="NLM_lpage">1257</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00312</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00312" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyrs7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1252-1257&author=C.+A.+Kuttruffauthor=M.+Ferraraauthor=T.+Bretschneiderauthor=S.+Hoererauthor=S.+Handschuhauthor=B.+Nosseauthor=H.+Romigauthor=P.+Nicklinauthor=G.+J.+Roth&title=Discovery+of+BI-2545%3A+A+novel+autotaxin+inhibitor+that+significantly+reduces+LPA+levels+in+vivo&doi=10.1021%2Facsmedchemlett.7b00312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of BI-2545: A Novel Autotaxin Inhibitor That Significantly Reduces LPA Levels in Vivo</span></div><div class="casAuthors">Kuttruff, Christian A.; Ferrara, Marco; Bretschneider, Tom; Hoerer, Stefan; Handschuh, Sandra; Nosse, Bernd; Romig, Helmut; Nicklin, Paul; Roth, Gerald J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1252-1257</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to find new therapeutic interventions addressing the unmet medical need of patients with idiopathic pulmonary fibrosis, we initiated a program to identify new autotaxin (ATX) inhibitors.  Starting from a recently published compd. (PF-8380), we identified several highly potent ATX inhibitors with improved pharmacokinetic and safety profiles.  Further optimization efforts resulted in the identification of a single-digit nanomolar lead compd. (BI-2545) that shows substantial lowering of LPA in vivo and is therefore considered a valuable tool for further studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBCx8QfJg11rVg90H21EOLACvtfcHk0lgJgUo6DZpdtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyrs7jN&md5=fc6ab8a9f174bf56639b81a1820474b4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00312%26sid%3Dliteratum%253Aachs%26aulast%3DKuttruff%26aufirst%3DC.%2BA.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DBretschneider%26aufirst%3DT.%26aulast%3DHoerer%26aufirst%3DS.%26aulast%3DHandschuh%26aufirst%3DS.%26aulast%3DNosse%26aufirst%3DB.%26aulast%3DRomig%26aufirst%3DH.%26aulast%3DNicklin%26aufirst%3DP.%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26atitle%3DDiscovery%2520of%2520BI-2545%253A%2520A%2520novel%2520autotaxin%2520inhibitor%2520that%2520significantly%2520reduces%2520LPA%2520levels%2520in%2520vivo%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1252%26epage%3D1257%26doi%3D10.1021%2Facsmedchemlett.7b00312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perrakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moolenaar, W. H.</span></span> <span> </span><span class="NLM_article-title">Autotaxin: structure-function and signaling</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1010</span>– <span class="NLM_lpage">1018</span>, <span class="refDoi"> DOI: 10.1194/jlr.R046391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1194%2Fjlr.R046391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=24548887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Cjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1010-1018&author=A.+Perrakisauthor=W.+H.+Moolenaar&title=Autotaxin%3A+structure-function+and+signaling&doi=10.1194%2Fjlr.R046391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin: structure-function and signaling</span></div><div class="casAuthors">Perrakis, Anastassis; Moolenaar, Wouter H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1010-1018</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX), or ecto-nucleotide pyrophosphatase/phosphodiesterase-2, is a secreted lysophospholipase D (lysoPLD) that hydrolyzes extracellular lysophospholipids into the lipid mediator lysophosphatidic acid (LPA), a ligand for specific G protein-coupled receptors.  ATX-LPA signaling is essential for development and has been implicated in a great diversity of (patho)physiol. processes, ranging from lymphocyte homing to tumor progression.  Structural and functional studies have revealed what makes ATX a unique lysoPLD, and how secreted ATX binds to its target cells.  The ATX catalytic domain shows a characteristic bimetallic active site followed by a shallow binding groove that can accommodate nucleotides as well as the glycerol moiety of lysophospholipids, and by a deep lipid-binding pocket.  In addn., the catalytic domain has an open tunnel of unknown function adjacent to the active site.  Here, the authors discuss the authors' current understanding of ATX structure-function relationships and signaling mechanisms, and how ATX isoforms use distinct mechanisms to target LPA prodn. to the plasma membrane, notably binding to integrins and heparan sulfate proteoglycans.  The authors also briefly discuss the development of drug-like inhibitors of ATX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmVdFme7XRfLVg90H21EOLACvtfcHk0lgJgUo6DZpdtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Cjtbs%253D&md5=d4813d9b7b37541e5e8ae739cebddc09</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1194%2Fjlr.R046391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.R046391%26sid%3Dliteratum%253Aachs%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26atitle%3DAutotaxin%253A%2520structure-function%2520and%2520signaling%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1010%26epage%3D1018%26doi%3D10.1194%2Fjlr.R046391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desroy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Housseman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joncour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labeguere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grassot, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picolet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annoot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triballeau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monjardet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakselman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncoroni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tallec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanque, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottereaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandervoort, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auberval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrvacic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oste, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Aar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brys, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckmann, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methyli midazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a first-in-class autotaxin inhibitor undergoing clinical evaluation for the treatment of idiopathic pulmonary fibrosis</span>. <i>J Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3580</span>– <span class="NLM_lpage">3590</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00032</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFCntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3580-3590&author=N.+Desroyauthor=C.+Houssemanauthor=X.+Bockauthor=A.+Joncourauthor=N.+Bienvenuauthor=L.+Cherelauthor=V.+Labeguereauthor=E.+Rondetauthor=C.+Peixotoauthor=J.+M.+Grassotauthor=O.+Picoletauthor=D.+Annootauthor=N.+Triballeauauthor=A.+Monjardetauthor=E.+Wakselmanauthor=V.+Roncoroniauthor=S.+Le+Tallecauthor=R.+Blanqueauthor=C.+Cottereauxauthor=N.+Vandervoortauthor=T.+Christopheauthor=P.+Mollatauthor=M.+Lamersauthor=M.+Aubervalauthor=B.+Hrvacicauthor=J.+Ralicauthor=L.+Osteauthor=E.+van+der%0AAarauthor=R.+Brysauthor=B.+Heckmann&title=Discovery+of+2-%5B%5B2-ethyl-6-%5B4-%5B2-%283-hydroxyazetidin-1-yl%29-2-oxoethyl%5Dpiperazin-1-yl%5D-8-methyli+midazo%5B1%2C2-a%5Dpyridin-3-yl%5Dmethylamino%5D-4-%284-fluorophenyl%29thiazole-5-carbonitrile+%28GLPG1690%29%2C+a+first-in-class+autotaxin+inhibitor+undergoing+clinical+evaluation+for+the+treatment+of+idiopathic+pulmonary+fibrosis&doi=10.1021%2Facs.jmedchem.7b00032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis</span></div><div class="casAuthors">Desroy, Nicolas; Housseman, Christopher; Bock, Xavier; Joncour, Agnes; Bienvenu, Natacha; Cherel, Laetitia; Labeguere, Virginie; Rondet, Emilie; Peixoto, Christophe; Grassot, Jean-Marie; Picolet, Olivier; Annoot, Denis; Triballeau, Nicolas; Monjardet, Alain; Wakselman, Emanuelle; Roncoroni, Veronique; Le Tallec, Sandrine; Blanque, Roland; Cottereaux, Celine; Vandervoort, Nele; Christophe, Thierry; Mollat, Patrick; Lamers, Marieke; Auberval, Marielle; Hrvacic, Boska; Ralic, Jovica; Oste, Line; van der Aar, Ellen; Brys, Reginald; Heckmann, Bertrand</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3580-3590</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin is a circulating enzyme with a major role in the prodn. of lysophosphatic acid (LPA) species in blood.  A role for the autotaxin/LPA axis has been suggested in many disease areas including pulmonary fibrosis.  Structural modifications of the known autotaxin inhibitor lead compd. 1, to attenuate hERG inhibition, remove CYP3A4 time-dependent inhibition, and improve pharmacokinetic properties, led to the identification of clin. candidate GLPG1690 (11).  Compd. 11 was able to cause a sustained redn. of LPA levels in plasma in vivo and was shown to be efficacious in a bleomycin-induced pulmonary fibrosis model in mice and in reducing extracellular matrix deposition in the lung while also reducing LPA 18:2 content in bronchoalveolar lavage fluid.  Compd. 11 is currently being evaluated in an exploratory phase 2a study in idiopathic pulmonary fibrosis patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMGaRp0Gq5ErVg90H21EOLACvtfcHk0liRSP34-6-k5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFCntL8%253D&md5=1038c79f5085e5719e9f1f2141941bb6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00032%26sid%3Dliteratum%253Aachs%26aulast%3DDesroy%26aufirst%3DN.%26aulast%3DHousseman%26aufirst%3DC.%26aulast%3DBock%26aufirst%3DX.%26aulast%3DJoncour%26aufirst%3DA.%26aulast%3DBienvenu%26aufirst%3DN.%26aulast%3DCherel%26aufirst%3DL.%26aulast%3DLabeguere%26aufirst%3DV.%26aulast%3DRondet%26aufirst%3DE.%26aulast%3DPeixoto%26aufirst%3DC.%26aulast%3DGrassot%26aufirst%3DJ.%2BM.%26aulast%3DPicolet%26aufirst%3DO.%26aulast%3DAnnoot%26aufirst%3DD.%26aulast%3DTriballeau%26aufirst%3DN.%26aulast%3DMonjardet%26aufirst%3DA.%26aulast%3DWakselman%26aufirst%3DE.%26aulast%3DRoncoroni%26aufirst%3DV.%26aulast%3DLe%2BTallec%26aufirst%3DS.%26aulast%3DBlanque%26aufirst%3DR.%26aulast%3DCottereaux%26aufirst%3DC.%26aulast%3DVandervoort%26aufirst%3DN.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DMollat%26aufirst%3DP.%26aulast%3DLamers%26aufirst%3DM.%26aulast%3DAuberval%26aufirst%3DM.%26aulast%3DHrvacic%26aufirst%3DB.%26aulast%3DRalic%26aufirst%3DJ.%26aulast%3DOste%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DHeckmann%26aufirst%3DB.%26atitle%3DDiscovery%2520of%25202-%255B%255B2-ethyl-6-%255B4-%255B2-%25283-hydroxyazetidin-1-yl%2529-2-oxoethyl%255Dpiperazin-1-yl%255D-8-methyli%2520midazo%255B1%252C2-a%255Dpyridin-3-yl%255Dmethylamino%255D-4-%25284-fluorophenyl%2529thiazole-5-carbonitrile%2520%2528GLPG1690%2529%252C%2520a%2520first-in-class%2520autotaxin%2520inhibitor%2520undergoing%2520clinical%2520evaluation%2520for%2520the%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DJ%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3580%26epage%3D3590%26doi%3D10.1021%2Facs.jmedchem.7b00032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saga, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohhata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komichi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibaya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishikawa, K.</span></span> <span> </span><span class="NLM_article-title">A novel highly potent autotaxin/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tension</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e93230</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0093230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1371%2Fjournal.pone.0093230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=24747415" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=H.+Sagaauthor=A.+Ohhataauthor=A.+Hayashiauthor=M.+Katohauthor=T.+Maedaauthor=H.+Mizunoauthor=Y.+Takadaauthor=Y.+Komichiauthor=H.+Otaauthor=N.+Matsumuraauthor=M.+Shibayaauthor=T.+Sugiyamaauthor=S.+Nakadeauthor=K.+Kishikawa&title=A+novel+highly+potent+autotaxin%2FENPP2+inhibitor+produces+prolonged+decreases+in+plasma+lysophosphatidic+acid+formation+in+vivo+and+regulates+urethral+tension&doi=10.1371%2Fjournal.pone.0093230"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0093230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0093230%26sid%3Dliteratum%253Aachs%26aulast%3DSaga%26aufirst%3DH.%26aulast%3DOhhata%26aufirst%3DA.%26aulast%3DHayashi%26aufirst%3DA.%26aulast%3DKatoh%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DT.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DKomichi%26aufirst%3DY.%26aulast%3DOta%26aufirst%3DH.%26aulast%3DMatsumura%26aufirst%3DN.%26aulast%3DShibaya%26aufirst%3DM.%26aulast%3DSugiyama%26aufirst%3DT.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DKishikawa%26aufirst%3DK.%26atitle%3DA%2520novel%2520highly%2520potent%2520autotaxin%252FENPP2%2520inhibitor%2520produces%2520prolonged%2520decreases%2520in%2520plasma%2520lysophosphatidic%2520acid%2520formation%2520in%2520vivo%2520and%2520regulates%2520urethral%2520tension%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0093230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Los Santos, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, S. H.</span></span> <span> </span><span class="NLM_article-title">The bleomycin model of pulmonary fibrosis</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1627</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-7113-8_2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1007%2F978-1-4939-7113-8_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=28836192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Wrtr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1627&publication_year=2017&pages=27-42&author=T.+Liuauthor=F.+G.+De+Los+Santosauthor=S.+H.+Phan&title=The+bleomycin+model+of+pulmonary+fibrosis&doi=10.1007%2F978-1-4939-7113-8_2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The bleomycin model of pulmonary fibrosis</span></div><div class="casAuthors">Liu, Tianju; De Los Santos, Francina Gonzalez; Phan, Sem H.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1627</span>
        (<span class="NLM_cas:issue">Fibrosis</span>),
    <span class="NLM_cas:pages">27-42</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Interstitial lung disease (ILD) comprises a large no. of chronic lung disease characterized by varying degrees of inflammation and fibrosis.  Mostly they are idiopathic including idiopathic pulmonary fibrosis (IPF), which is a specific disorder characterized by progressive fibrosis leading commonly to end-stage lung disease, respiratory failure, and fatal outcome.  IPF and many of these fibrotic ILDs lack effective therapy despite recent approval of two drugs to slow progression in certain IPF patients.  Because there are no natural models for IPF, the use of animal models that reproduce key known features of the disease is warranted.  Thus, different animal models have been developed to investigate key mechanisms underlying pathogenesis of pulmonary fibrosis and identify potential therapeutic targets for IPF.  While no animal model can recapitulate all features of human disease, several are available to address select features of IPF and other fibrotic ILDs.  Historically, among the first to be developed and used widely is the bleomycin model, which is the best-characterized and currently most extensively used animal model due to its ability to reproduce many aspects of IPF and other fibrotic ILDs, good reproducibility, and ease of induction.  Studies using the bleomycin model have identified many of the cellular and mol. mechanisms now recognized as being important in pathogenesis of IPF and other fibrotic ILDs, as well as novel therapies for these diseases, including two recent drugs approved for treatment of IPF.  This chapter will describe commonly used techniques for induction of the model by endotracheal administration of bleomycin through surgical and nonsurgical (transoral instillation).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7zhefOwniDrVg90H21EOLACvtfcHk0lgi5cZsEIzbkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Wrtr%252FP&md5=4e0b11fdfe460302931a473610da7b0b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-7113-8_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-7113-8_2%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DDe%2BLos%2BSantos%26aufirst%3DF.%2BG.%26aulast%3DPhan%26aufirst%3DS.%2BH.%26atitle%3DThe%2520bleomycin%2520model%2520of%2520pulmonary%2520fibrosis%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2017%26volume%3D1627%26spage%3D27%26epage%3D42%26doi%3D10.1007%2F978-1-4939-7113-8_2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Esther C. Y. Lee, Andrew J. McRiner, Katy E. Georgiadis, Julie Liu, Zooey Wang, Andrew D. Ferguson, Benjamin Levin, Moritz von Rechenberg, Christopher D. Hupp, Michael I. Monteiro, Anthony D. Keefe, Allison Olszewski, Charles J. Eyermann, Paolo Centrella, Yanbin Liu, Shilpi Arora, John W. Cuozzo, Ying Zhang, Matthew A. Clark, Christelle Huguet, <span class="NLM_string-name hlFld-ContribAuthor">Anna Kohlmann</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel, Potent Inhibitors of Hydroxy Acid Oxidase 1 (HAO1) Using DNA-Encoded Chemical Library Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6730-6744. <a href="https://doi.org/10.1021/acs.jmedchem.0c02271" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02271%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%25252C%252BPotent%252BInhibitors%252Bof%252BHydroxy%252BAcid%252BOxidase%252B1%252B%252528HAO1%252529%252BUsing%252BDNA-Encoded%252BChemical%252BLibrary%252BScreening%26aulast%3DLee%26aufirst%3DEsther%2BC.%2BY.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D31122020%26date%3D06052021%26volume%3D64%26issue%3D10%26spage%3D6730%26epage%3D6744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rongfeng Wu, Tian Du, Wenbo Sun, Alex Shaginian, Sen Gao, Jin Li, Jinqiao Wan, <span class="NLM_string-name hlFld-ContribAuthor">Guansai Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalization of DNA-Tagged Alkenes Enabled by Visible-Light-Induced C–H Activation of N-Aryl Tertiary Amines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (9)
                                     , 3486-3490. <a href="https://doi.org/10.1021/acs.orglett.1c00924" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00924</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00924%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DFunctionalization%252Bof%252BDNA-Tagged%252BAlkenes%252BEnabled%252Bby%252BVisible-Light-Induced%252BC%2525E2%252580%252593H%252BActivation%252Bof%252BN-Aryl%252BTertiary%252BAmines%26aulast%3DWu%26aufirst%3DRongfeng%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D17032021%26date%3D28042021%26volume%3D23%26issue%3D9%26spage%3D3486%26epage%3D3490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jeremy S. Disch, Jennifer M. Duffy, Esther C. Y. Lee, Diana Gikunju, Betty Chan, Benjamin Levin, Michael I. Monteiro, Sarah A. Talcott, Anthony C. Lau, Fei Zhou, Anton Kozhushnyan, Neil E. Westlund, Patrick B. Mullins, Yan Yu, Moritz von Rechenberg, Junyi Zhang, Yelena A. Arnautova, Yanbin Liu, Ying Zhang, Andrew J. McRiner, Anthony D. Keefe, Anna Kohlmann, Matthew A. Clark, John W. Cuozzo, Christelle Huguet, <span class="NLM_string-name hlFld-ContribAuthor">Shilpi Arora</span>. </span><span class="cited-content_cbyCitation_article-title">Bispecific Estrogen Receptor α Degraders Incorporating Novel Binders Identified Using DNA-Encoded Chemical Library Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 5049-5066. <a href="https://doi.org/10.1021/acs.jmedchem.1c00127" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00127%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBispecific%252BEstrogen%252BReceptor%252B%2525CE%2525B1%252BDegraders%252BIncorporating%252BNovel%252BBinders%252BIdentified%252BUsing%252BDNA-Encoded%252BChemical%252BLibrary%252BScreening%26aulast%3DDisch%26aufirst%3DJeremy%2BS.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D22012021%26date%3D12042021%26volume%3D64%26issue%3D8%26spage%3D5049%26epage%3D5066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">J. Willem M. Nissink, Sana Bazzaz, Carolyn Blackett, Matthew A. Clark, Olga Collingwood, Jeremy S. Disch, Diana Gikunju, Kristin Goldberg, John P. Guilinger, Elizabeth Hardaker, Edward J. Hennessy, Rachael Jetson, Anthony D. Keefe, William McCoull, Lindsay McMurray, Allison Olszewski, Ross Overman, Alexander Pflug, Marian Preston, Philip B. Rawlins, Emma Rivers, Marianne Schimpl, Paul Smith, Caroline Truman, Elizabeth Underwood, Juli Warwicker, Jon Winter-Holt, Simon Woodcock, <span class="NLM_string-name hlFld-ContribAuthor">Ying Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Generating Selective Leads for Mer Kinase Inhibitors—Example of a Comprehensive Lead-Generation Strategy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3165-3184. <a href="https://doi.org/10.1021/acs.jmedchem.0c01904" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01904</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01904%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGenerating%252BSelective%252BLeads%252Bfor%252BMer%252BKinase%252BInhibitors%2525E2%252580%252594Example%252Bof%252Ba%252BComprehensive%252BLead-Generation%252BStrategy%26aulast%3DNissink%26aufirst%3DJ.%2BWillem%2BM.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D23112020%26date%3D08032021%26volume%3D64%26issue%3D6%26spage%3D3165%26epage%3D3184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sixiu Liu, Jingjing Qi, Weiwei Lu, Xuan Wang, <span class="NLM_string-name hlFld-ContribAuthor">Xiaojie Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Studies toward DNA-Encoded Heterocycles Based on the On-DNA Formation of α,β-Unsaturated Ketones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (3)
                                     , 908-913. <a href="https://doi.org/10.1021/acs.orglett.0c04118" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c04118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c04118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c04118%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthetic%252BStudies%252Btoward%252BDNA-Encoded%252BHeterocycles%252BBased%252Bon%252Bthe%252BOn-DNA%252BFormation%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B2-Unsaturated%252BKetones%26aulast%3DLiu%26aufirst%3DSixiu%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D13122020%26date%3D14012021%26volume%3D23%26issue%3D3%26spage%3D908%26epage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isaline F.S.F.  Castan</span>, <span class="hlFld-ContribAuthor ">Jessica S.  Graham</span>, <span class="hlFld-ContribAuthor ">Catherine L.A.  Salvini</span>, <span class="hlFld-ContribAuthor ">Harriet A.  Stanway-Gordon</span>, <span class="hlFld-ContribAuthor ">Michael J.  Waring</span>. </span><span class="cited-content_cbyCitation_article-title">On the design of lead-like DNA-encoded chemical libraries. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>43 </em>, 116273. <a href="https://doi.org/10.1016/j.bmc.2021.116273" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116273%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOn%252Bthe%252Bdesign%252Bof%252Blead-like%252BDNA-encoded%252Bchemical%252Blibraries%26aulast%3DCastan%26aufirst%3DIsaline%2BF.S.F.%26date%3D2021%26volume%3D43%26spage%3D116273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiran  Huang</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances on the Selection Methods of DNA‐Encoded Libraries. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2021,</strong> <em>22 </em>
                                    (14)
                                     , 2384-2397. <a href="https://doi.org/10.1002/cbic.202100144" title="DOI URL">https://doi.org/10.1002/cbic.202100144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.202100144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.202100144%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DRecent%252BAdvances%252Bon%252Bthe%252BSelection%252BMethods%252Bof%252BDNA%2525E2%252580%252590Encoded%252BLibraries%26aulast%3DHuang%26aufirst%3DYiran%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D14%26spage%3D2384%26epage%3D2397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Wenyin  Shen</span>, <span class="hlFld-ContribAuthor ">Jianzhao  Peng</span>, <span class="hlFld-ContribAuthor ">Yuqing  Deng</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of isoform/domain-selective fragments from the selection of DNA-encoded dynamic library. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>10 </em>, 116328. <a href="https://doi.org/10.1016/j.bmc.2021.116328" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116328</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116328%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bisoform%25252Fdomain-selective%252Bfragments%252Bfrom%252Bthe%252Bselection%252Bof%252BDNA-encoded%252Bdynamic%252Blibrary%26aulast%3DZhou%26aufirst%3DYu%26date%3D2021%26volume%3D10%26spage%3D116328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura-Ancuta  Pop</span>, <span class="hlFld-ContribAuthor ">Oana  Zanoaga</span>, <span class="hlFld-ContribAuthor ">Paul  Chiroi</span>, <span class="hlFld-ContribAuthor ">Andreea  Nutu</span>, <span class="hlFld-ContribAuthor ">Schuyler  S. Korban</span>, <span class="hlFld-ContribAuthor ">Cristina  Stefan</span>, <span class="hlFld-ContribAuthor ">Alexandru  Irimie</span>, <span class="hlFld-ContribAuthor ">Ioana  Berindan-Neagoe</span>. </span><span class="cited-content_cbyCitation_article-title">Microarrays and NGS for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.5772/intechopen.96657" title="DOI URL">https://doi.org/10.5772/intechopen.96657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.96657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.96657%26sid%3Dliteratum%253Aachs%26atitle%3DMicroarrays%252Band%252BNGS%252Bfor%252BDrug%252BDiscovery%26aulast%3DPop%26aufirst%3DLaura-Ancuta%26date%3D2021%26date%3D2021%26pub%3DIntechOpen%26atitle%3DDrug%252BDesign%252B-%252BNovel%252BAdvances%252Bin%252Bthe%252BOmics%252BField%252Band%252BApplications%26aulast%3DAditya%2BParikesit%26aufirst%3DArli%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wentao  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Qian  Lin</span>, <span class="hlFld-ContribAuthor ">Mei-Hsuan  Tsai</span>, <span class="hlFld-ContribAuthor ">Rui  Zhang</span>, <span class="hlFld-ContribAuthor ">Lijun  Fan</span>, <span class="hlFld-ContribAuthor ">Jack D.  Scott</span>, <span class="hlFld-ContribAuthor ">Guansai  Liu</span>, <span class="hlFld-ContribAuthor ">Jinqiao  Wan</span>. </span><span class="cited-content_cbyCitation_article-title">Development of DNA-compatible hydroxycarbonylation reactions using chloroform as a source of carbon monoxide. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>38 </em>, 116118. <a href="https://doi.org/10.1016/j.bmc.2021.116118" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116118%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BDNA-compatible%252Bhydroxycarbonylation%252Breactions%252Busing%252Bchloroform%252Bas%252Ba%252Bsource%252Bof%252Bcarbon%252Bmonoxide%26aulast%3DLiu%26aufirst%3DWentao%26date%3D2021%26volume%3D38%26spage%3D116118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dominik K.  Kölmel</span>, <span class="hlFld-ContribAuthor ">Hongyao  Zhu</span>, <span class="hlFld-ContribAuthor ">Mark E.  Flanagan</span>, <span class="hlFld-ContribAuthor ">Sylvie K.  Sakata</span>, <span class="hlFld-ContribAuthor ">Anthony R.  Harris</span>, <span class="hlFld-ContribAuthor ">Jinqiao  Wan</span>, <span class="hlFld-ContribAuthor ">Barry A.  Morgan</span>. </span><span class="cited-content_cbyCitation_article-title">Employing Photocatalysis for the Design and Preparation of DNA‐Encoded Libraries: A Case Study. </span><span class="cited-content_cbyCitation_journal-name">The Chemical Record</span><span> <strong>2021,</strong> <em>21 </em>
                                    (4)
                                     , 616-630. <a href="https://doi.org/10.1002/tcr.202000148" title="DOI URL">https://doi.org/10.1002/tcr.202000148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/tcr.202000148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Ftcr.202000148%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Chemical%2520Record%26atitle%3DEmploying%252BPhotocatalysis%252Bfor%252Bthe%252BDesign%252Band%252BPreparation%252Bof%252BDNA%2525E2%252580%252590Encoded%252BLibraries%25253A%252BA%252BCase%252BStudy%26aulast%3DK%25C3%25B6lmel%26aufirst%3DDominik%2BK.%26date%3D2021%26date%3D2021%26volume%3D21%26issue%3D4%26spage%3D616%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhifeng  Yu</span>, <span class="hlFld-ContribAuthor ">Angela F.  Ku</span>, <span class="hlFld-ContribAuthor ">Justin L.  Anglin</span>, <span class="hlFld-ContribAuthor ">Rajesh  Sharma</span>, <span class="hlFld-ContribAuthor ">Melek Nihan  Ucisik</span>, <span class="hlFld-ContribAuthor ">John C.  Faver</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Pranavanand  Nyshadham</span>, <span class="hlFld-ContribAuthor ">Nicholas  Simmons</span>, <span class="hlFld-ContribAuthor ">Kiran L.  Sharma</span>, <span class="hlFld-ContribAuthor ">Sureshbabu  Nagarajan</span>, <span class="hlFld-ContribAuthor ">Kevin  Riehle</span>, <span class="hlFld-ContribAuthor ">Gundeep  Kaur</span>, <span class="hlFld-ContribAuthor ">Banumathi  Sankaran</span>, <span class="hlFld-ContribAuthor ">Marta  Storl-Desmond</span>, <span class="hlFld-ContribAuthor ">Stephen S.  Palmer</span>, <span class="hlFld-ContribAuthor ">Damian W.  Young</span>, <span class="hlFld-ContribAuthor ">Choel  Kim</span>, <span class="hlFld-ContribAuthor ">Martin M.  Matzuk</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and characterization of bromodomain 2–specific inhibitors of BRDT. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2021,</strong> <em>118 </em>
                                    (9)
                                     , e2021102118. <a href="https://doi.org/10.1073/pnas.2021102118" title="DOI URL">https://doi.org/10.1073/pnas.2021102118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2021102118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2021102118%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DDiscovery%252Band%252Bcharacterization%252Bof%252Bbromodomain%252B2%2525E2%252580%252593specific%252Binhibitors%252Bof%252BBRDT%26aulast%3DYu%26aufirst%3DZhifeng%26date%3D2021%26date%3D2021%26volume%3D118%26issue%3D9%26spage%3De2021102118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Selahattin  Ede</span>, <span class="hlFld-ContribAuthor ">Mandy  Schenk</span>, <span class="hlFld-ContribAuthor ">Donald  Bierer</span>, <span class="hlFld-ContribAuthor ">Hilmar  Weinmann</span>, <span class="hlFld-ContribAuthor ">Keith  Graham</span>. </span><span class="cited-content_cbyCitation_article-title">Improved Diazo-Transfer Reaction for DNA-Encoded Chemistry and Its Potential Application for Macrocyclic DEL-Libraries. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (6)
                                     , 1790. <a href="https://doi.org/10.3390/molecules26061790" title="DOI URL">https://doi.org/10.3390/molecules26061790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26061790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26061790%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DImproved%252BDiazo-Transfer%252BReaction%252Bfor%252BDNA-Encoded%252BChemistry%252Band%252BIts%252BPotential%252BApplication%252Bfor%252BMacrocyclic%252BDEL-Libraries%26aulast%3DEde%26aufirst%3DSelahattin%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D6%26spage%3D1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabita  Singh</span>, <span class="hlFld-ContribAuthor ">Joytri  Dutta</span>, <span class="hlFld-ContribAuthor ">Archita  Ray</span>, <span class="hlFld-ContribAuthor ">Ashish  Jaiswal</span>, <span class="hlFld-ContribAuthor ">Ulaganathan  Mabalirajan</span>. </span><span class="cited-content_cbyCitation_article-title">A Refined Approach to Target the Molecular and Cellular Mechanisms in Pulmonary Fibrosis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 311-336. <a href="https://doi.org/10.1007/978-981-33-6827-9_13" title="DOI URL">https://doi.org/10.1007/978-981-33-6827-9_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-33-6827-9_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-33-6827-9_13%26sid%3Dliteratum%253Aachs%26atitle%3DA%252BRefined%252BApproach%252Bto%252BTarget%252Bthe%252BMolecular%252Band%252BCellular%252BMechanisms%252Bin%252BPulmonary%252BFibrosis%26aulast%3DSingh%26aufirst%3DSabita%26date%3D2021%26date%3D2021%26spage%3D311%26epage%3D336%26pub%3DSpringer%2520Singapore%26atitle%3DTargeting%252BCellular%252BSignalling%252BPathways%252Bin%252BLung%252BDiseases%26aulast%3DDua%26aufirst%3DKamal%26date%3D2021%26volume%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Conole</span>, <span class="hlFld-ContribAuthor ">James  H Hunter</span>, <span class="hlFld-ContribAuthor ">Michael  J Waring</span>. </span><span class="cited-content_cbyCitation_article-title">The maturation of DNA encoded libraries: opportunities for new users. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2020,</strong> <em>39 </em><a href="https://doi.org/10.4155/fmc-2020-0285" title="DOI URL">https://doi.org/10.4155/fmc-2020-0285</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0285%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bmaturation%252Bof%252BDNA%252Bencoded%252Blibraries%25253A%252Bopportunities%252Bfor%252Bnew%252Busers%26aulast%3DConole%26aufirst%3DDaniel%26date%3D2020%26date%3D2020%26volume%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rongfeng  Wu</span>, <span class="hlFld-ContribAuthor ">Sen  Gao</span>, <span class="hlFld-ContribAuthor ">Tian  Du</span>, <span class="hlFld-ContribAuthor ">Kunliang  Cai</span>, <span class="hlFld-ContribAuthor ">Xuemin  Cheng</span>, <span class="hlFld-ContribAuthor ">Jing  Fan</span>, <span class="hlFld-ContribAuthor ">Jing  Feng</span>, <span class="hlFld-ContribAuthor ">Alex  Shaginian</span>, <span class="hlFld-ContribAuthor ">Jin  Li</span>, <span class="hlFld-ContribAuthor ">Jinqiao  Wan</span>, <span class="hlFld-ContribAuthor ">Guansai  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring Aldol Reactions on DNA and Applications to Produce Diverse Structures: An Example of Expanding Chemical Space of DNA‐Encoded Compounds by Diversity‐Oriented Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – An Asian Journal</span><span> <strong>2020,</strong> <em>15 </em>
                                    (23)
                                     , 4033-4037. <a href="https://doi.org/10.1002/asia.202001105" title="DOI URL">https://doi.org/10.1002/asia.202001105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.202001105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.202001105%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520An%2520Asian%2520Journal%26atitle%3DExploring%252BAldol%252BReactions%252Bon%252BDNA%252Band%252BApplications%252Bto%252BProduce%252BDiverse%252BStructures%25253A%252BAn%252BExample%252Bof%252BExpanding%252BChemical%252BSpace%252Bof%252BDNA%2525E2%252580%252590Encoded%252BCompounds%252Bby%252BDiversity%2525E2%252580%252590Oriented%252BSynthesis%26aulast%3DWu%26aufirst%3DRongfeng%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D23%26spage%3D4033%26epage%3D4037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huang-Chi  Du</span>, <span class="hlFld-ContribAuthor ">Martin M.  Matzuk</span>, <span class="hlFld-ContribAuthor ">Ying-Chu  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 5-substituted tetrazoles
              via
              DNA-conjugated nitrile. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (45)
                                     , 9221-9226. <a href="https://doi.org/10.1039/D0OB02021D" title="DOI URL">https://doi.org/10.1039/D0OB02021D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB02021D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB02021D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252B5-substituted%252Btetrazoles%252Bvia%252BDNA-conjugated%252Bnitrile%26aulast%3DDu%26aufirst%3DHuang-Chi%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D45%26spage%3D9221%26epage%3D9226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christiana  Magkrioti</span>, <span class="hlFld-ContribAuthor ">Eleanna  Kaffe</span>, <span class="hlFld-ContribAuthor ">Elli-Anna  Stylianaki</span>, <span class="hlFld-ContribAuthor ">Camelia  Sidahmet</span>, <span class="hlFld-ContribAuthor ">Georgia  Melagraki</span>, <span class="hlFld-ContribAuthor ">Antreas  Afantitis</span>, <span class="hlFld-ContribAuthor ">Alexios N.  Matralis</span>, <span class="hlFld-ContribAuthor ">Vassilis  Aidinis</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (19)
                                     , 7002. <a href="https://doi.org/10.3390/ijms21197002" title="DOI URL">https://doi.org/10.3390/ijms21197002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21197002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21197002%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DStructure-Based%252BDiscovery%252Bof%252BNovel%252BChemical%252BClasses%252Bof%252BAutotaxin%252BInhibitors%26aulast%3DMagkrioti%26aufirst%3DChristiana%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D19%26spage%3D7002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Scheme for synthesis of the DNA-encoded chemical library of 225 million compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Three-dimensional (3D) scatter plots showing individual enriched features against autotaxin. (a) Selection output showing phosphonate-containing families in red and green and family C in blue. (b) is the same as for (a), but with phosphonate-containing families removed and the vertical scale adjusted with the four most enriched disynthons indicated. The <i>x</i>- and <i>y</i>-axes represent individual building blocks at the indicated cycles of synthesis. The <i>z</i>-axis represents a statistical metric of enrichment significance (ENRv1) for each disynthon (negative log<sub>10</sub> of the asymptotic significance value).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Representative Compounds from Family C Off-DNA<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NH<sub>2</sub>Me, EDCI, HOBT, DIEA, DMF, RT; (b) HCl (gas), MeOH, RT; (c) (<i>R</i>)-2-((<i>tert</i>-butoxycarbonyl) amino)-2-cyclohexylacetic acid, EDCI, HOBT, DIEA, DMF, RT; (d) substituted benzoic acid, EDCI, HOBT, DIEA, DMF, RT.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>1</b> and Its Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) methyl <i>D</i>-valinate.HCl, HATU, DIEA, CH<sub>2</sub>Cl<sub>2</sub>; (b) LiOH, THF, H<sub>2</sub>O; (c) 1<i>H</i>-indazol-5-amine, TMSCN, AcOH; (d) K<sub>2</sub>CO<sub>3</sub>, CbzCl, THF/H<sub>2</sub>O; (e) NCOSO<sub>2</sub>Cl, CH<sub>2</sub>Cl<sub>2</sub>, HCl/H<sub>2</sub>O; (f) (Boc)<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub>, THF; (g) Mel, K<sub>2</sub>CO<sub>3</sub>, DMF; (h) HCl/dioxane; (i) <b>1a</b>, HATU, DIEA, CH<sub>2</sub>Cl<sub>2</sub>; (j) Pd/C, H<sub>2</sub>, MeOH</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of N-Substituted 1,3,8-Triazaspiro[4,5]decan-4-one<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Mel, NaH, THF; (b) HCl (g), MeOH; (c) trimethoxymethane, AcOH; (d) NaBH4, MeOH; THF; (e) HCl/dioxane; (f) 2-bromopyridine, Pd<sub>2</sub>(dba)<sub>3</sub>, X-Phos, <i>t</i>-BuOK, toluene.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <i>N</i>-1,3,8-Triazaspiro[4.5]decane-2,4-dione<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) substituted aniline, TMSCN, AcOH; (b) NCOSO<sub>2</sub>Cl, CH<sub>2</sub>Cl<sub>2</sub>, HCl/H<sub>2</sub>O; (c) (Boc)<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub>, THF; (d) Mel, K<sub>2</sub>CO<sub>3</sub>, DMF; (e) NaOH, MeOH; (f) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF; (g) HCl/dioxane.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cocrystal structure of compound <b>1</b> in the active site of autotaxin (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W35">6W35</a>). The ligand is shown in green, the binding site residues are depicted in gold, and water molecules are represented as red spheres. Yellow dashes indicate hydrogen-bonding networks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>1</b> plasma levels exceed IC<sub>90</sub> for up to 12 h when dosed orally in mice. A total of nine mice were dosed orally with compound <b>1</b> at 30 mg/kg, and plasma concentrations were determined up to 12 h using three mice per time point (green). The IC<sub>90</sub> of compound <b>1</b> in mouse plasma is indicated (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>1</b> inhibits LPA production <i>in vivo</i>. A range of compound <b>1</b> doses was orally administered to rats, and both LPA 20:4 and compound <b>1</b> levels were measured by liquid chromatography mass spectrometry (LCMS/MS) in rat blood 4 h post dosing. Average percent inhibition of LPA levels was then plotted against plasma levels of compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Oral dosing of compound <b>1</b> demonstrates efficacy in prophylactic (a) and therapeutic (b) models of bleomycin-induced lung fibrosis. Lung hydroxyproline levels are plotted for each mouse. Median levels and p-values relative to bleomycin + vehicle are indicated for each group (* ≤ 0.05, ** ≤ 0.01). GLPG1690 (GLPG) was used as a control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/medium/jm0c00688_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>1</b> reduces lung fibrosis in the therapeutic bleomycin model. Representative trichrome-stained thin sections of mouse lungs are shown for each compound <b>1</b> dose group. Darkly stained regions are indicative of advanced fibrosis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00688/20200716/images/large/jm0c00688_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00688&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i66">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakanaga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span> <span> </span><span class="NLM_article-title">Autotaxin--an LPA producing enzyme with diverse functions</span>. <i>J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1093/jb/mvq052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1093%2Fjb%2Fmvq052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=20495010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlChsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2010&pages=13-24&author=K.+Nakanagaauthor=K.+Hamaauthor=J.+Aoki&title=Autotaxin%2D%2Dan+LPA+producing+enzyme+with+diverse+functions&doi=10.1093%2Fjb%2Fmvq052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin-an LPA producing enzyme with diverse functions</span></div><div class="casAuthors">Nakanaga, Keita; Hama, Kotaro; Aoki, Junken</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-24</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX) is an ecto-enzyme responsible for lysophosphatidic acid (LPA) prodn. in blood.  ATX is present in various biol. fluids such as cerebrospinal and seminal fluids and accounts for bulk LPA prodn. in these fluids.  ATX is a member of the nucleotide pyrophosphatase/phosphodiesterase (NPP) family and was originally isolated from conditioned medium of melanoma cells as an autocrine motility stimulating factor.  LPA, a second-generation lipid mediator, binds to its cognate G protein-coupled receptors through which it exerts a no. of biol. functions including influencing cell motility and proliferation stimulating activity.  Some of the biol. roles of LPA can be mediated by ATX.  However, there are other LPA-producing pathways independent of ATX.  The accumulating evidences for physiol. and pathol. functions of ATX strongly support that ATX is an important therapeutic target.  This review summarizes the historical aspects, structural basis, pathophysiol. functions identified in mice studies and clin. relevance discovered by measuring the blood ATX level in human.  The general features and functions of each NPP family member will be also briefly reviewed.  The presence of the ATX gene in other model organisms and recently developed ATX inhibitors, both of which will be definitely useful for further functional anal. of ATX, will also be mentioned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd2JaqHS4pL7Vg90H21EOLACvtfcHk0lgIljg6SUwZcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlChsLg%253D&md5=584a80ff7d28d8bdec20ff6615897a25</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvq052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvq052%26sid%3Dliteratum%253Aachs%26aulast%3DNakanaga%26aufirst%3DK.%26aulast%3DHama%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26atitle%3DAutotaxin--an%2520LPA%2520producing%2520enzyme%2520with%2520diverse%2520functions%26jtitle%3DJ.%2520Biochem.%26date%3D2010%26volume%3D148%26spage%3D13%26epage%3D24%26doi%3D10.1093%2Fjb%2Fmvq052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukaya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohta, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span> <span> </span><span class="NLM_article-title">Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">17634</span>– <span class="NLM_lpage">17639</span>, <span class="refDoi"> DOI: 10.1074/jbc.M313927200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1074%2Fjbc.M313927200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=14744855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1Gntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=17634-17639&author=K.+Hamaauthor=J.+Aokiauthor=M.+Fukayaauthor=Y.+Kishiauthor=T.+Sakaiauthor=R.+Suzukiauthor=H.+Ohtaauthor=T.+Yamoriauthor=M.+Watanabeauthor=J.+Chunauthor=H.+Arai&title=Lysophosphatidic+acid+and+autotaxin+stimulate+cell+motility+of+neoplastic+and+non-neoplastic+cells+through+LPA1&doi=10.1074%2Fjbc.M313927200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic Acid and Autotaxin Stimulate Cell Motility of Neoplastic and Non-neoplastic Cells through LPA1</span></div><div class="casAuthors">Hama, Kotaro; Aoki, Junken; Fukaya, Masahiro; Kishi, Yasuhiro; Sakai, Teruyuki; Suzuki, Rika; Ohta, Hideo; Yamori, Takao; Watanabe, Masahiko; Chun, Jerold; Arai, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">17634-17639</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is a tumor cell motility-stimulating factor originally isolated from melanoma cell supernatant that has been implicated in regulation of invasive and metastatic properties of cancer cells.  Recently, the authors showed that ATX is identical to lysophospholipase D, which converts lysophosphatidylcholine to a potent bioactive phospholipid mediator, lysophosphatidic acid (LPA), raising the possibility that autocrine or paracrine prodn. of LPA by ATX contributes to tumor cell motility.  Here the authors demonstrate that LPA and ATX mediate cell motility-stimulating activity through the LPA receptor, LPA1.  In fibroblasts isolated from lpa1-/- mice, but not from wild-type or lpa2-/-, cell motility stimulated with LPA and ATX was completely absent.  In the lpa1-/- cells, LPA-stimulated lamellipodia formation was markedly diminished with a concomitant decrease in Rac1 activation.  LPA stimulated the motility of multiple human cancer cell lines expressing LPA1, and the motility was attenuated by an LPA1-selective antagonist, Ki16425.  The present study suggests that ATX and LPA1 represent potential targets for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXizglGW6GZ7Vg90H21EOLACvtfcHk0ljKwCQkXI6cEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1Gntb8%253D&md5=1e8f83147cd198f84a531c6b4b629719</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M313927200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M313927200%26sid%3Dliteratum%253Aachs%26aulast%3DHama%26aufirst%3DK.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DFukaya%26aufirst%3DM.%26aulast%3DKishi%26aufirst%3DY.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DOhta%26aufirst%3DH.%26aulast%3DYamori%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DArai%26aufirst%3DH.%26atitle%3DLysophosphatidic%2520acid%2520and%2520autotaxin%2520stimulate%2520cell%2520motility%2520of%2520neoplastic%2520and%2520non-neoplastic%2520cells%2520through%2520LPA1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D17634%26epage%3D17639%26doi%3D10.1074%2Fjbc.M313927200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Meeteren, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruurs, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stortelers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouwman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rooijen, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradere, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettit, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakelam, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saulnier-Blache, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mummery, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moolenaar, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonkers, J.</span></span> <span> </span><span class="NLM_article-title">Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5015</span>– <span class="NLM_lpage">5022</span>, <span class="refDoi"> DOI: 10.1128/MCB.02419-05</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1128%2FMCB.02419-05" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=16782887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVSlurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=5015-5022&author=L.+A.+van%0AMeeterenauthor=P.+Ruursauthor=C.+Stortelersauthor=P.+Bouwmanauthor=M.+A.+van+Rooijenauthor=J.+P.+Pradereauthor=T.+R.+Pettitauthor=M.+J.+Wakelamauthor=J.+S.+Saulnier-Blacheauthor=C.+L.+Mummeryauthor=W.+H.+Moolenaarauthor=J.+Jonkers&title=Autotaxin%2C+a+secreted+lysophospholipase+D%2C+is+essential+for+blood+vessel+formation+during+development&doi=10.1128%2FMCB.02419-05"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development</span></div><div class="casAuthors">van Meeteren, Laurens A.; Ruurs, Paula; Stortelers, Catelijne; Bouwman, Peter; van Rooijen, Marga A.; Pradere, Jean Philippe; Pettit, Trevor R.; Wakelam, Michael J. O.; Saulnier-Blache, Jean Sebastien; Mummery, Christine L.; Moolenaar, Wouter H.; Jonkers, Jos</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5015-5022</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Autotaxin (ATX), or nucleotide pyrophosphatase-phosphodiesterase 2, is a secreted lysophospholipase D that promotes cell migration, metastasis, and angiogenesis.  ATX generates lysophosphatidic acid (LPA), a lipid mitogen and motility factor that acts on several G protein-coupled receptors.  Here we report that ATX-deficient mice die at embryonic day 9.5 (E9.5) with profound vascular defects in yolk sac and embryo resembling the Gα13 knockout phenotype.  Furthermore, at E8.5, ATX-deficient embryos showed allantois malformation, neural tube defects, and asym. headfolds.  The onset of these abnormalities coincided with increased expression of ATX and LPA receptors in normal embryos.  ATX heterozygous mice appear healthy but show half-normal ATX activity and plasma LPA levels.  Our results reveal a crit. role for ATX in vascular development, indicate that ATX is the major LPA-producing enzyme in vivo, and suggest that the vascular defects in ATX-deficient embryos may be explained by loss of LPA signaling through Gα13.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoymaMrK5zKdLVg90H21EOLACvtfcHk0ljKwCQkXI6cEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVSlurs%253D&md5=d2f5f00f531895912bc2932ff868db73</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FMCB.02419-05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.02419-05%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BMeeteren%26aufirst%3DL.%2BA.%26aulast%3DRuurs%26aufirst%3DP.%26aulast%3DStortelers%26aufirst%3DC.%26aulast%3DBouwman%26aufirst%3DP.%26aulast%3Dvan%2BRooijen%26aufirst%3DM.%2BA.%26aulast%3DPradere%26aufirst%3DJ.%2BP.%26aulast%3DPettit%26aufirst%3DT.%2BR.%26aulast%3DWakelam%26aufirst%3DM.%2BJ.%26aulast%3DSaulnier-Blache%26aufirst%3DJ.%2BS.%26aulast%3DMummery%26aufirst%3DC.%2BL.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26aulast%3DJonkers%26aufirst%3DJ.%26atitle%3DAutotaxin%252C%2520a%2520secreted%2520lysophospholipase%2520D%252C%2520is%2520essential%2520for%2520blood%2520vessel%2520formation%2520during%2520development%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2006%26volume%3D26%26spage%3D5015%26epage%3D5022%26doi%3D10.1128%2FMCB.02419-05" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igarashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshima, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nangaku, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yatomi, Y.</span></span> <span> </span><span class="NLM_article-title">Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation</span>. <i>Clin. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>388</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.1016/j.cca.2007.10.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1016%2Fj.cca.2007.10.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=17963703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOltLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2008&pages=51-58&author=K.+Nakamuraauthor=K.+Igarashiauthor=K.+Ideauthor=R.+Ohkawaauthor=S.+Okuboauthor=H.+Yokotaauthor=A.+Masudaauthor=N.+Oshimaauthor=T.+Takeuchiauthor=M.+Nangakuauthor=S.+Okudairaauthor=H.+Araiauthor=H.+Ikedaauthor=J.+Aokiauthor=Y.+Yatomi&title=Validation+of+an+autotaxin+enzyme+immunoassay+in+human+serum+samples+and+its+application+to+hypoalbuminemia+differentiation&doi=10.1016%2Fj.cca.2007.10.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation</span></div><div class="casAuthors">Nakamura, Kazuhiro; Igarashi, Koji; Ide, Kazufumi; Ohkawa, Ryunosuke; Okubo, Shigeo; Yokota, Hiromitsu; Masuda, Akiko; Oshima, Noriko; Takeuchi, Takumi; Nangaku, Masaomi; Okudaira, Shinichi; Arai, Hiroyuki; Ikeda, Hitoshi; Aoki, Junken; Yatomi, Yutaka</div><div class="citationInfo"><span class="NLM_cas:title">Clinica Chimica Acta</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">388</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">51-58</span>CODEN:
                <span class="NLM_cas:coden">CCATAR</span>;
        ISSN:<span class="NLM_cas:issn">0009-8981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Background: Autotaxin (ATX), a tumor cell motility-stimulating factor, regulates the blood concns. of lysophosphatidic acid (LPA), an important and multi-functional bioactive lipid, through its lysophospholipase D activity (lysoPLD).  The introduction of ATX measurements into clin. lab. testing is urgently needed.  Methods: Anti-human ATX monoclonal antibodies were produced by immunization of recombinant human ATX expressed in a baculovirus system.  An immunoassay for the quant. detn. of ATX was established, and human serum samples were assayed.  Results: The within-run and between-run precision, interference, detection limit, and linearity studies were satisfactory.  The central 95 percentile ref. interval for the serum ATX antigen concn. in healthy subjects was 0.468-1.134 mg/l (n = 120) and was strongly correlated with the serum lysoPLD activity.  The ATX concn. was significantly (p < 0.001) higher in women (0.625-1.323 mg/l) than in men (0.438-0.914 mg/l).  The serum ATX concns. were increased in patients with chronic liver diseases and decreased in postoperative prostate cancer patients but were not altered in nephrosis patients.  Thus, serum ATX antigen concns. could be used to discriminate these hypoalbuminemia conditions.  Conclusions: The present ATX antigen assay may be useful for clin. lab. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAP_2yrAa16LVg90H21EOLACvtfcHk0liZOTHzDCqZvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOltLbE&md5=1870c68e6ddd690bca9bf1f26721806a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cca.2007.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cca.2007.10.005%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DK.%26aulast%3DIde%26aufirst%3DK.%26aulast%3DOhkawa%26aufirst%3DR.%26aulast%3DOkubo%26aufirst%3DS.%26aulast%3DYokota%26aufirst%3DH.%26aulast%3DMasuda%26aufirst%3DA.%26aulast%3DOshima%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DNangaku%26aufirst%3DM.%26aulast%3DOkudaira%26aufirst%3DS.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DJ.%26aulast%3DYatomi%26aufirst%3DY.%26atitle%3DValidation%2520of%2520an%2520autotaxin%2520enzyme%2520immunoassay%2520in%2520human%2520serum%2520samples%2520and%2520its%2520application%2520to%2520hypoalbuminemia%2520differentiation%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D2008%26volume%3D388%26spage%3D51%26epage%3D58%26doi%3D10.1016%2Fj.cca.2007.10.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oikonomou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouratis, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzouvelekis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaffe, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valavanis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilaras, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karameris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prestwich, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aidinis, V.</span></span> <span> </span><span class="NLM_article-title">Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis</span>. <i>Am. J. Respir. Cell Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1165/rcmb.2012-0004OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1165%2Frcmb.2012-0004OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=22744859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A280%3ADC%252BC38jlvVGisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=566-574&author=N.+Oikonomouauthor=M.+A.+Mouratisauthor=A.+Tzouvelekisauthor=E.+Kaffeauthor=C.+Valavanisauthor=G.+Vilarasauthor=A.+Karamerisauthor=G.+D.+Prestwichauthor=D.+Bourosauthor=V.+Aidinis&title=Pulmonary+autotaxin+expression+contributes+to+the+pathogenesis+of+pulmonary+fibrosis&doi=10.1165%2Frcmb.2012-0004OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis</span></div><div class="casAuthors">Oikonomou Nikos; Mouratis Marios-Angelos; Tzouvelekis Argyris; Kaffe Eleanna; Valavanis Christos; Vilaras George; Karameris Andreas; Prestwich Glenn D; Bouros Demosthenes; Aidinis Vassilis</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory cell and molecular biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">566-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic form of diffuse lung disease occurring mainly in older adults.  Increased lysophosphatidic acid (LPA) concentrations have been reported in the alveolar space of both idiopathic pulmonary fibrosis patients and a corresponding animal model, whereas the genetic deletion or pharmacological inhibition of LPA receptor 1 attenuated the development of the modeled disease, suggesting a direct involvement of LPA in disease pathogenesis.  In this report, increased concentrations of autotaxin (ATX; ENPP2), the enzyme largely responsible for extracellular LPA production, were detected in both murine and human fibrotic lungs.  The genetic deletion of ATX from bronchial epithelial cells or macrophages attenuated disease severity, establishing ATX as a novel player in IPF pathogenesis.  Furthermore, the pharmacological inhibition of ATX attenuated the development of the modeled disease, suggesting that ATX is a possible therapeutic target in IPF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLNdXayAacMr5XHngOXiV_fW6udTcc2eYobo3xDARTrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jlvVGisw%253D%253D&md5=f89e6297df4584c0b50c4ef5a33b0565</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2012-0004OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2012-0004OC%26sid%3Dliteratum%253Aachs%26aulast%3DOikonomou%26aufirst%3DN.%26aulast%3DMouratis%26aufirst%3DM.%2BA.%26aulast%3DTzouvelekis%26aufirst%3DA.%26aulast%3DKaffe%26aufirst%3DE.%26aulast%3DValavanis%26aufirst%3DC.%26aulast%3DVilaras%26aufirst%3DG.%26aulast%3DKarameris%26aufirst%3DA.%26aulast%3DPrestwich%26aufirst%3DG.%2BD.%26aulast%3DBouros%26aufirst%3DD.%26aulast%3DAidinis%26aufirst%3DV.%26atitle%3DPulmonary%2520autotaxin%2520expression%2520contributes%2520to%2520the%2520pathogenesis%2520of%2520pulmonary%2520fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D47%26spage%3D566%26epage%3D574%26doi%3D10.1165%2Frcmb.2012-0004OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montesi, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathai, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorshkova, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berdyshev, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tager, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shea, B. S.</span></span> <span> </span><span class="NLM_article-title">Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis</span>. <i>BMC Pulm. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>, <span class="NLM_elocation-id">5</span> <span class="refDoi"> DOI: 10.1186/1471-2466-14-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1186%2F1471-2466-14-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=24468008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A280%3ADC%252BC2czptlOqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&author=S.+B.+Montesiauthor=S.+K.+Mathaiauthor=L.+N.+Brennerauthor=I.+A.+Gorshkovaauthor=E.+V.+Berdyshevauthor=A.+M.+Tagerauthor=B.+S.+Shea&title=Docosatetraenoyl+LPA+is+elevated+in+exhaled+breath+condensate+in+idiopathic+pulmonary+fibrosis&doi=10.1186%2F1471-2466-14-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis</span></div><div class="casAuthors">Montesi Sydney B; Mathai Susan K; Brenner Laura N; Gorshkova Irina A; Berdyshev Evgeny V; Tager Andrew M; Shea Barry S</div><div class="citationInfo"><span class="NLM_cas:title">BMC pulmonary medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with no effective medical therapies.  Recent research has focused on identifying the biological processes essential to the development and progression of fibrosis, and on the mediators driving these processes.  Lysophosphatidic acid (LPA), a biologically active lysophospholipid, is one such mediator.  LPA has been found to be elevated in bronchoalveolar lavage (BAL) fluid of IPF patients, and through interaction with its cell surface receptors, it has been shown to drive multiple biological processes implicated in the development of IPF.  Accordingly, the first clinical trial of an LPA receptor antagonist in IPF has recently been initiated.  In addition to being a therapeutic target, LPA also has potential to be a biomarker for IPF.  There is increasing interest in exhaled breath condensate (EBC) analysis as a non-invasive method for biomarker detection in lung diseases, but to what extent LPA is present in EBC is not known.  METHODS:  In this study, we used liquid chromatography-tandem mass spectrometry (LC-MS/MS) to assess for the presence of LPA in the EBC and plasma from 11 IPF subjects and 11 controls.  RESULTS:  A total of 9 different LPA species were detectable in EBC.  Of these, docosatetraenoyl (22:4) LPA was significantly elevated in the EBC of IPF subjects when compared to controls (9.18 pM vs. 0.34 pM; p = 0.001).  A total of 13 different LPA species were detectable in the plasma, but in contrast to the EBC, there were no statistically significant differences in plasma LPA species between IPF subjects and controls.  CONCLUSIONS:  These results demonstrate that multiple LPA species are detectable in EBC, and that 22:4 LPA levels are elevated in the EBC of IPF patients.  Further research is needed to determine the significance of this elevation of 22:4 LPA in IPF EBC, as well as its potential to serve as a biomarker for disease severity and/or progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOxFjWK8pBEny-c-E1v-fmfW6udTcc2eZuGiDvvzNlWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czptlOqtA%253D%253D&md5=596c17030d7c144d3730e54b71f89829</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2F1471-2466-14-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2466-14-5%26sid%3Dliteratum%253Aachs%26aulast%3DMontesi%26aufirst%3DS.%2BB.%26aulast%3DMathai%26aufirst%3DS.%2BK.%26aulast%3DBrenner%26aufirst%3DL.%2BN.%26aulast%3DGorshkova%26aufirst%3DI.%2BA.%26aulast%3DBerdyshev%26aufirst%3DE.%2BV.%26aulast%3DTager%26aufirst%3DA.%2BM.%26aulast%3DShea%26aufirst%3DB.%2BS.%26atitle%3DDocosatetraenoyl%2520LPA%2520is%2520elevated%2520in%2520exhaled%2520breath%2520condensate%2520in%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DBMC%2520Pulm.%2520Med.%26date%3D2014%26volume%3D14%26doi%3D10.1186%2F1471-2466-14-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maher, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Aar, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Steen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allamassey, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desrivot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fieuw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuyts, W.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial</span>. <i>Lancet Respir. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">635</span>, <span class="refDoi"> DOI: 10.1016/S2213-2600(18)30181-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1016%2FS2213-2600%2818%2930181-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=29792287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpslygs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=627-635&author=T.+M.+Maherauthor=E.+M.+van+der+Aarauthor=O.+Van+de+Steenauthor=L.+Allamasseyauthor=J.+Desrivotauthor=S.+Dupontauthor=L.+Fagardauthor=P.+Fordauthor=A.+Fieuwauthor=W.+Wuyts&title=Safety%2C+tolerability%2C+pharmacokinetics%2C+and+pharmacodynamics+of+GLPG1690%2C+a+novel+autotaxin+inhibitor%2C+to+treat+idiopathic+pulmonary+fibrosis+%28FLORA%29%3A+a+phase+2a+randomised+placebo-controlled+trial&doi=10.1016%2FS2213-2600%2818%2930181-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial</span></div><div class="casAuthors">Maher, Toby M.; van der Aar, Ellen M.; Van de Steen, Olivier; Allamassey, Lisa; Desrivot, Julie; Dupont, Sonia; Fagard, Liesbeth; Ford, Paul; Fieuw, Ann; Wuyts, Wim</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Respiratory Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-635</span>CODEN:
                <span class="NLM_cas:coden">LRMAAU</span>;
        ISSN:<span class="NLM_cas:issn">2213-2600</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Idiopathic pulmonary fibrosis (IPF) causes irreversible loss of lung function.  People with IPF have increased concns. of autotaxin in lung tissue and lysophosphatidic acid (LPA) in bronchoalveolar lavage fluid and exhaled condensate.  GLPG1690 (Galapagos, Mechelen, Belgium) is a novel, potent, selective autotaxin inhibitor with good oral exposure.  We explored the effects of GLPG1690 in patients with IPF.  This was a randomised, double-blind, placebo-controlled phase 2a study done in 17 centers in Italy, Ukraine and the UK.  Eligible patients were aged 40 years or older, non-smokers, not taking pirfenidone or nintedanib, and had a centrally confirmed diagnosis of IPF.  We used a computer-generated randomisation schedule to assign patients 1:3 to receive placebo or 600 mg oral GLPG1690 once daily for 12 wk.  The primary outcomes were safety (adverse events), tolerability, pharmacokinetics, and pharmacodynamics.  Spirometry was assessed as a secondary outcome.  This trial is registered with ClinicalTrials.gov, no. NCT02738801.  Between March 24, 2016, and May 2, 2017, 72 patients were screened., of whom 49 were ineligible and 23 were enrolled in eight centers (six in Ukraine and two in the UK).  Six patients were assigned to receive placebo and 17 to receive GLPG1690. 20 patients completed the study after one in each group discontinued because of adverse events and one in the GLPG1690 group withdrew consent.  Four (67%) patients in the placebo group and 11 (65%) in the GLPG1690 group had treatment-emergent adverse events, most of which were mild to moderate.  The most frequent events in the GLPG1690 group were infections and infestations (ten events) and respiratory, thoracic, and mediastinal disorders (eight events) with no apparent differences from the placebo group.  Two (12%) patients in the GLPG1690 group had events that were judged to be related to treatment.  Serious adverse events were seen in two patients in the placebo group (one had a urinary tract infection, acute kidney injury, and lower respiratory tract infection and the other had atrioventricular block, second degree) and one in the GLPG1690 group (cholangiocarcinoma that resulted in discontinuation of treatment).  No patients died.  The pharmacokinetic and pharmacodynamic profiles of GLPG1690 were similar to those previously shown in healthy controls.  LPA C18:2 concns. in plasma were consistently decreased.  Mean change from baseline in forced vital capacity at week 12 was 25 mL (95% CI -75 to 124) for GLPG1690 and -70 mL (-208 to 68 mL) for placebo.  Our findings support further development of GLPG1690 as a novel treatment for IPF.Galapagos.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1oZ4wAtGZurVg90H21EOLACvtfcHk0ljef8i_1FDDHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpslygs7k%253D&md5=e46089ac67abde0d487855d4a265d153</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS2213-2600%2818%2930181-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS2213-2600%252818%252930181-4%26sid%3Dliteratum%253Aachs%26aulast%3DMaher%26aufirst%3DT.%2BM.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%2BM.%26aulast%3DVan%2Bde%2BSteen%26aufirst%3DO.%26aulast%3DAllamassey%26aufirst%3DL.%26aulast%3DDesrivot%26aufirst%3DJ.%26aulast%3DDupont%26aufirst%3DS.%26aulast%3DFagard%26aufirst%3DL.%26aulast%3DFord%26aufirst%3DP.%26aulast%3DFieuw%26aufirst%3DA.%26aulast%3DWuyts%26aufirst%3DW.%26atitle%3DSafety%252C%2520tolerability%252C%2520pharmacokinetics%252C%2520and%2520pharmacodynamics%2520of%2520GLPG1690%252C%2520a%2520novel%2520autotaxin%2520inhibitor%252C%2520to%2520treat%2520idiopathic%2520pulmonary%2520fibrosis%2520%2528FLORA%2529%253A%2520a%2520phase%25202a%2520randomised%2520placebo-controlled%2520trial%26jtitle%3DLancet%2520Respir.%2520Med.%26date%3D2018%26volume%3D6%26spage%3D627%26epage%3D635%26doi%3D10.1016%2FS2213-2600%2818%2930181-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daccord, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, T. M.</span></span> <span> </span><span class="NLM_article-title">Recent advances in understanding idiopathic pulmonary fibrosis</span>. <i>F1000Res</i> <span class="NLM_year" style="font-weight: bold;">2016</span>, <span class="NLM_elocation-id">F1000</span> <span class="refDoi"> DOI: 10.12688/f1000research.8209.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.12688%2Ff1000research.8209.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=27303645" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=C.+Daccordauthor=T.+M.+Maher&title=Recent+advances+in+understanding+idiopathic+pulmonary+fibrosis&doi=10.12688%2Ff1000research.8209.1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.12688%2Ff1000research.8209.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12688%252Ff1000research.8209.1%26sid%3Dliteratum%253Aachs%26aulast%3DDaccord%26aufirst%3DC.%26aulast%3DMaher%26aufirst%3DT.%2BM.%26atitle%3DRecent%2520advances%2520in%2520understanding%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DF1000Res%26date%3D2016%26doi%3D10.12688%2Ff1000research.8209.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maher, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreuter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuyts, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbruggen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutvoet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fieuw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abi-Saab, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijsenbeek, M.</span></span> <span> </span><span class="NLM_article-title">Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)</span>. <i>BMJ Open Respir. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e000422</span> <span class="refDoi"> DOI: 10.1136/bmjresp-2019-000422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1136%2Fbmjresp-2019-000422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=31179008" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&author=T.+M.+Maherauthor=M.+Kreuterauthor=D.+J.+Ledererauthor=K.+K.+Brownauthor=W.+Wuytsauthor=N.+Verbruggenauthor=S.+Stutvoetauthor=A.+Fieuwauthor=P.+Fordauthor=W.+Abi-Saabauthor=M.+Wijsenbeek&title=Rationale%2C+design+and+objectives+of+two+phase+III%2C+randomised%2C+placebo-controlled+studies+of+GLPG1690%2C+a+novel+autotaxin+inhibitor%2C+in+idiopathic+pulmonary+fibrosis+%28ISABELA+1+and+2%29&doi=10.1136%2Fbmjresp-2019-000422"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1136%2Fbmjresp-2019-000422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmjresp-2019-000422%26sid%3Dliteratum%253Aachs%26aulast%3DMaher%26aufirst%3DT.%2BM.%26aulast%3DKreuter%26aufirst%3DM.%26aulast%3DLederer%26aufirst%3DD.%2BJ.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DWuyts%26aufirst%3DW.%26aulast%3DVerbruggen%26aufirst%3DN.%26aulast%3DStutvoet%26aufirst%3DS.%26aulast%3DFieuw%26aufirst%3DA.%26aulast%3DFord%26aufirst%3DP.%26aulast%3DAbi-Saab%26aufirst%3DW.%26aulast%3DWijsenbeek%26aufirst%3DM.%26atitle%3DRationale%252C%2520design%2520and%2520objectives%2520of%2520two%2520phase%2520III%252C%2520randomised%252C%2520placebo-controlled%2520studies%2520of%2520GLPG1690%252C%2520a%2520novel%2520autotaxin%2520inhibitor%252C%2520in%2520idiopathic%2520pulmonary%2520fibrosis%2520%2528ISABELA%25201%2520and%25202%2529%26jtitle%3DBMJ%2520Open%2520Respir.%2520Res.%26date%3D2019%26volume%3D6%26doi%3D10.1136%2Fbmjresp-2019-000422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yatomi, Y.</span></span> <span> </span><span class="NLM_article-title">Autotaxin in liver fibrosis</span>. <i>Clin. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>413</i></span>,  <span class="NLM_fpage">1817</span>– <span class="NLM_lpage">1821</span>, <span class="refDoi"> DOI: 10.1016/j.cca.2012.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1016%2Fj.cca.2012.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=22820036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1KrsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2012&pages=1817-1821&author=H.+Ikedaauthor=Y.+Yatomi&title=Autotaxin+in+liver+fibrosis&doi=10.1016%2Fj.cca.2012.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin in liver fibrosis</span></div><div class="casAuthors">Ikeda, Hitoshi; Yatomi, Yutaka</div><div class="citationInfo"><span class="NLM_cas:title">Clinica Chimica Acta</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">413</span>
        (<span class="NLM_cas:issue">23-24</span>),
    <span class="NLM_cas:pages">1817-1821</span>CODEN:
                <span class="NLM_cas:coden">CCATAR</span>;
        ISSN:<span class="NLM_cas:issn">0009-8981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX) hydrolyzes lysophosphatidylcholine to produce lysophosphatidic acid (LPA), a multi-functional bioactive lipid mediator.  ATX is a major determinant of LPA levels in the blood, and the pathophysiol. functions of ATX are thought to be largely attributed to its ability to produce LPA.  Liver fibrosis is one of the rare disorders exhibiting the increased ATX and LPA levels in the blood.  This review summarizes the recent findings on the relation between ATX or LPA and liver fibrosis, the usefulness of serum ATX levels to predict the stages of liver fibrosis, and speculated roles of increased serum ATX and plasma LPA levels in liver fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4F1Go0hSrrLVg90H21EOLACvtfcHk0li7oZZXrvYFtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1KrsrvJ&md5=daa6c56f61eeb2132f81ca4d1e5a2ebd</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cca.2012.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cca.2012.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DIkeda%26aufirst%3DH.%26aulast%3DYatomi%26aufirst%3DY.%26atitle%3DAutotaxin%2520in%2520liver%2520fibrosis%26jtitle%3DClin.%2520Chim.%2520Acta%26date%3D2012%26volume%3D413%26spage%3D1817%26epage%3D1821%26doi%3D10.1016%2Fj.cca.2012.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benesch, M. G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, I. T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMullen, T. P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brindley, D. N.</span></span> <span> </span><span class="NLM_article-title">Coming of age for autotaxin and lysophosphatidate signaling: clinical applications for preventing, detecting and targeting tumor-promoting inflammation</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">73</span> <span class="refDoi"> DOI: 10.3390/cancers10030073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.3390%2Fcancers10030073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtV2htLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&author=M.+G.+K.+Beneschauthor=I.+T.+K.+MacIntyreauthor=T.+P.+W.+McMullenauthor=D.+N.+Brindley&title=Coming+of+age+for+autotaxin+and+lysophosphatidate+signaling%3A+clinical+applications+for+preventing%2C+detecting+and+targeting+tumor-promoting+inflammation&doi=10.3390%2Fcancers10030073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Coming of age for autotaxin and lysophosphatidate signaling: clinical applications for preventing, detecting and targeting tumor-promoting inflammation</span></div><div class="casAuthors">Benesch, Matthew G. K.; MacIntyre, Iain T. K.; McMullen, Todd P. W.; Brindley, David N.</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">73/1-73/25</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Aquarter-century after the discovery of autotaxin in cell culture, the autotaxin-lysophosphatidate (LPA)-lipid phosphate phosphatase axis is nowa promising clin. target for treating chronic inflammatory conditions, mitigating fibrosis progression, and improving the efficacy of existing cancer chemotherapies and radiotherapy.  Nearly half of the literature on this axis has been published during the last five years.  In cancer biol., LPA signaling is increasingly being recognized as a centralmediator of the progression of chronic inflammation in the establishment of a tumormicroenvironment which promotes cancer growth, immune evasion, metastasis, and treatment resistance.  In this review, we will summarize recent advances made in understanding LPA signaling with respect to chronic inflammation and cancer.  We will also provide perspectives on the applications of inhibitors of LPA signaling in preventing cancer initiation, as adjuncts extending the efficacy of current cancer treatments by blocking inflammation caused by either the cancer or the cancer therapy itself, and by disruption of the tumormicroenvironment.  Overall, LPA, a simplemol. thatmediates a plethora of biol. effects, can be targeted at its levels of prodn. by autotaxin, LPA receptors or through LPA degrdn. by lipid phosphate phosphatases.  Drugs for these applications will soon be entering clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF5wFMu-ZgPbVg90H21EOLACvtfcHk0li7oZZXrvYFtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtV2htLnL&md5=11bb9a865e10b031baf1253c470db9fd</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3390%2Fcancers10030073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers10030073%26sid%3Dliteratum%253Aachs%26aulast%3DBenesch%26aufirst%3DM.%2BG.%2BK.%26aulast%3DMacIntyre%26aufirst%3DI.%2BT.%2BK.%26aulast%3DMcMullen%26aufirst%3DT.%2BP.%2BW.%26aulast%3DBrindley%26aufirst%3DD.%2BN.%26atitle%3DComing%2520of%2520age%2520for%2520autotaxin%2520and%2520lysophosphatidate%2520signaling%253A%2520clinical%2520applications%2520for%2520preventing%252C%2520detecting%2520and%2520targeting%2520tumor-promoting%2520inflammation%26jtitle%3DCancers%26date%3D2018%26volume%3D10%26doi%3D10.3390%2Fcancers10030073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodnow, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumelin, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefe, A. D.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span>. <i>Nat. Rev. Drug Discov.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1038%2Fnrd.2016.213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=27932801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=131-147&author=R.+A.+Goodnowauthor=C.+E.+Dumelinauthor=A.+D.+Keefe&title=DNA-encoded+chemistry%3A+enabling+the+deeper+sampling+of+chemical+space&doi=10.1038%2Fnrd.2016.213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span></div><div class="casAuthors">Goodnow, Robert A. Jr; Dumelin, Christoph E.; Keefe, Anthony D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-147</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  DNA-encoded chem. library technologies are increasingly being adopted in drug discovery for hit and lead generation.  DNA-encoded chem. enables the exploration of chem. spaces four to five orders of magnitude more deeply than is achievable by traditional high-throughput screening methods.  Operation of this technol. requires developing a range of capabilities including aq. synthetic chem., building block acquisition, oligonucleotide conjugation, large-scale mol. biol. transformations, selection methodologies, PCR, sequencing, sequence data anal. and the anal. of large chem. spaces.  This Review provides an overview of the development and applications of DNA-encoded chem., highlighting the challenges and future directions for the use of this technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdEd70MeexerVg90H21EOLACvtfcHk0ljHX5h2tpT9cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM&md5=7ca97b01d75e600378799baf77665c07</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.213%26sid%3Dliteratum%253Aachs%26aulast%3DGoodnow%26aufirst%3DR.%2BA.%26aulast%3DDumelin%26aufirst%3DC.%2BE.%26aulast%3DKeefe%26aufirst%3DA.%2BD.%26atitle%3DDNA-encoded%2520chemistry%253A%2520enabling%2520the%2520deeper%2520sampling%2520of%2520chemical%2520space%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discov.%26date%3D2017%26volume%3D16%26spage%3D131%26epage%3D147%26doi%3D10.1038%2Fnrd.2016.213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neri, D.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded chemical libraries: foundations and applications in lead discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1828</span>– <span class="NLM_lpage">1834</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2016.07.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1016%2Fj.drudis.2016.07.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=27477486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ymsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1828-1834&author=G.+Zimmermannauthor=D.+Neri&title=DNA-encoded+chemical+libraries%3A+foundations+and+applications+in+lead+discovery&doi=10.1016%2Fj.drudis.2016.07.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-encoded chemical libraries: foundations and applications in lead discovery</span></div><div class="casAuthors">Zimmermann, Gunther; Neri, Dario</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1828-1834</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  DNA-encoded chem. libraries have emerged as a powerful tool for hit identification in the pharmaceutical industry and in academia.  Similar to biol. display techniques (such as phage display technol.), DNA-encoded chem. libraries contain a link between the displayed chem. building block and an amplifiable genetic barcode on DNA.  Using routine procedures, libraries contg. millions to billions of compds. can be easily produced within a few weeks.  The resulting compd. libraries are screened in a single test tube against proteins of pharmaceutical interest and hits can be identified by PCR amplification of DNA barcodes and subsequent high-throughput sequencing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBDbHHc6g_krVg90H21EOLACvtfcHk0ljHX5h2tpT9cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ymsbvK&md5=112af87dee3a38ebf41d1a094943cbc7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2016.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2016.07.013%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DG.%26aulast%3DNeri%26aufirst%3DD.%26atitle%3DDNA-encoded%2520chemical%2520libraries%253A%2520foundations%2520and%2520applications%2520in%2520lead%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D1828%26epage%3D1834%26doi%3D10.1016%2Fj.drudis.2016.07.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhaus, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vossenkamper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1247-1261&author=P.+A.+Harrisauthor=S.+B.+Bergerauthor=J.+U.+Jeongauthor=R.+Nagillaauthor=D.+Bandyopadhyayauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=P.+M.+Eidamauthor=J.+N.+Fingerauthor=S.+J.+Hoffmanauthor=J.+Kangauthor=V.+Kasparcovaauthor=B.+W.+Kingauthor=R.+Lehrauthor=Y.+Lanauthor=L.+K.+Leisterauthor=J.+D.+Lichauthor=T.+T.+MacDonaldauthor=N.+A.+Millerauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+Rahmanauthor=M.+A.+Reillyauthor=A.+R.+Rendinaauthor=E.+J.+Riveraauthor=M.+C.+Schaefferauthor=C.+A.+Sehonauthor=R.+R.+Singhausauthor=H.+H.+Sunauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=A.+Vossenkamperauthor=P.+Wardauthor=D.+D.+Wisnoskiauthor=D.+Zhangauthor=R.+W.+Marquisauthor=P.+J.+Goughauthor=J.+Bertin&title=Discovery+of+a+first-in-class+receptor+interacting+protein+1+%28RIP1%29+kinase+specific+clinical+candidate+%28GSK2982772%29+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Facs.jmedchem.6b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases</span></div><div class="casAuthors">Harris, Philip A.; Berger, Scott B.; Jeong, Jae U.; Nagilla, Rakesh; Bandyopadhyay, Deepak; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Eidam, Patrick M.; Finger, Joshua N.; Hoffman, Sandra J.; Kang, James; Kasparcova, Viera; King, Bryan W.; Lehr, Ruth; Lan, Yunfeng; Leister, Lara K.; Lich, John D.; MacDonald, Thomas T.; Miller, Nathan A.; Ouellette, Michael T.; Pao, Christina S.; Rahman, Attiq; Reilly, Michael A.; Rendina, Alan R.; Rivera, Elizabeth J.; Schaeffer, Michelle C.; Sehon, Clark A.; Singhaus, Robert R.; Sun, Helen H.; Swift, Barbara A.; Totoritis, Rachel D.; Vossenkamper, Anna; Ward, Paris; Wisnoski, David D.; Zhang, Daohua; Marquis, Robert W.; Gough, Peter J.; Bertin, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1247-1261</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RIP1 regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases.  Small-mol. inhibitors of RIP1 kinase that are suitable for advancement into the clinic have yet to be described.  Herein, the authors report the lead optimization of a benzoxazepinone hit from a DNA-encoded library and the discovery and profile of clin. candidate GSK2982772 (compd. I), currently in phase 2a clin. studies for psoriasis, rheumatoid arthritis, and ulcerative colitis.  Compd. I potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking many TNF-dependent cellular responses.  Highlighting its potential as a novel anti-inflammatory agent, the inhibitor was also able to reduce spontaneous prodn. of cytokines from human ulcerative colitis explants.  The highly favorable physicochem. and ADMET properties of I, combined with high potency, led to a predicted low oral dose in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZGRDTQv-vs7Vg90H21EOLACvtfcHk0ljzhXZ0fA6HPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D&md5=ee0c3c60bb1351dff696490ac9edb1cc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01751%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DMacDonald%26aufirst%3DT.%2BT.%26aulast%3DMiller%26aufirst%3DN.%2BA.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRivera%26aufirst%3DE.%2BJ.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DSinghaus%26aufirst%3DR.%2BR.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DVossenkamper%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520first-in-class%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%2520specific%2520clinical%2520candidate%2520%2528GSK2982772%2529%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1247%26epage%3D1261%26doi%3D10.1021%2Facs.jmedchem.6b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakdawala, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNulty, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerfield, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded library screening identifies benzo[b][1,4]oxazepin-4-ones as highly potent and monoselective receptor interacting protein 1 kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2163</span>– <span class="NLM_lpage">2178</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01898</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01898" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2163-2178&author=P.+A.+Harrisauthor=B.+W.+Kingauthor=D.+Bandyopadhyayauthor=S.+B.+Bergerauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=J.+N.+Fingerauthor=L.+C.+Gradyauthor=S.+J.+Hoffmanauthor=J.+U.+Jeongauthor=J.+Kangauthor=V.+Kasparcovaauthor=A.+S.+Lakdawalaauthor=R.+Lehrauthor=D.+E.+McNultyauthor=R.+Nagillaauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+R.+Rendinaauthor=M.+C.+Schaefferauthor=J.+D.+Summerfieldauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=P.+Wardauthor=A.+Zhangauthor=D.+Zhangauthor=R.+W.+Marquisauthor=J.+Bertinauthor=P.+J.+Gough&title=DNA-encoded+library+screening+identifies+benzo%5Bb%5D%5B1%2C4%5Doxazepin-4-ones+as+highly+potent+and+monoselective+receptor+interacting+protein+1+kinase+inhibitors&doi=10.1021%2Facs.jmedchem.5b01898"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors</span></div><div class="casAuthors">Harris, Philip A.; King, Bryan W.; Bandyopadhyay, Deepak; Berger, Scott B.; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Finger, Joshua N.; Grady, LaShadric C.; Hoffman, Sandra J.; Jeong, Jae U.; Kang, James; Kasparcova, Viera; Lakdawala, Ami S.; Lehr, Ruth; McNulty, Dean E.; Nagilla, Rakesh; Ouellette, Michael T.; Pao, Christina S.; Rendina, Alan R.; Schaeffer, Michelle C.; Summerfield, Jennifer D.; Swift, Barbara A.; Totoritis, Rachel D.; Ward, Paris; Zhang, Aming; Zhang, Daohua; Marquis, Robert W.; Bertin, John; Gough, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2163-2178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent discovery of the role of receptor interacting protein 1 (RIP1) kinase in tumor necrosis factor (TNF)-mediated inflammation has led to its emergence as a highly promising target for the treatment of multiple inflammatory diseases.  The authors screened RIP1 against GSK's DNA-encoded small-mol. libraries and identified a novel highly potent benzoxazepinone inhibitor series.  The authors demonstrate that this template possesses complete monokinase selectivity for RIP1 plus unique species selectivity for primate vs. nonprimate RIP1.  The authors elucidate the conformation of RIP1 bound to this benzoxazepinone inhibitor driving its high kinase selectivity and design specific mutations in murine RIP1 to restore potency to levels similar to primate RIP1.  This series differentiates itself from known RIP1 inhibitors in combining high potency and kinase selectivity with good pharmacokinetic profiles in rodents.  The favorable developability profile of this benzoxazepinone template, as exemplified by compd. 14 (GSK'481), makes it an excellent starting point for further optimization into a RIP1 clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4XvpziWGWg7Vg90H21EOLACvtfcHk0lgOj-FiCheCVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Kqsr8%253D&md5=d6325dcaed97b7c339d1830ca041298c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01898%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DGrady%26aufirst%3DL.%2BC.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DLakdawala%26aufirst%3DA.%2BS.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSummerfield%26aufirst%3DJ.%2BD.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26atitle%3DDNA-encoded%2520library%2520screening%2520identifies%2520benzo%255Bb%255D%255B1%252C4%255Doxazepin-4-ones%2520as%2520highly%2520potent%2520and%2520monoselective%2520receptor%2520interacting%2520protein%25201%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2163%26epage%3D2178%26doi%3D10.1021%2Facs.jmedchem.5b01898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazaar, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, D. I.</span></span> <span> </span><span class="NLM_article-title">Discovering Drugs with DNA-Encoded Library Technology: From concept to clinic with an inhibitor of soluble epoxide hydrolase</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">837</span>– <span class="NLM_lpage">842</span>, <span class="refDoi"> DOI: 10.1002/cbic.201700014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1002%2Fcbic.201700014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=28281333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvVWjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=837-842&author=S.+L.+Belyanskayaauthor=Y.+Dingauthor=J.+F.+Callahanauthor=A.+L.+Lazaarauthor=D.+I.+Israel&title=Discovering+Drugs+with+DNA-Encoded+Library+Technology%3A+From+concept+to+clinic+with+an+inhibitor+of+soluble+epoxide+hydrolase&doi=10.1002%2Fcbic.201700014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering Drugs with DNA-Encoded Library Technology: From Concept to Clinic with an Inhibitor of Soluble Epoxide Hydrolase</span></div><div class="casAuthors">Belyanskaya, Svetlana L.; Ding, Yun; Callahan, James F.; Lazaar, Aili L.; Israel, David I.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">837-842</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">DNA-encoded chem. library technol. was developed with the vision of its becoming a transformational platform for drug discovery.  The hope was that a new paradigm for the discovery of low-mol.-wt. drugs would be enabled by combining the vast mol. diversity achievable with combinatorial chem., the information-encoding attributes of DNA, the power of mol. biol., and a streamlined selection-based discovery process.  Here, we describe the discovery and early clin. development of GSK2256294, an inhibitor of sol. epoxide hydrolase (sEH, EPHX2), by using encoded-library technol. (ELT).  GSK2256294 is an orally bioavailable, potent and selective inhibitor of sEH that has a long half life and produced no serious adverse events in a first-time-in-human clin. study.  To our knowledge, GSK2256294 is the first mol. discovered from this technol. to enter human clin. testing and represents a realization of the vision that DNA-encoded chem. library technol. can efficiently yield mols. with favorable properties that can be readily progressed into high-quality drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7WTPZp2SE0rVg90H21EOLACvtfcHk0lgOj-FiCheCVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvVWjurk%253D&md5=a34e28c8817864356f6ff689e9236940</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201700014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201700014%26sid%3Dliteratum%253Aachs%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DLazaar%26aufirst%3DA.%2BL.%26aulast%3DIsrael%26aufirst%3DD.%2BI.%26atitle%3DDiscovering%2520Drugs%2520with%2520DNA-Encoded%2520Library%2520Technology%253A%2520From%2520concept%2520to%2520clinic%2520with%2520an%2520inhibitor%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DChemBioChem%26date%3D2017%26volume%3D18%26spage%3D837%26epage%3D842%26doi%3D10.1002%2Fcbic.201700014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koval, E. E.</span></span> <span> </span><span class="NLM_article-title">Koval, E. E. X-Rx announces FDA acceptance of IND application for X-165</span>. <a href="https://www.businesswire.com/news/home/20190124005063/en/X-Rx-Announces-FDA-Acceptance-IND-Application-X-165" class="extLink">https://www.businesswire.com/news/home/20190124005063/en/X-Rx-Announces-FDA-Acceptance-IND-Application-X-165</a>. Accessed June 14, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=E.+E.+Koval&title=Koval%2C+E.+E.+X-Rx+announces+FDA+acceptance+of+IND+application+for+X-165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DKoval%26aufirst%3DE.%2BE.%26atitle%3DKoval%252C%2520E.%2520E.%2520X-Rx%2520announces%2520FDA%2520acceptance%2520of%2520IND%2520application%2520for%2520X-165%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bleisch, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durbin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klimkowski, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rito, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruber, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mudra, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oskins, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swearingen, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thirunavukkarasu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, B. H.</span></span> <span> </span><span class="NLM_article-title">Novel autotaxin inhibitors for the treatment of osteoarthritis pain: lead optimization via structure-based drug design</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">857</span>– <span class="NLM_lpage">861</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00207</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00207" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Ggtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=857-861&author=S.+B.+Jonesauthor=L.+A.+Pfeiferauthor=T.+J.+Bleischauthor=T.+J.+Beauchampauthor=J.+D.+Durbinauthor=V.+J.+Klimkowskiauthor=N.+E.+Hughesauthor=C.+J.+Ritoauthor=Y.+Daoauthor=J.+M.+Gruberauthor=H.+Buiauthor=M.+G.+Chambersauthor=S.+Chandrasekharauthor=C.+Linauthor=D.+J.+McCannauthor=D.+R.+Mudraauthor=J.+L.+Oskinsauthor=C.+A.+Swearingenauthor=K.+Thirunavukkarasuauthor=B.+H.+Norman&title=Novel+autotaxin+inhibitors+for+the+treatment+of+osteoarthritis+pain%3A+lead+optimization+via+structure-based+drug+design&doi=10.1021%2Facsmedchemlett.6b00207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design</span></div><div class="casAuthors">Jones, Spencer B.; Pfeifer, Lance A.; Bleisch, Thomas J.; Beauchamp, Thomas J.; Durbin, Jim D.; Klimkowski, V. Joseph; Hughes, Norman E.; Rito, Christopher J.; Dao, Yen; Gruber, Joseph M.; Bui, Hai; Chambers, Mark G.; Chandrasekhar, Srinivasan; Lin, Chaohua; McCann, Denis J.; Mudra, Daniel R.; Oskins, Jennifer L.; Swearingen, Craig A.; Thirunavukkarasu, Kannan; Norman, Bryan H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">857-861</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to develop a novel therapeutic agent aimed at addressing the unmet need of patients with osteoarthritis pain, the authors set out to develop an inhibitor for autotaxin with excellent potency and phys. properties to allow for the clin. investigation of autotaxin-induced nociceptive and neuropathic pain.  An initial hit identification campaign led to an aminopyrimidine series with an autotaxin IC50 of 500 nM.  X-ray crystallog. enabled the optimization to a lead compd. I that demonstrated favorable potency (IC50 = 2 nM), PK properties, and a robust PK/PD relationship.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8LOQIFg8_0bVg90H21EOLACvtfcHk0lgZ_YXn7GTDng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Ggtr3K&md5=c167f3fb691f8916fbce425701f8c7e8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00207%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%2BB.%26aulast%3DPfeifer%26aufirst%3DL.%2BA.%26aulast%3DBleisch%26aufirst%3DT.%2BJ.%26aulast%3DBeauchamp%26aufirst%3DT.%2BJ.%26aulast%3DDurbin%26aufirst%3DJ.%2BD.%26aulast%3DKlimkowski%26aufirst%3DV.%2BJ.%26aulast%3DHughes%26aufirst%3DN.%2BE.%26aulast%3DRito%26aufirst%3DC.%2BJ.%26aulast%3DDao%26aufirst%3DY.%26aulast%3DGruber%26aufirst%3DJ.%2BM.%26aulast%3DBui%26aufirst%3DH.%26aulast%3DChambers%26aufirst%3DM.%2BG.%26aulast%3DChandrasekhar%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DMcCann%26aufirst%3DD.%2BJ.%26aulast%3DMudra%26aufirst%3DD.%2BR.%26aulast%3DOskins%26aufirst%3DJ.%2BL.%26aulast%3DSwearingen%26aufirst%3DC.%2BA.%26aulast%3DThirunavukkarasu%26aufirst%3DK.%26aulast%3DNorman%26aufirst%3DB.%2BH.%26atitle%3DNovel%2520autotaxin%2520inhibitors%2520for%2520the%2520treatment%2520of%2520osteoarthritis%2520pain%253A%2520lead%2520optimization%2520via%2520structure-based%2520drug%2520design%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D857%26epage%3D861%26doi%3D10.1021%2Facsmedchemlett.6b00207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuttruff, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bretschneider, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Handschuh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosse, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicklin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, G. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of BI-2545: A novel autotaxin inhibitor that significantly reduces LPA levels in vivo</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1252</span>– <span class="NLM_lpage">1257</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00312</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00312" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyrs7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1252-1257&author=C.+A.+Kuttruffauthor=M.+Ferraraauthor=T.+Bretschneiderauthor=S.+Hoererauthor=S.+Handschuhauthor=B.+Nosseauthor=H.+Romigauthor=P.+Nicklinauthor=G.+J.+Roth&title=Discovery+of+BI-2545%3A+A+novel+autotaxin+inhibitor+that+significantly+reduces+LPA+levels+in+vivo&doi=10.1021%2Facsmedchemlett.7b00312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of BI-2545: A Novel Autotaxin Inhibitor That Significantly Reduces LPA Levels in Vivo</span></div><div class="casAuthors">Kuttruff, Christian A.; Ferrara, Marco; Bretschneider, Tom; Hoerer, Stefan; Handschuh, Sandra; Nosse, Bernd; Romig, Helmut; Nicklin, Paul; Roth, Gerald J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1252-1257</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to find new therapeutic interventions addressing the unmet medical need of patients with idiopathic pulmonary fibrosis, we initiated a program to identify new autotaxin (ATX) inhibitors.  Starting from a recently published compd. (PF-8380), we identified several highly potent ATX inhibitors with improved pharmacokinetic and safety profiles.  Further optimization efforts resulted in the identification of a single-digit nanomolar lead compd. (BI-2545) that shows substantial lowering of LPA in vivo and is therefore considered a valuable tool for further studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBCx8QfJg11rVg90H21EOLACvtfcHk0lgZ_YXn7GTDng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyrs7jN&md5=fc6ab8a9f174bf56639b81a1820474b4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00312%26sid%3Dliteratum%253Aachs%26aulast%3DKuttruff%26aufirst%3DC.%2BA.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DBretschneider%26aufirst%3DT.%26aulast%3DHoerer%26aufirst%3DS.%26aulast%3DHandschuh%26aufirst%3DS.%26aulast%3DNosse%26aufirst%3DB.%26aulast%3DRomig%26aufirst%3DH.%26aulast%3DNicklin%26aufirst%3DP.%26aulast%3DRoth%26aufirst%3DG.%2BJ.%26atitle%3DDiscovery%2520of%2520BI-2545%253A%2520A%2520novel%2520autotaxin%2520inhibitor%2520that%2520significantly%2520reduces%2520LPA%2520levels%2520in%2520vivo%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1252%26epage%3D1257%26doi%3D10.1021%2Facsmedchemlett.7b00312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perrakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moolenaar, W. H.</span></span> <span> </span><span class="NLM_article-title">Autotaxin: structure-function and signaling</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1010</span>– <span class="NLM_lpage">1018</span>, <span class="refDoi"> DOI: 10.1194/jlr.R046391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1194%2Fjlr.R046391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=24548887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1Cjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1010-1018&author=A.+Perrakisauthor=W.+H.+Moolenaar&title=Autotaxin%3A+structure-function+and+signaling&doi=10.1194%2Fjlr.R046391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin: structure-function and signaling</span></div><div class="casAuthors">Perrakis, Anastassis; Moolenaar, Wouter H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Lipid Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1010-1018</span>CODEN:
                <span class="NLM_cas:coden">JLPRAW</span>;
        ISSN:<span class="NLM_cas:issn">0022-2275</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology, Inc.</span>)
        </div><div class="casAbstract">A review.  Autotaxin (ATX), or ecto-nucleotide pyrophosphatase/phosphodiesterase-2, is a secreted lysophospholipase D (lysoPLD) that hydrolyzes extracellular lysophospholipids into the lipid mediator lysophosphatidic acid (LPA), a ligand for specific G protein-coupled receptors.  ATX-LPA signaling is essential for development and has been implicated in a great diversity of (patho)physiol. processes, ranging from lymphocyte homing to tumor progression.  Structural and functional studies have revealed what makes ATX a unique lysoPLD, and how secreted ATX binds to its target cells.  The ATX catalytic domain shows a characteristic bimetallic active site followed by a shallow binding groove that can accommodate nucleotides as well as the glycerol moiety of lysophospholipids, and by a deep lipid-binding pocket.  In addn., the catalytic domain has an open tunnel of unknown function adjacent to the active site.  Here, the authors discuss the authors' current understanding of ATX structure-function relationships and signaling mechanisms, and how ATX isoforms use distinct mechanisms to target LPA prodn. to the plasma membrane, notably binding to integrins and heparan sulfate proteoglycans.  The authors also briefly discuss the development of drug-like inhibitors of ATX.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmVdFme7XRfLVg90H21EOLACvtfcHk0ljXPUHgvSMzwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1Cjtbs%253D&md5=d4813d9b7b37541e5e8ae739cebddc09</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1194%2Fjlr.R046391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.R046391%26sid%3Dliteratum%253Aachs%26aulast%3DPerrakis%26aufirst%3DA.%26aulast%3DMoolenaar%26aufirst%3DW.%2BH.%26atitle%3DAutotaxin%253A%2520structure-function%2520and%2520signaling%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2014%26volume%3D55%26spage%3D1010%26epage%3D1018%26doi%3D10.1194%2Fjlr.R046391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desroy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Housseman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joncour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labeguere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grassot, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picolet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annoot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triballeau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monjardet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakselman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncoroni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tallec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanque, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottereaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandervoort, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auberval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrvacic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oste, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Aar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brys, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckmann, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methyli midazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a first-in-class autotaxin inhibitor undergoing clinical evaluation for the treatment of idiopathic pulmonary fibrosis</span>. <i>J Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3580</span>– <span class="NLM_lpage">3590</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00032</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFCntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3580-3590&author=N.+Desroyauthor=C.+Houssemanauthor=X.+Bockauthor=A.+Joncourauthor=N.+Bienvenuauthor=L.+Cherelauthor=V.+Labeguereauthor=E.+Rondetauthor=C.+Peixotoauthor=J.+M.+Grassotauthor=O.+Picoletauthor=D.+Annootauthor=N.+Triballeauauthor=A.+Monjardetauthor=E.+Wakselmanauthor=V.+Roncoroniauthor=S.+Le+Tallecauthor=R.+Blanqueauthor=C.+Cottereauxauthor=N.+Vandervoortauthor=T.+Christopheauthor=P.+Mollatauthor=M.+Lamersauthor=M.+Aubervalauthor=B.+Hrvacicauthor=J.+Ralicauthor=L.+Osteauthor=E.+van+der%0AAarauthor=R.+Brysauthor=B.+Heckmann&title=Discovery+of+2-%5B%5B2-ethyl-6-%5B4-%5B2-%283-hydroxyazetidin-1-yl%29-2-oxoethyl%5Dpiperazin-1-yl%5D-8-methyli+midazo%5B1%2C2-a%5Dpyridin-3-yl%5Dmethylamino%5D-4-%284-fluorophenyl%29thiazole-5-carbonitrile+%28GLPG1690%29%2C+a+first-in-class+autotaxin+inhibitor+undergoing+clinical+evaluation+for+the+treatment+of+idiopathic+pulmonary+fibrosis&doi=10.1021%2Facs.jmedchem.7b00032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis</span></div><div class="casAuthors">Desroy, Nicolas; Housseman, Christopher; Bock, Xavier; Joncour, Agnes; Bienvenu, Natacha; Cherel, Laetitia; Labeguere, Virginie; Rondet, Emilie; Peixoto, Christophe; Grassot, Jean-Marie; Picolet, Olivier; Annoot, Denis; Triballeau, Nicolas; Monjardet, Alain; Wakselman, Emanuelle; Roncoroni, Veronique; Le Tallec, Sandrine; Blanque, Roland; Cottereaux, Celine; Vandervoort, Nele; Christophe, Thierry; Mollat, Patrick; Lamers, Marieke; Auberval, Marielle; Hrvacic, Boska; Ralic, Jovica; Oste, Line; van der Aar, Ellen; Brys, Reginald; Heckmann, Bertrand</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3580-3590</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin is a circulating enzyme with a major role in the prodn. of lysophosphatic acid (LPA) species in blood.  A role for the autotaxin/LPA axis has been suggested in many disease areas including pulmonary fibrosis.  Structural modifications of the known autotaxin inhibitor lead compd. 1, to attenuate hERG inhibition, remove CYP3A4 time-dependent inhibition, and improve pharmacokinetic properties, led to the identification of clin. candidate GLPG1690 (11).  Compd. 11 was able to cause a sustained redn. of LPA levels in plasma in vivo and was shown to be efficacious in a bleomycin-induced pulmonary fibrosis model in mice and in reducing extracellular matrix deposition in the lung while also reducing LPA 18:2 content in bronchoalveolar lavage fluid.  Compd. 11 is currently being evaluated in an exploratory phase 2a study in idiopathic pulmonary fibrosis patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMGaRp0Gq5ErVg90H21EOLACvtfcHk0ljXPUHgvSMzwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFCntL8%253D&md5=1038c79f5085e5719e9f1f2141941bb6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00032%26sid%3Dliteratum%253Aachs%26aulast%3DDesroy%26aufirst%3DN.%26aulast%3DHousseman%26aufirst%3DC.%26aulast%3DBock%26aufirst%3DX.%26aulast%3DJoncour%26aufirst%3DA.%26aulast%3DBienvenu%26aufirst%3DN.%26aulast%3DCherel%26aufirst%3DL.%26aulast%3DLabeguere%26aufirst%3DV.%26aulast%3DRondet%26aufirst%3DE.%26aulast%3DPeixoto%26aufirst%3DC.%26aulast%3DGrassot%26aufirst%3DJ.%2BM.%26aulast%3DPicolet%26aufirst%3DO.%26aulast%3DAnnoot%26aufirst%3DD.%26aulast%3DTriballeau%26aufirst%3DN.%26aulast%3DMonjardet%26aufirst%3DA.%26aulast%3DWakselman%26aufirst%3DE.%26aulast%3DRoncoroni%26aufirst%3DV.%26aulast%3DLe%2BTallec%26aufirst%3DS.%26aulast%3DBlanque%26aufirst%3DR.%26aulast%3DCottereaux%26aufirst%3DC.%26aulast%3DVandervoort%26aufirst%3DN.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DMollat%26aufirst%3DP.%26aulast%3DLamers%26aufirst%3DM.%26aulast%3DAuberval%26aufirst%3DM.%26aulast%3DHrvacic%26aufirst%3DB.%26aulast%3DRalic%26aufirst%3DJ.%26aulast%3DOste%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DHeckmann%26aufirst%3DB.%26atitle%3DDiscovery%2520of%25202-%255B%255B2-ethyl-6-%255B4-%255B2-%25283-hydroxyazetidin-1-yl%2529-2-oxoethyl%255Dpiperazin-1-yl%255D-8-methyli%2520midazo%255B1%252C2-a%255Dpyridin-3-yl%255Dmethylamino%255D-4-%25284-fluorophenyl%2529thiazole-5-carbonitrile%2520%2528GLPG1690%2529%252C%2520a%2520first-in-class%2520autotaxin%2520inhibitor%2520undergoing%2520clinical%2520evaluation%2520for%2520the%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DJ%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3580%26epage%3D3590%26doi%3D10.1021%2Facs.jmedchem.7b00032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saga, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohhata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katoh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komichi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibaya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishikawa, K.</span></span> <span> </span><span class="NLM_article-title">A novel highly potent autotaxin/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tension</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e93230</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0093230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1371%2Fjournal.pone.0093230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=24747415" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=H.+Sagaauthor=A.+Ohhataauthor=A.+Hayashiauthor=M.+Katohauthor=T.+Maedaauthor=H.+Mizunoauthor=Y.+Takadaauthor=Y.+Komichiauthor=H.+Otaauthor=N.+Matsumuraauthor=M.+Shibayaauthor=T.+Sugiyamaauthor=S.+Nakadeauthor=K.+Kishikawa&title=A+novel+highly+potent+autotaxin%2FENPP2+inhibitor+produces+prolonged+decreases+in+plasma+lysophosphatidic+acid+formation+in+vivo+and+regulates+urethral+tension&doi=10.1371%2Fjournal.pone.0093230"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0093230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0093230%26sid%3Dliteratum%253Aachs%26aulast%3DSaga%26aufirst%3DH.%26aulast%3DOhhata%26aufirst%3DA.%26aulast%3DHayashi%26aufirst%3DA.%26aulast%3DKatoh%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DT.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DKomichi%26aufirst%3DY.%26aulast%3DOta%26aufirst%3DH.%26aulast%3DMatsumura%26aufirst%3DN.%26aulast%3DShibaya%26aufirst%3DM.%26aulast%3DSugiyama%26aufirst%3DT.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DKishikawa%26aufirst%3DK.%26atitle%3DA%2520novel%2520highly%2520potent%2520autotaxin%252FENPP2%2520inhibitor%2520produces%2520prolonged%2520decreases%2520in%2520plasma%2520lysophosphatidic%2520acid%2520formation%2520in%2520vivo%2520and%2520regulates%2520urethral%2520tension%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0093230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Los Santos, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, S. H.</span></span> <span> </span><span class="NLM_article-title">The bleomycin model of pulmonary fibrosis</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1627</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-7113-8_2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=10.1007%2F978-1-4939-7113-8_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=28836192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Wrtr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1627&publication_year=2017&pages=27-42&author=T.+Liuauthor=F.+G.+De+Los+Santosauthor=S.+H.+Phan&title=The+bleomycin+model+of+pulmonary+fibrosis&doi=10.1007%2F978-1-4939-7113-8_2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The bleomycin model of pulmonary fibrosis</span></div><div class="casAuthors">Liu, Tianju; De Los Santos, Francina Gonzalez; Phan, Sem H.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1627</span>
        (<span class="NLM_cas:issue">Fibrosis</span>),
    <span class="NLM_cas:pages">27-42</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Interstitial lung disease (ILD) comprises a large no. of chronic lung disease characterized by varying degrees of inflammation and fibrosis.  Mostly they are idiopathic including idiopathic pulmonary fibrosis (IPF), which is a specific disorder characterized by progressive fibrosis leading commonly to end-stage lung disease, respiratory failure, and fatal outcome.  IPF and many of these fibrotic ILDs lack effective therapy despite recent approval of two drugs to slow progression in certain IPF patients.  Because there are no natural models for IPF, the use of animal models that reproduce key known features of the disease is warranted.  Thus, different animal models have been developed to investigate key mechanisms underlying pathogenesis of pulmonary fibrosis and identify potential therapeutic targets for IPF.  While no animal model can recapitulate all features of human disease, several are available to address select features of IPF and other fibrotic ILDs.  Historically, among the first to be developed and used widely is the bleomycin model, which is the best-characterized and currently most extensively used animal model due to its ability to reproduce many aspects of IPF and other fibrotic ILDs, good reproducibility, and ease of induction.  Studies using the bleomycin model have identified many of the cellular and mol. mechanisms now recognized as being important in pathogenesis of IPF and other fibrotic ILDs, as well as novel therapies for these diseases, including two recent drugs approved for treatment of IPF.  This chapter will describe commonly used techniques for induction of the model by endotracheal administration of bleomycin through surgical and nonsurgical (transoral instillation).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7zhefOwniDrVg90H21EOLACvtfcHk0lhNPDk5-kpmaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Wrtr%252FP&md5=4e0b11fdfe460302931a473610da7b0b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-7113-8_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-7113-8_2%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DT.%26aulast%3DDe%2BLos%2BSantos%26aufirst%3DF.%2BG.%26aulast%3DPhan%26aufirst%3DS.%2BH.%26atitle%3DThe%2520bleomycin%2520model%2520of%2520pulmonary%2520fibrosis%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2017%26volume%3D1627%26spage%3D27%26epage%3D42%26doi%3D10.1007%2F978-1-4939-7113-8_2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W35" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W35','PDB','6W35'); return false;">PDB: 6W35</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i57"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00688">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_12046"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00688?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00688</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthesis of intermediates, NMR spectra and LCMS profile, animal model supplemental data, and cocrystallization protocol (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00688/suppl_file/jm0c00688_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and associated biological assay data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00688/suppl_file/jm0c00688_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00688/suppl_file/jm0c00688_si_001.pdf">jm0c00688_si_001.pdf (857.23 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00688/suppl_file/jm0c00688_si_002.csv">jm0c00688_si_002.csv (2.01 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB ID for the cocrystal structure of compound <b>1</b> with human autotaxin is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6W35">6W35</a>. The authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00688&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-14%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00688" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00688" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799915bfde51991","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
